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The optic nerve of the amphibian Xenopus laevis shortens in length by approximately one-half 
during its metamorphosis from tadpole to frog. This dramatic shortening event takes place over 
the course of only a few days at metamorphic climax, when levels of thyroid hormone, the master 
transcriptional regulator of amphibian metamorphosis, peaks. The shortening of the optic nerve is 
associated with the remodeling of the retinal ganglion cell axons which make up the nerve. My 
thesis work focused on how the myelinated axons remodel during optic nerve shortening using 
primarily electron microscopy based quantitative analyses and reconstructions. Through cell type 
specific transgenic overexpression of a dominant negative thyroid hormone receptor α construct, 
the remodeling process was found to involve the distinct but coordinated activities of retinal 
ganglion cells, oligodendrocytes and astrocytes. Myelin remodeling, in contrast to demyelination, 
does not involve an immune response.  Myelin segments decrease in length proportionally with 
the optic nerve itself and this shortening involves the production of focal myelin-axon 
detachments and myelin protrusions from otherwise intact myelin segments. Astrocyte processes 
selectively remove these local myelin dystrophies from the remodeling segments. This process 
uses known phagocytic machinery, including the opsonin Mfge8 and the downstream effector 
involved in cytoskeletal rearrangement, Rac1, as determined by transgenic overexpression of 
dominant negative constructs in astrocytes. By the end of shortening, one quarter of all myelin in 
the optic nerve is associated with astrocytes. However, the astrocytes are able to efficiently clear 
the myelin they internalize within approximately one month after the completion of 
metamorphosis. These results provide evidence for a new role for astrocytes in the developmental 
remodeling of myelin segments. 
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Chapter 1: Introduction 
 
Metamorphosis is the developmental period during which an animal transitions from a 
larval to an adult body plan. Many animals undergo a metamorphic transition during 
development, although these transitions are more commonly found in invertebrates. Within 
vertebrates, metamorphosis occurs in amphibians and teleost fish, a classification which includes 
approximately half of the living species of vertebrates on Earth (Paris and Laudet, 2008). This 
transition typically has both ecological and morphological components, such as the change from 
aquatic filter feeding herbivorous larval tadpoles to terrestrial carnivorous adult frogs. These 
changes in the ecological niche of the animal can only occur following the appropriate 
physiological transformations of the respiratory and digestive systems (Burggren and West, 1982; 
Ishizuya-Oka et al., 1996). The degree of morphological change varies widely by species, anuran 
frogs, such as Xenopus laevis, undergo some of the most radical physical transformations of any 
metamorphic species. Furthermore, unlike the metamorphic transitions of invertebrates, such as 
insects, which also undergo extensive physical changes, the larval tadpoles do not experience a 
period of dormancy, but rather remain active throughout the transition (Gilbert et al., 1996).  
 
Role of thyroid hormone in metamorphosis 
In vertebrates, the period of metamorphosis is defined and controlled by thyroid 
hormones (Etkin, 1963). Thyroid hormones are produced in the thyroid gland and involves the 
iodination of the amino acid tyrosine (Boron, 2003). The major form of thyroid hormone secreted 
from the thyroid gland into the bloodstream is thyroxin, which is the compound formed by the 
coupling of two di-iodotyrosine molecules, 3, 5, 3’, 5’-tetraiodothyronine (T4). Although 
metamorphosis is characterized by a surge in circulating levels of thyroid hormone, thyroxin is 
not the potent activator of metamorphic changes. Instead, metamorphosis is primarily driven by 3, 
5, 3’- triiodothyroacetic acid (T3), which is produced by the removal of the 5’ iodotyrosine 
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molecule from T4 by the type II deiodinase (D2) (Huang et al., 2001). The dependence of 
metamorphosis in X. laevis on thyroid hormone has been demonstrated through the precocious 
induction of metamorphic changes in pre-metamorphic tadpoles following exposure to exogenous 
T3 (Tata, 1968).  
The biological activity of T3 comes primarily through its effect on gene expression as a 
nuclear transcription factor through association with thyroid hormone receptors (Lazar, 1993). 
There are two major types of thyroid hormone receptors, classified as alpha and beta. The alpha 
receptor is generally constitutively expressed in X. laevis and is present early in development, 
before thyroid hormone, likely derived from maternal mRNA, although, unlike in mammals, it 
does not appear to play a critical role in early embryogenesis (Kawahara et al., 1991). The 
expression of the receptor does increase throughout development and may allow the tadpoles to 
initiate different response programs as the levels of thyroid hormone increase throughout the pre-
metamorphic period, such that the animals undergo a stereotyped developmental program that is 
synchronized with thyroid hormone levels. The beta receptor, on the other hand, is found at much 
lower levels than the alpha receptor, is primarily localized to head region, and is regulated by the 
alpha receptor such that it is potently induced by thyroid hormone (Machuca et al., 1995). Both 
types of receptors, however, are induced by thyroid hormone such that increased levels of thyroid 
hormone elevate the production of the receptors which mediate the activity of the hormone. 
Elevations in the titer of thyroid hormone in X. laevis lead to a two fold increase in levels of 
thyroid hormone receptor alpha and a twenty fold increase in levels of the beta receptor during 
metamorphosis (Yaoita et al., 1990).   
 
Thyroid hormone mechanism of action 
The receptor is a nuclear hormone transcription factor which binds to DNA at thyroid or 
T3 response elements (TREs) in the promoter regions of genes. The receptors can bind to the 
TREs in their monomeric form, but it is a very low affinity interaction (Kliewer et al., 1992; Leid 
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et al., 1992). The thyroid hormone receptors are typically found as heterodimers complexed with 
retinoid X receptors which increases the stability of the interaction with the DNA, and in the 
absence of thyroid hormone these complexes act to repress gene transcription since in the 
unbound state the complex associates with co-repressors (Fondell et al., 1993; Hörlein et al., 
1995). In genes that are negatively regulated by thyroid hormone the binding of un-liganded 
thyroid hormone receptor homodimers to the TRE facilitates transcription, whereas the presence 
of the hormone leads to repression, and may involve the recruitment of histone modifying 
complexes (Fondell et al., 1993; Piedrafita et al., 1995). Following the direct import of T3 or 
conversion from T4 to T3 in the cytoplasm, T3 diffuses or is transported into the nucleus where it 
binds to receptor complexes bound the TREs in order to influence gene expression (Halpern and 
Hinkle, 1982). The binding of T3 leads to a conformational change in the thyroid hormone 
receptor which results in the release of the co-repressor molecules (Bendik and Pfahl, 1995).  One 
of the genes regulated by thyroid hormone is the type III deiodinase (D3) which removes the 5 
iodotyrosine molecule from T3 to create the inactive metabolite 3, 3’-diiodothyronine (T2), 
thereby completing the regulatory feedback loop (Wang and Brown, 1993).  
Thyroid hormone can also mediate cellular activity through non-genomic actions. These 
actions are thought to be mediated through various signaling cascades at the plasma membrane or 
in the cytoplasm, including free calcium, cyclic-AMP, and protein kinase signaling (Davis et al., 
2008). These cascades are generally important for influencing cell proliferation and motility. 
Activation of cell surface integrin receptors, particularly αVβ3, can initiate protein kinase 
signaling cascades which can regulate the activity of various plasma membrane transporters, such 
as the Na/H exchanger and Na, K ATPase (Cheng et al., 2010).  As a result of this role in 
modulating ion currents, these non-genomic actions appear to be most relevant in areas dependent 
on ionic conductions, such as the heart and nervous system (Davis and Davis, 2002; Leonard, 
2008). Furthermore, thyroid hormone mediated integrin activity can enhance the genomic actions 
of thyroid hormone by promoting the translocation of thyroid hormone receptors into the nucleus 
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(Cao et al., 2009).  Although these non-genomic actions have important physiological effects on 
an organism, they are unlikely to be able to induce the sweeping changes seen during amphibian 
metamorphosis. Indeed, work utilizing transgenic overexpression of dominant negative receptors 
revealed that interference with the genomic action of thyroid hormone, through its receptor can 
prevent both spontaneous and T3 induced metamorphosis in X. laevis (Buchholz et al., 2004). 
Therefore, amphibian metamorphosis is primarily driven by changes in gene expression mediated 
by the transcriptional regulation of TRE containing genes via the thyroid hormone bound receptor 
complex.  
 
Nervous system remodeling during X. laevis metamorphosis 
During metamorphosis, morphological changes affect every major organ system in X. 
laevis, including the nervous system, which must rewire in order for the animal to properly 
control its altered body (Gilbert, 2000). The animal must innervate its newly formed structures, 
such as the limbs, while de-innervating larval features. Since the metamorphic tadpoles remain 
active throughout this period, it is critical that the nervous system rewires appropriately, as a loss 
of mobility would make them vulnerable to predation.  Additionally, the metamorphic animal 
needs to modify existing connections.  
One of the most dramatic remodeling events in X. laevis involves the change in the shape 
of the head from wide and round in the larval tadpole to narrow and triangular in the post-
metamorphic frog. This morphological change in head shape is associated with the modification 
of several cranial nerves, most notably the olfactory and optic nerves (cranial nerves I and II) 
which emerge from the forebrain, rather than the brainstem (Wiechmann and Wirsig-Wiechmann, 
2003). Since these nerves are attached to organs located along the peripheral boundary of the 
head, with the olfactory nerve connecting the olfactory organ, which consists of the principle 
cavity epithelium and the rostral vomeronasal organ, to the olfactory bulb and the optic nerve 
connecting the laterally oriented eyes to the optic tectum in the brain, changes in the size and 
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shape of the head have profound effects on the length of these nerves (Burd, 1991; Cullen and 
Webster, 1979). Throughout the early part of development, as the head, along with the rest of the 
animal grows in size, these nerves grow longer to accommodate the increasing distance between 
the outer boundary of the head and the brain. The growth occurs slowly over the period of several 
weeks until the head reaches maximal size at the developmental stage described by Nieuwkoop 
and Faber (Nieuwkoop and Faber, 1956) (NF) Stage 60.  In contrast, the metamorphic remodeling 
of the head occurs extremely rapidly over the course of several days between NF Stages 60 and 
66. As a result, both the olfactory and optic nerves shorten dramatically over this period (Burd, 
1991; Cullen and Webster, 1979). Although the decrease in length experienced by the olfactory 
nerve is the most severe, it is designed to cope with turnover and the generation of cellular debris 
(Higgs and Burd, 2001).  The olfactory system undergoes continuous turnover of olfactory 
receptor neurons and in mammals it has been shown that the glial cells of the olfactory nerve, 
olfactory ensheathing cells, can engulf apoptotic neurons (Su et al., 2013), and thus it is likely 
that they serve a similar function with debris generated by shortening axons during 
metamorphosis.  
The optic nerve also dramatically shortens to over one-half its length during metamorphic 
climax (Cullen and Webster, 1979), however, it does not undergo continuous turnover and 
approximately ten percent of its axons are ensheathed in myelin (Gaze and Peters, 1961). The 
optic nerve is comprised of the axons of retinal ganglion cells (RGCs) whose cell bodies are 
located in the retina of the eye. The axons exit the eye at the optic disk and course along the 
length of the optic nerve until they ultimately terminate in the brain, primarily in the thalamus and 
optic tectum (Hoskins and Grobstein, 1985; Wiechmann and Wirsig-Wiechmann, 2003). The 
optic nerve also contains two major classes of glial cells, astrocytes and oligodendrocytes (Cima 
and Grant, 1982b).  In Xenopus, the RGC axons are unmyelinated in the eye and a small subset 




Myelin structure and composition in X. laevis 
Myelin exists in the form of regularly spaced segments, which enable fast and efficient 
transfer of information over long distances though the salutatory propagation of action potentials 
from one Node of Ranvier to the next (Huxley and Stampfli, 1949). The myelin segments 
themselves are lipid (70% by weight), particularly cholesterol (approximately 27%), rich cellular 
processes, produced by Schwann cells, in the peripheral nervous system, or oligodendrocytes, in 
the central nervous system, with highly specialized architecture that enables them to form the 
compact membranous wraps around axons that are key to their insulating function (Quarles et al., 
2006). Although all myelin membranes are lipid rich, the exact composition of the membranes 
can vary by species and developmental stage (Cuzner et al., 1965; Horrocks, 1968). For example, 
in mammals, juveniles have a lower percentage of proteins in their myelin as well as a higher 
ratio of phospholipids to galactolipids than their adult counterparts (Morell et al., 1972; 
Svennerholm and Vanier, 1978). The myelin associated proteins and galactolipids are important 
for the stabilization of axo-glial interactions required for the proper formation of the Nodes of 
Ranvier and the maintenance of mature myelin (Dupree et al., 1998; Marcus et al., 2002). One 
notable aspect of species specificity is that X. laevis has much a higher percentage of 
monogalactyl diglyceride in their myelin, which is important for myelination and oligodendrocyte 
process formation, than mammals (Trapp et al., 1980). It may be some of these characteristic 
differences in Xenopus myelin which facilitate the vast transformations of its nervous system 
during metamorphosis. Although most of the differences in myelin composition between species 
do not follow a clear evolutionary trajectory (Kirschner et al., 1989), they may be relevant to 
differences in the plasticity of the nervous system between juvenile and aged animals and across 
taxa.  
 
Mechanisms involved in axon myelination 
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  Myelinating oligodendrocytes are produced by the differentiation of oligodendrocyte 
precursor cells (OPCs), which can be identified by the expression of the chondroitin sulfate NG2 
and the platelet derived epidermal growth factor α receptor (PDGFRα) (Dawson et al., 2003; Hall 
et al., 1996). The presence of OPCs in the central region of the optic nerve of X. laevis can first be 
detected around NF Stage 48 (Cima and Grant, 1982b). Mature oligodendrocytes and the first 
myelin segments are found on axons in the center of the nerve at Stage 48/49. Myelination then 
proceeds in both directions along the axons over the course of development.  In mammals, the 
differentiation of OPCs occurs in response to various signaling molecules, including thyroid 
hormone through the alpha receptors, and decreases in Wnt/β-catenin signaling cascades (Emery, 
2010). OPCs also receive synaptic input from axons, and the differentiation of OPCs may be 
modulated by the postsynaptic response of axonal neurotransmitter release, such as the activation 
of glutamatergic NMDA receptors (Li et al., 2013). Mature oligodendrocytes lose these synaptic 
connections and express myelin associated genes such as myelin basic protein (Mbp) and 
proteolipid protein (Plp) (Baumann and Pham-Dinh, 2001; Kukley et al., 2010). The expression 
of these genes in mammals is also induced by thyroid hormone (Barradas et al., 2001; Farsetti et 
al., 1991).  
The decision by an oligodendrocyte to produce a myelin segment along a particular axon 
involves the integration of a variety of signals derived from axons, largely in the form of adhesive 
signaling molecules such as neural cell adhesion molecule, neuregulin, contactin, and laminin, or 
activity derived signals like glutamate (Lundgaard et al., 2013; Piaton et al., 2010). The signaling 
responses are mediated through ErbB, integrin, and NMDA receptors on oligodendrocytes. 
Astrocytes can also promote myelination in response to ATP derived from electrical activity in 
axons. P2 purinergic receptor activation on astrocytes leads to the release of the pro-myelination 
cytokine leukemia inhibitory factor (Ishibashi et al., 2006). Juvenile myelin, including that found 
in X. laevis tadpoles is also enriched in the enzyme 2’,3’-cyclic nucleotide 3’-phosphodiesterase 
(Trapp et al., 1980), which is important for oligodendrocyte process initiation, and thus is found 
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at highest levels during periods of active myelination (Lee et al., 2005). These diverse signals are 
integrated by the oligodendrocyte largely through the signaling cascades of the non-receptor 
tyrosine kinase, Fyn, and translated into changes in the cytoskeleton of oligodendrocyte processes 
as well as the synthesis and trafficking of myelin proteins (Kramer-Albers and White, 2011).  
Additionally, myelination is largely dependent on axon size, as the axons must exceed a particular 
diameter for the oligodendrocyte derived myelin membranes to initiate wrapping of the axon 
(Matthews, 1968).  
The myelin membranes form concentric wraps around the axon. This occurs by the 
consecutive wrapping of the inner tongue of the oligodendrocyte myelin sheath layer. The inner 
tongue serves as the myelin growth zone where vesicles containing the newly synthesized 
components for the myelin membrane are trafficked via cytoplasmic channels (Snaidero et al., 
2014). The extent of the network of these myelinic cytoplasmic channels is correlated with the 
myelination potential of the oligodendrocytes, such that these channels are most prevalent during 
periods of peak myelination and are primarily closed following the maturation of the organism. 
Adhesion between the wraps of myelin is largely mediated by myelin proteins, such as Mbp and 
Plp (Boison et al., 1995; Min et al., 2009). The compaction of the myelin is also dependent on 
lipid composition of the membrane, and is reflected in developmental changes in myelin as the 
nervous system matures (Coetzee et al., 1999; Saher et al., 2011).  Additionally, the compaction 
is further orchestrated by electrostatic interactions between the lipid bilayers that are facilitated 
by the down regulation of the glycocalyx, whose abundance of negatively charged 
polysaccharides usually fosters membrane repulsion (Bakhti et al., 2013). 
Interactions between axon and myelin membranes 
  Adhesive complexes also exist between the axonal plasma membrane and the innermost 
myelin membrane. Since a myelin sheath along an axon is composed of individual segments 
separated by unmyelinated regions (the Nodes of Ranvier), each segment must be tethered to a 
particular location of the axon. The myelin segment can be divided into three major regions, the 
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paranodes, which are the boundary regions of the segment, the juxtaparanodes, which are 
immediately adjacent to the paranodes, and the internodal region which makes up the majority of 
the segment (Zoupi et al., 2011). Although some adhesion between the axon and myelin 
membranes occurs in the internodal region, such as through myelin-associated glycoprotein 
(MAG) (Trapp et al., 1989), most of the adhesive complexes are localized to the juxtaparanodal 
and paranodal regions. The paranodal adhesive interactions are the strongest and are mediated by 
the interaction between contactin and contactin-associated-protein on axons and the Neurofascin 
155kDa isoform on oligodendrocyte derived membranes (Nave, 2010). Since these adhesive 
complexes are important for stabilizing the myelin segments to the axon, the clustering of these 
components is also developmentally regulated by changes in myelin composition, particularly 
galactolipids (Dupree et al., 1998). In this way, adhesion between myelin and axons is weaker 
during early development, and likely provides for enhanced plasticity in the growing animal.  
 
Mechanisms of myelin segment growth and plasticity 
The ability to maintain efficient conduction over long distances in the nervous system 
requires the proper amount of myelin on an axon. Optimal conduction is achieved through the 
correct ratio of myelin to axon size, and this ratio can vary across species and regions of the 
nervous system based on the environment and function of the signal carried by a particular set of 
axons (Baumann and Pham-Dinh, 2001). In terms of myelin, the two major parameters that 
influence the speed of conduction are the length and thickness of the myelin segment.  In general, 
larger caliber axons require thicker myelin sheaths and are associated with longer internodal 
distances, which enable the fastest conduction (Waxman, 1980). The proper width and length of 
myelin segments is likely established at least in part during the myelination process. 
Observational electron microscopy studies have reported that the initial establishment of myelin 
segments in the peripheral nervous system is itself a dynamic process, involving the elongation, 
shortening, and/or removal of individual segments. In vivo imaging in zebrafish has confirmed 
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that the initiation of myelination in the central nervous system is similarly dynamic (Liu et al., 
2013).   
Once established, the myelin segments must remain sufficiently plastic to accommodate 
developmental axonal growth. Developmental increases in axon diameter are coupled to the 
addition of membrane wraps to myelin segments ensheathing axons, thereby maintaining the near 
linear relationship between axon caliber and myelin thickness necessary for optimal conduction 
(Berthold et al., 1983; Friede and Miyagishi, 1972). In the peripheral nervous system, the length 
of segments has also been shown to be regulated, as Schwann cell derived myelin segments 
elongate in proportion to developmental increases in nerve length, increasing internodal distances 
by as much as a factor of four (Sherman and Brophy, 2005). The Schwann cell segments elongate 
in a cell autonomous manner due to passive stretching which requires the microtubule based 
transport of myelin protein components toward the growing ends of the segment, similar to the 
transport of myelin components along cytoplasmic channels during initial myelination (Court et 
al., 2004). Since each Schwann cell typically produces a single myelin segment, it can readily 
respond to growth related axon cues. In contrast, it is more complicated to tailor myelin to axon 
size in the central nervous system, since an individual oligodendrocyte can produce up to 40 
myelin segments on axons of different calibers (Almeida et al., 2011). Although oligodendrocyte 
segments must also accommodate growth, the mechanisms governing these processes are less 
well understood.  
Furthermore, myelin segments in the central nervous system have been shown to be 
modifiable in a learning or activity dependent manner, which may underlie some of the 
restructuring of connections in the brain upon the acquisition of a new skill (Fields, 2008; 
McKenzie et al., 2014). Imaging studies have revealed changes in white matter regions associated 
with learning a particular motor skill, which is likely due to learning related new myelination or 
increases in the thickness of existing myelin segments (Sampaio-Baptista et al., 2013). These 
changes in myelination likely alter conduction speeds and thereby affect the signaling dynamics 
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of selective neural circuits. De novo myelination in the mature nervous system of rodents appears 
to involve the differentiation of OPCs into new myelinating oligodendrocytes, rather than an 
increase in process initiation by existing cells (Young et al., 2013). However, it was recently 
shown that new myelination in the adult nervous system of humans involves an increase in 
myelin production by pre-existing oligodendrocytes (Yeung et al., 2014), suggesting that there 
may be a variety of mechanisms involved in myelin plasticity, and their relevance may be species 
and context dependent. Meanwhile, increases in myelin thickness are mediated largely by 
extracellular-related-kinase mediated signaling in oligodendrocytes (Ishii et al., 2012). 
Interestingly, another form of learning related plasticity may involve the selective removal of 
myelin segments. High resolution electron microscopy has allowed for the 3-dimensional 
reconstruction of axons from various regions in the mouse cerebral cortex and found widespread 
evidence for intermittent myelination of axons, in which axons had long unmyelinated stretches 
which contained both afferent and efferent synapses (Tomassy et al., 2014). Since the presence of 
myelin prevents the formation of these synapses, the selective addition or removal of segments 
could influence the location of these synapses, and thus affect intracellular signaling or 
conduction along the axon.  
 
Importance of proper myelination 
Disruption of any of the processes involved in regulating myelin composition, initiation, 
plasticity or maintenance will interfere with signal processing in the nervous system. Sustained 
hypo-myelination or hyper-myelination of axons can lead to the onset of neuropathy and other 
pathologies.  The interplay between pro-myelin phosphatidylinositol 3,4,5-triphosphate (PIP3) 
and myelin inhibiting phosphatase and tensin homolog (Pten) regulates the level of myelin 
production (Goebbels et al., 2010). Although PIP3 can be used to reopen the cytoplasmic 
channels necessary for active myelination by oligodendrocytes (Snaidero et al., 2014), if it is not 
properly balanced with the correct level of Pten signaling, then axons will become hyper-
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myelinated (Goebbels et al., 2010). Interestingly, small hyper-myelinations are present on newly 
myelinated axons during development, which may be due to a bias in pro-myelin signaling during 
this period (Snaidero et al., 2014). These hyper-myelinations, however, are resolved as the animal 
matures. Chronic hyper-myelination of axons, on the other hand, is often associated with the 
formation of myelin whorls, redundant loops, and tomaculas (Adlkofer et al., 1995; Sander et al., 
2000). These myelin dystrophies can interfere with conduction by affecting the structural 
integrity of the myelin insulation. Hypo-myelination or dysmyelination can occur due to improper 
myelination during development (Di Rocco et al., 2004), or as a result of injury or disease related 
demyelination. 
Demyelination, or the loss of myelin on axons, can occur due to problems in myelin 
structure, such as a genetic lack of adequate adhesive complexes or environmental toxins which 
disrupt membrane composition, or through autoimmune disorders in which healthy myelin is 
attacked and removed (Popescu and Lucchinetti, 2012). Demyelination is more common in the 
adult animal (Bartzokis et al., 2010; Newbould et al., 2014). During early development myelin 
membranes are likely more plastic since they are loosely associated with axons and one another 
in order to accommodate growth and can be more easily replaced by the large pool of newly 
differentiating oligodendrocytes. As the system matures, however, any disruptions to the integrity 
of the myelin or the axo-glial interactions can lead to the loss of the myelin segment (Carenini et 
al., 1996; Filbin et al., 1999; Marcus et al., 2002). The loss of myelin is not only detrimental to 
the axon which has lost its insulation and trophic support, but also to the health of the entire 
surrounding area as well.  
 
Clearance of myelin from the nervous system 
 The presence of myelin debris prevents the onset of repair, such that in the context of 
injury or disease, the damage can continue in an unmitigated manner until the debris is cleared 
(Neumann et al., 2009). Inhibitory molecules in the myelin debris such as Nogo and 
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oligodendrocyte myelin glycoprotein prevent regenerative axon outgrowth and block the 
differentiation of OPCs into mature oligodendrocytes, thus inhibiting re-myelination (Filbin, 
2003). As an extremely lipid rich structure, myelin is difficult for cells to breakdown and will 
persist at the site of damage unless contacted by a phagocytic cell capable of myelin 
internalization. The myelin debris is usually cleared by immune system derived professional 
phagocytic cells, namely macrophages and microglia (Griffin et al., 1992). Microglia are 
recruited to the site of myelin damage in response to the chemokine CXCL10, which is released 
by local astrocytes in response to myelin damage, through the chemokine receptor CXCR3 
(Rappert et al., 2004; Skripuletz et al., 2013). These phagocytes not only remove the inhibitory 
myelin debris, but also release a variety of immuno-inflammatory cytokines. Although some of 
these cytokines may stimulate repair mechanisms by promoting OPC differentiation or neuronal 
growth and survival, other molecules can have cytotoxic effects and disrupt synaptic function 
(Stoll et al., 2000). Phagocytosis of myelin by microglia is primarily mediated through the 
complement-receptor-3, which also appears to have a role in regulating the level of myelin a cell 
will internalize (Rotshenker, 2003). Although it facilitates the internalization of myelin, activation 
of the receptor also down-regulates further intake of myelin through the activation of the tyrosine 
kinase, Syk, which ultimately controls the ability of the actin cytoskeleton to mediate process 
formation necessary for the phagocytic activities of the cell (Gitik et al., 2011; Hadas et al., 
2012). Therefore, these phagocytes have a limit to the amount of myelin debris they will 
internalize, likely to avoid metabolically overloading the cell. Thus, the clearance of a large area 
of myelin debris would require a massive infiltration of monocytes.  
 
Role of phagocytosis in nervous system development 
Although myelin is always a difficult substance for cells to metabolize, the clearance rate, 
and thus regeneration rate in the context of injury, is greatly enhanced in juveniles (Kang and 
Lichtman, 2013) and in a subset of vertebrates, including X. laevis (Tanaka and Ferretti, 2009) 
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Large scale clearance of cellular debris is a major part of nervous system development in general. 
Apoptotic, or programmed cell death is an integral part of the developing nervous system, and 
occurs largely through early overproduction of neurons and glial cells in the context of limited 
trophic support (Oppenheim, 1991). Neurons that fail to innervate their target, and other cells 
initiating the programmed cell death pathway will begin to activate caspase-3 through cleavage, 
and be targeted for removal (Simon et al., 2012; Srinivasan et al., 1998). Phagocytes such as 
microglia, recognize these apoptotic cells through ‘eat me’ signals on the surface of the cell. The 
best characterized of these signals is the exposure of phosphatidylserine by the flipping of the 
phospholipid from the inner to the outer leaflet of the plasma membrane (Fadok et al., 1998). The 
exposed phosphatidylserine can be recognized directly or indirectly through the association with 
an opsonin by a variety of phagocytic receptors including the receptor tyrosine kinase MER 
(Mertk), phosphatidylserine receptor, and integrin receptors (namely αVβ3 and αVβ5) 
(Ravichandran, 2010). Apoptotic clearance can also be mediated through a set of cell death 
related genes originally described in Caenorhabditis elegans as the cell death abnormal (ced) 
genes, with cell corpse recognition occurring through the ced-1 receptor (Zhou et al., 2001). Axon 
and synaptic pruning, or the modification of existing connections are also important features of 
nervous system development which rely on the phagocytosis of cellular components (Bishop et 
al., 2004; Corty and Freeman, 2013; Stevens et al., 2007). It is the rapid and regulated clearance 
of cellular and axonal debris from the developing nervous system that facilitates the system to 
wire properly and not experience any lasting pathology.  
A key aspect of phagocytosis mediated developmental nervous system remodeling is that 
unlike in mature animals, it does not rely primarily on the infiltration of professional phagocytes, 
such as macrophages and microglia. Instead, phagocytosis is mediated by local macroglial 
populations, most notably astrocytes (Mallat et al., 2005). Astrocytes, like oligodendrocytes, have 
generally been regarded as supportive cells in the central nervous system. However, these 
supportive roles are vital to the health and activity of neurons, and thus underlie key aspects of 
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the establishment, maintenance and modification of neuronal circuitry and communication. Just 
as conduction velocities and axon viability are compromised by the loss of insulation, signaling 
and trophic support provided by myelinating oligodendrocytes, the loss of astrocytic activities 
would severely diminish the capacity of the nervous system to function. Indeed, astrocytes are 
also important for maintaining the integrity of myelinated axons, as evidenced by the 
demyelinating pathology associated with Alexander’s disease, which is caused by a genetic 
mutation in glial fibrillary acidic protein (GFAP), which encodes for an integral cytoskeletal 
structural element in astrocytes (Brenner et al., 2001).  
Among the many vital functions carried out by astrocytes are: the regulation of ionic 
concentrations, communication with the vasculature, clearance of metabolites, metabolic support 
to neurons, removal of glutamate and maintenance of glutamatergic transmission by neurons, as 
well as the formation and stability of synapses (Clarke and Barres, 2013; Kimelberg and 
Nedergaard, 2010). In these, and many other ways, the astrocytes locally modulate the 
environment of the nervous system, which ultimately affects the functioning of the surrounding 
neural circuitry. By controlling the formation sites of synapses, the availability of the glucose rich 
blood supply and thus energy, and the availability of glutamate as well as its persistence at 
synaptic and extrasynaptic sites, the astrocytes shape and modify the activity level of neurons and 
the strength of their connections. Consequently, it has been found that astrocytes are involved in 
the orchestration of gamma oscillations, which are patterned waves of activity that have been 
implicated in some forms of memory, which are disrupted in various neurological disorders, such 
as Alzheimer’s disease (Lee et al., 2014). Furthermore, astrocyte dysfunction is a common feature 
of a wide variety of neurodegenerative diseases, and the progressive loss or disruption of 
astrocyte activities may contribute to aging related cognitive decline (García‐Matas et al., 2008; 
Lima et al., 2014; Simpson et al., 2011). 
 
Properties of Astrocytes 
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 Astrocytes can also modify their properties in response to nervous system damage, and 
become reactive. These astrocytes are typically identified by their hypertrophic morphology and 
up-regulation of GFAP (Ridet et al., 1997). Similar to a microglial infiltration, the presence of 
these reactive astrocytes can be a double edged sword. Their release of neuro-inflammatory 
molecules and formation of a glial scar can inhibit regeneration, however, they also play vital 
roles in ensuring the survival of the surrounding tissue (Sofroniew, 2005). The removal of 
potentially excitotoxic neurotransmitter, excess ions and cellular debris help to restore balance to 
the extracellular environment, which in turn leads to the restoration of neural function. While 
chronic reactive gliosis is deleterious, the activity of reactive astrocytes in response to acute 
injury facilitates repair and improves recovery outcomes. Consequently, the incomplete removal 
of neurotoxic debris by reactive astrocytes is believed to contribute to the progression of various 
neurodegenerative disorders (Sokolowski and Mandell, 2011).  
Although all astrocytes contribute to the health and maintenance of the nervous system, 
they are a diverse cell population, such that astrocytes in different regions exhibit different 
characteristics and sub-specialties (Oberheim et al., 2012). Differences in astrocytes also account 
for variation in cognition, plasticity and other key aspects of the nervous system throughout one’s 
ontogeny as well as through phylogeny. For instance, the astrocytes of primates have been found 
to be more diverse, larger and complex (Oberheim et al., 2009) than other mammals, and the 
incorporation of human derived astrocytes in rodent brains leads to an enhancement of memory 
and overall cognitive function based on behavioral testing (Windrem et al., 2014).  
 
Astrocytes and regeneration 
Some classes of animals, most notably amphibians and fish have an extensive capacity 
for regeneration in the central nervous system following injury, such as optic nerve transection. 
Recent evidence suggests that differences in gene expression, signal secretion, intercellular 
interactions, and thus the way the astrocytes regulate the microenvironment following injury in 
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these animals account for a large part of their regenerative advantage (Garcia and Koke, 2009). 
Another key aspect may be the ability of the optic nerve astrocytes in these species to contribute 
to the rapid clearance of cellular debris, including myelin. Indeed, large amounts of axon and 
myelin debris have been visualized within optic nerve astrocytes in goldfish following nerve 
transection (Colavincenzo and Levine, 2000). Therefore, it is likely that these species with higher 
levels of plasticity maintain more developmentally immature astrocytes and/or can reactivate the 
genetic programs necessary for phagocytosis and neural remodeling. In support of this idea, 
astrocytes in the optic nerve of fish and amphibians do not express the mature astrocyte marker 
GFAP, but instead their cytoskeleton is comprised of cytokeratin 8 (Koke et al., 2010; Rungger-
Brändle et al., 1989). Additionally, astrocytes in these animals express brain lipid binding protein 
(Blbp, which is encoded by the fabp7 gene) which is usually associated with newly differentiated 
immature astrocytes (Ge et al., 2012). Blbp has also been found to be up-regulated in a subset of 
astrocytes after demyelinating injuries in mammals and is associated with higher rates of re-
myelination and recovery (Kipp et al., 2011b; White et al., 2010). The Blbp expressing astrocytes 
appear to promote the differentiation of OPCs and other repair mechanisms similar to what is 
seen in fish and amphibians.  
 
Phagocytic astrocytes in development 
 During development, young astrocytes tend to be in a more reactive-like state, without 
being immunogenic, and thus have a greater capacity to shape the developing nervous system 
through their phagocytic activity. The phagocytic activity of these young astrocytes has been 
shown to be important for shaping developing neural circuitry, through the elimination of 
selective synapses (Chung et al., 2013). Furthermore, this activity has been shown to involve the 
same molecular machinery generally associated with phagocytosis by microglia, namely the 
receptors Mertk, and the ced-1 homolog, Megf10. Indeed, transcriptional profiling of forebrain 
astrocytes has revealed the expression of the entire ced pathway and various other known 
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phagocytosis related genes in these cells (Cahoy et al., 2008). The high expression of phagocytic 
machinery by astrocytes then may underlie the ability of the developing nervous system to so 
efficiently clear debris and the plasticity to modify neural circuitry.  
Metamorphosis is an accelerated period of development which involves large amounts of 
cell death and requires enhanced plasticity to remodel tissue. This is particularly relevant for the 
nervous system which loses and modifies existing neural circuits in order to accommodate new 
ones. Although metamorphosis is clearly a developmental event, it occurs during the larval period 
well after embryogenesis and neural patterning, when the nervous system has already begun to 
mature. The metamorphic modification of neural circuitry in the fruit fly, Drosophila, has been 
shown to involve glial cell mediated neuronal pruning. Ensheathing glial cells as well as 
astrocytes activate the phagocytic receptor, the Drosophila ced-1 homolog Draper, in response to 
the steroid hormone which mediates metamorphosis in insects, ecdysone (Awasaki et al., 2006; 
Tasdemir-Yilmaz and Freeman, 2014). Interestingly, the particular phagocytic receptor signaling 
pathway activated by the glial cells was dependent on whether an entire cell corpse or selected 
neurites on otherwise intact neurons were to be internalized (Tasdemir-Yilmaz and Freeman, 
2014).  Ecdysone was also critical for the recruitment and mobilization of these phagocytic glial 
cells to the sites of remodeling (Awasaki et al., 2006). Therefore, it appears that metamorphosis 
related signaling, at least in insects, can induce glia into a phagocytically active state reminiscent 
of those involved in the clearance of apoptotic cellular debris and axon pruning during early 
neural development.  
 
Potential role of astrocytes in X. laevis metamorphosis 
As part of the highly regulated process of amphibian metamorphosis, the metamorphic 
shortening and remodeling of the optic nerve in X. laevis may be similar to ecdysone mediated 
neurite pruning in Drosophila, in the involvement of highly phagocytic local astrocytes. Blbp is 
involved in lipid metabolism and homeostasis and its expression in astrocytes also appears to 
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support neural remodeling. Interestingly, expression of Blbp is regulated by another set of nuclear 
hormone receptors Rev-erbα and retinoic acid receptor (Schnell et al., 2014), whereas the 
expression of some other members of the fatty acid binding protein family is directly regulated by 
thyroid hormone (Nakagawa et al., 1994; Shi and Hayes, 1994). Furthermore, similar to thyroid 
hormone, expression of Blbp in astrocytes has been linked to the promotion of cellular migration 
(Kipp et al., 2011a), which is conducive to phagocytosis.  
  Previous electron microscopy based descriptions of optic nerve shortening in X. laevis  
have noted the presence of myelin derived debris inside cells (Cima and Grant, 1982b), which 
were presumed to be astrocytes based on the low numbers of microglia found in the nerve at this 
time (Goodbrand and Gaze, 1991). As more developmentally immature cells, these Blbp 
expressing astrocytes may have a greater capacity to efficiently internalize myelin. That 
astrocytes may contribute to the clearance of myelin is suggested by the finding that a subset of 
astrocytes in the mouse optic nerve head express genes typically associated with the phagocytosis 
of myelin (Nguyen et al., 2011). Furthermore, the characteristic myelin composition of X. laevis, 
and moreover that of metamorphic tadpole myelin, may make any myelin debris generated at this 
time more amenable phagocytic substrates. Therefore, I examined the process of metamorphic 
optic nerve shortening and the role of thyroid hormone with respect to the changes that take place 
in myelinated RGC axons. Furthermore, I investigated the potential presence and role of 
phagocytically active astrocytes in the remodeling of myelin segments on shortening axons 









Chapter 2: Characterization of the optic nerve during metamorphic remodeling in X. laevis 
 
One of the most dramatic morphological remodeling events that occur during 
metamorphosis in the amphibian Xenopus laevis is the change in structure of the head to become 
smaller in size and more triangular in shape (Figure 2.1). A major aspect of this change is a shift 
to more rostro-dorsally positioned eyes to allow for the onset of binocular vision in the frog, 
relative to the laterally oriented eyes of the pre-metamorphic tadpole (Grant et al., 1980). In order 
to achieve this head remodeling, there must be concomitant remodeling and shortening of various 
cranial nerves, including the optic nerve.  
In order to determine the consequence of shortening on the overall structure as well as the 
individual components of the optic nerve, I selected four stages of animals, as determined by 
Nieuwkoop and Faber (NF) staging criteria (Nieuwkoop and Faber, 1956), for analysis. I used 
animals at the NF Stages 58, 62, 66, and 4 weeks after completing metamorphosis. At Stage 58 
the animals are pre-metamorphic tadpoles in which the head has not yet reached maximal size 
and is still round with laterally oriented eyes, at Stage 62 the animals are in mid-metamorphic 
climax in which the head is significantly smaller and the eyes are still relatively laterally 
positioned, at Stage 66 the animals have reached the immediate conclusion of metamorphosis in 
which the head has decreased to its smallest size and remodeling is complete (Figure 2.1), and at 
4 weeks after metamorphosis the animals are juvenile frogs in an active growth phase.  This set of 
animals allowed for the comparison of optic nerves at two active stages of remodeling (Stages 62 
and 66) with those prior to the onset and well after the completion of metamorphic head and 
nerve remodeling. Analyses of the optic nerve were carried out using electron and light level 
microscopy in order to obtain structural and expression data, respectively.  
 




First, I confirmed that the optic nerves do shorten to approximately one-half their length 
during the period of metamorphic head remodeling (Cullen and Webster, 1979). I found that the 
length of the optic nerve decreased from 4.83 ± 0.54 mm at Stage 58 to 2.17 ± 0.20 mm at Stage 
66 (Figure 2.2A). The length of the nerve did not significantly change during the next 4 weeks 
following metamorphosis, which likely reflects that relative to body size the head did not grow 
much during this time, and this measure may vary in different cohorts of animals depending on 
their growth rate. In addition to length, I also examined the cross-sectional area of the optic 
nerves during these stages. The area of the nerve showed an inverse relationship to the length 
such that the cross-sectional area doubled from 810 ± 560 μm2 at Stage 58 to 1,890 ± 195 μm2 at 
Stage 66 (Figure 2.2B). This widening represented a transient hypertrophy specific to the period 
of metamorphic remodeling. This hypertrophy is resolved within one month, as the nerve area 
decreased to 1,250 ± 250 μm2 in the juvenile frogs. Therefore, shortening leads to net loss of 
optic nerve volume.   
To determine whether the overall composition of the nerve is affected by metamorphic 
remodeling, immunolabeling of cross-sectional cryo-sections of optic nerve was performed using 
markers for the major components of the nerve: axons, myelin and astrocytes. The retinal 
ganglion cell (RGC) axons were labeled by the pan-axonal marker acetylated alpha tubulin, 
myelin was labeled by myelin basic protein (Mbp), and astrocytes were labeled by brain lipid 
binding protein (Blbp) (Figure 2.2C). The conserved pattern of immunolabeling across all 
examined stages, with myelinated axons preferentially localized to the nerve core and astrocytes 
extending radially oriented processes toward the pial surface, indicates that there is no major 
reorganization of the individual cellular components. However, the transient hypertrophy of the 
nerve during shortening suggested a possible alteration of the sub-structure. I was particularly 
interested in exploring the relationship between axons and their associated myelin sheaths as the 
optic nerve shortens. The response of myelin segments to axon shortening in the developing 
nervous system has not been previously described. This type of analysis requires an examination 
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of myelinated axons at the ultrastructural level.  Since light level microscopy cannot provide 
sufficient resolution to observe the detailed structure of the individual nerve components, I turned 
to electron microcopy. 
 
Electron microscopy based quantification of optic nerve myelin 
Transmission electron microscopy (TEM) was carried out in collaboration with Chung-ha 
Davis.  Animals were ordered from a commercial supplier (Xenopus Express) and six wild-type 
X. laevis were used for each of the specified stages (NF Stage 58, 62, 66, and 4 weeks post-
metamorphic). The optic nerves were dissected from the animals and processed for TEM using 
the protocol for Serial Block-face Scanning Electron Microscopy (SBEM) developed at the 
National Center for Microscopy and Imaging Research (Deerinck et al., 2010). The nerve lengths 
described in Figure 2.2A were obtained at the time of dissection. There can be variation in the 
thickness of the myelin sheath along the length of the nerve, as well as asymmetries in sheath 
thickness depending on the position of the axons within the nerve bundle (Fraher, 1992).  
Therefore, comparisons between the nerves of animals at different developmental stages need to 
be made at the same location along the length of the nerve and include an analysis of axons in all 
positions throughout the width of the nerve. The center region of the optic nerve has been 
previously reported to undergo the most dramatic remodeling during metamorphic optic nerve 
shortening in X. laevis (Cima and Grant, 1982b). Therefore, in order to perform an effective 
comparison across stages, the centermost region, relative to length, of all nerves was embedded in 
Durcupan resin in a cross-sectional orientation. Ten micrographs were captured along designated 
coordinates spanning all regions of the cross-sections for each optic nerve at 5000X 
magnification using a H7600 Hitachi transmission electron microscope. The sectioning and 
imaging were both performed at the Wilmer microscopy core by Chung-ha Davis. The TEM 




In order to understand how myelin is affected by axon shortening in the metamorphic 
optic nerve, I performed myelin centered manual tracing of the TEM micrographs. I found that 
not all myelin was associated with axons, thus myelin was sub-classified into two categories: 
myelin associated with axons and myelin not associated with a contiguous sheath surrounding an 
axon, which I refer to as debris myelin.  The outermost boundary of the axon associated myelin 
sheaths, axon plasma membrane, enlargements of the peri-axonal space between the myelin and 
axon plasma membranes, and debris myelin structures were manually traced as segments in 
IPLab software. Each component class was assigned a different segment color. An example of the 
tracing scheme is shown for each stage in Figure 2.2D, in which myelin sheaths are dark blue, 
axons are yellow, peri-axonal vacuoles are white, and debris myelin is light blue. Afterwards, the 
segmented areas on the traced images were quantified using custom scripts in IPLab written by 
my advisor. An independent measure of myelin was also obtained in which  myelin was 
automatically segmented based on it being the most-electron dense structure in the micrographs, 
using the mean and standard deviation of the manually traced myelin segments to automatically 
tailor the segmentation cut-offs to different micrographs. The measured values from the ten 
micrographs for each nerve were combined and normalized to the area of nerve measured relative 
to the total area of the nerve cross-section. The values from the two nerves from each animal were 
averaged to obtain a single set of metrics representing each animal.  
 
The myelinated axons of RGCs remodel rather than degenerate in accordance with 
metamorphic optic nerve shortening 
The quantification of the traced TEM micrographs revealed that in conjunction with the 
nerve as a whole, the myelinated axons also experience a transient hypertrophy specifically 
during the period of optic nerve shortening.  The mean cross-sectional area of myelinated axons 
increased from 0.68 ± 0.02 μm2 at Stage 58 to 1.12 ± 0.10 μm2 at Stage 66, and then subsequently 
returned to 0.57 ± 0.11 μm2 within one month following the completion of metamorphosis 
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(Figure 2.3A). The increased area of the myelinated axons alone, however, is not sufficient to 
account for the overall hypertrophy of the optic nerve area.  An expansion of the extracellular 
space was visible in the optic nerve TEM micrographs during metamorphic stages, but was not 
amenable to quantification using contrast based segmentation. Similar increases in extracellular 
space have been noted during peak periods of myelination in other developing vertebrate systems 
(Williams et al., 1986). Therefore, an increase in the number of myelinated axons may contribute 
to the expansion of the optic nerve cross-sectional area during metamorphosis.  
Previous studies have indicated that in X. laevis, the generation of RGCs in the retina and 
myelination of axons in the optic nerve is highest during early development, but continues at a 
low level throughout the lifespan of the animal (Gaze and Peters, 1961; Wilson, 1971).  I found 
that this proliferative trend is not interrupted by optic nerve shortening, since the animals 
experience an increase in both RGCs and myelinated axon number during metamorphic climax. 
Using segmentation based quantification of RGCs expressing rbpms (also known as hermes) 
(Figure 2.3B), which has been shown to specifically label RGCs in frog the retina (Gerber et al., 
1999a) and in mammals (Kwong et al., 2010), the number of RGCs in the retina was found to 
increase from 29,000 ± 4,640 at Stage 58 to 38,600 ± 5,730 at Stage 62 (Figure 2.3C), which is 
the period that the optic nerve undergoes the greatest decrease in length (Figure 2.2A).  The retina 
quantification was performed in IPLab using a custom script written by my advisor (Soto et al., 
2008). Similarly, the quantification of the traced TEM micrographs indicated that myelination 
also increased during this period. The number of myelinated axons in the optic nerve increased 
from 891 ± 101 at Stage 58 to 1,456 ± 302 at Stage 66. The greatest number of myelinated axons, 
though, was found in the optic nerves of the juvenile frogs, which is consistent with an increase in 
myelination throughout the lifespan of the animal. The rate of new myelination, however, is 
highest during metamorphic climax in which an average of 564 ± 320 new axons are myelinated 
over approximately 10 days for a rate of about 56 ± 31 axons per day. After metamorphosis the 
rate drops off such that an average of 624 ± 480 axons are myelinated over approximately 30 
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days leading to a rate of about 21 ± 16 axons per day. Therefore, metamorphic climax likely 
represents a period of peak myelination in the developing optic nerve of X. laevis.  
Since new myelination is generally associated with the differentiation of OPCs to mature 
myelinating oligodendrocytes, I quantified the amount of OPCs, as defined by expression of 
pdgfrα, and mature oligodendrocytes, as defined by expression of plp, using in situ hybridization 
in longitudinal optic nerve cryo-sections over the course of metamorphic remodeling (Figure 
2.3E). While the numbers of OPCs and oligodendrocytes per unit area were unchanged (Figure 
2.3F-G), the total number of mature oligodendrocytes in the optic nerve actually increased during 
metamorphic climax (Figure 2.3H). This suggests that rate of oligodendrocyte differentiation 
occurs roughly in proportion to the increase in overall optic nerve area (Figure 2.2B), which 
would explain why the density of cells was unchanged.  
The proliferation of RGCs and increased myelination during metamorphosis raises the 
possibility that myelinated axons are selectively lost as a result of nerve shortening and replaced 
with new axons. Therefore, I used immunohistochemistry to determine whether there was a 
selective loss of myelinated axons specifically at metamorphic climax. The neurofilament marker 
3A10 (Brand et al., 1996) labels large caliber axons, which are also surrounded by an Mbp 
labeled myelin sheath in the optic nerve of X. laevis (Figure 2.4A-B). Degenerating axons lose 
their 3A10 labeling in exchange for the degenerating cell and axon marker, cleaved- caspase-3 
(Schoenmann et al., 2010). Metamorphic optic nerve cross-sections were quantified using a 
segmentation based script in which the total amount of cleaved-caspase-3 signal that did and or 
did not overlap with Mbp was measured. Quantification of optic nerve cross-sections 
immunolabeled with Mbp, 3A10, and cleaved-caspase-3 (Figure 2.4C) revealed that there was no 
increase in cleaved-caspase-3 signal per unit area during metamorphosis (Figure 2.4D). 
Furthermore, there was no change in the proportion of degenerating myelinated axons during 
metamorphic climax relative to a time prior to the onset of optic nerve shortening (Figure 2.4E).  
These results indicate that the existing myelinated axons are not lost during nerve shortening. 
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Since the myelinated axons are maintained during shortening, it raises the question of how the 
myelin is affected by this transformation. 
 
Increases in the thickness of the myelin sheath surrounding axons occur after the 
completion of metamorphosis  
In most vertebrate systems, a near linear relationship is maintained between the growth of 
an axon and the thickness of its corresponding myelin sheath (Friede and Miyagishi, 1972; Friede 
and Samorajski, 1967), though the exact specifications of this relationship are dependent on axon 
type and species (Fraher and O'Sullivan, 2000). In some nerves, there can be a large discrepancy 
in the time between the onset of axon diameter growth and the increase in wraps of the myelin 
membrane around the axon (Schroder et al., 1978).  Since the increase in axon diameter during 
metamorphosis was a transient effect of remodeling rather than a sustained byproduct of growth, I 
wanted to determine whether myelin thickness increased concomitantly with axon size, or if a 
change in myelin thickness was delayed until after the conclusion of optic nerve shortening.  
Myelin thickness is generally measured in terms of a G-ratio, which is a measure of 
diameter of the inner myelin membrane relative to the diameter of the outer myelin membrane, 
such that an increase in myelin thickness is indicated by a decrease in the G-ratio (Rushton, 
1951). The standard calculation of G-ratio relies on the assumption that axon cross-sections are 
perfectly circular. However, the non-uniformity of axons in the metamorphic optic nerve was 
evident from the TEM micrographs, which required the modification of the G-ratio calculation. 
The deviation of axons from perfect circles can also be seen in the developing nerves of other 
vertebrates (Williams et al., 1986), thus asymmetric growth may indicate a general aspect of 
development rather than a feature specific to amphibian metamorphosis.  Instead of measuring 
myelin membrane diameters directly in the TEM micrographs, the diameters were extrapolated 
from the areas bound by the inner and outermost myelin membranes based on the quantification 
of the traced segments.  To differentiate this calculation from a classically defined G-ratio, I refer 
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to this metric as the G’-ratio.  The average values I obtained for G’-ratio, between 0.7 and 0.8, 
were highly consistent with the G-ratios calculated in the nerves of other species (Berthold et al., 
1983; Chomiak and Hu, 2009; Wakakuwa et al., 1987). The distribution of G’-ratios was 
relatively unchanged over the course of optic nerve shortening (Figure 2.5A). A significant shift 
in the distribution toward lower G’-ratios, or increased myelin thickness, did not occur until well 
after the completion of metamorphosis and nerve remodeling. This suggests that oligodendrocytes 
do not respond to the sudden axon hypertrophy during metamorphic climax with a compensatory 
increase in myelin thickness, but rather wait until remodeling has been completed and the nerve 
has stabilized.  
 
Axons have excess myelin relative to their size and also have focal enlargements of the peri-
axonal space during metamorphic optic nerve remodeling  
The G-ratio provides a metric of myelin thickness, but since it does not directly measure 
the size of the axon, it provides an incomplete description of the relationship between myelin and 
axons and how it may be affected by nerve shortening. The shortening of the axon might be 
expected to lead to a disassociation of myelin from the axon. A measure of the total area of 
myelin per optic nerve cross-section was highest at Stage 66, even though the total number of 
myelinated axons and the thickness of the myelin around each of those axons were greatest in the 
juvenile frog (Figure 2.5B). This suggests that there is an excess of myelin relative to the number 
of axons during metamorphosis, which could be indicative of an excess of myelin on each axon 
or the dissociation of myelin from axons.  Therefore, I also examined the ratio of the total area of 
the myelin sheath relative to the total area of axoplasm, based on the quantification of the 
segments in the traced TEM micrographs.  Although the ratio of myelin: axoplasm did not 
significantly increase until 4 weeks after metamorphosis, there was a trend toward an elevation in 
this ratio at the end of metamorphic climax (Figure 2.5C). Since this metamorphic elevation was 
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not due to an increase in myelin membrane wraps, or thickness, it suggested the presence of local 
regions of excess myelin. 
 Breakdown in the adhesion between an axon with the innermost membrane of the myelin 
sheath can lead to the presence of vacuoles in the peri-axonal space (Trapp et al., 1984), as well 
as the formation of myelin whorls or tomaculas (Cai et al., 2001; Runker et al., 2004). Indeed, the 
TEM micrograph cross-sections revealed the presence of focal enlargements of the peri-axonal 
space at all developmental time points, indicating it may be a general feature associated with the 
growth of myelinated axons (Figure 2.5D). The size of these focal enlargements of the periaxonal 
space, however, peaked at the end of metamorphic climax, as the area increased tenfold from 20.8 
± 6.9 μm2 at Stage 58 to 217 ± 111 μm2 at Stage 66. These focal peri-axonal space enlargements 
were not, however, accompanied by the focal splitting of the myelin lamellae. The adhesion 
between the myelin wraps appeared to remain intact, indicating that these focal detachments were 
not a byproduct of myelin unraveling or degeneration. This suggests that optic nerve shortening 
induces the production of focal axon-myelin detachments, perhaps through the local disruption of 
axo-glia adhesion.  
 
Internodal distance decreases on myelinated axons during metamorphic optic nerve 
shortening 
Myelin does not form a continuous structure along the entire length of an axon, but rather 
is composed of individual segments; consequently axo-glial adhesion is also not uniform along an 
axon. Adhesion complexes connecting myelin and axonal membranes are clustered at paranodes 
(Tait et al., 2000), which are the terminal boundaries of each myelin segment. Based on this non-
uniform distribution of adhesive complexes, the internodal regions of myelin with the weakest 
attachments would be expected to preferentially separate from the axon as it changes shape.  I 
wanted to determine whether the focal enlargements of the peri-axonal space observed in the 
TEM cross-sections from metamorphic optic nerves were a function of focal internodal myelin 
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detachments. In addition, the shortening of the axon might lead to disruptions of myelin structure 
not merely within a segment, but between segments as well. Since the size of the segments is 
generally optimized to the width and length of the axon, an abrupt decrease in axon size could 
lead to an overabundance of myelin segments relative to axon length. Depending on how the axon 
shortens relative to the position of the myelin segments, the intervening nodal regions between 
segments, which contain high densities of sodium channels necessary for maintain salutatory 
conduction, could be lost as segments run up against one another.  
In an initial attempt to ascertain whether adhesion complexes remained intact at 
paranodes and whether myelin segment spacing or length was affected by nerve shortening, I 
used an immunohistochemistry based approach. Optic nerve longitudinal cryo-sections were 
immunolabeled with antibodies to the myelin marker Mbp, the axonal marker 3A10 and the 
paranodal marker Neurofascin (Tait et al., 2000). Three-dimensional projections of the nerves 
obtained through confocal imaging were used to trace the distance between Neurofascin labeled 
paranodes along individual myelinated axons. The basic structure of the paranode, as determined 
by Neurofascin immunolabeling was maintained throughout the period of optic nerve remodeling 
(Figure 2.6A). Since Neurofascin is an integral part of the paranodal adhesive complex, it is likely 
that the preservation of Neurofascin labeling indicates that the adhesive complexes themselves 
are also maintained. The resolution of the immunolabeling of myelin with Mbp, however, was not 
sufficient to clearly delineate individual segments. Consequently, nodal structure and the spacing 
between segments could not be examined. The tracing of segments along axons defined by 
Neurofascin labeled boundaries, did reveal a change in segment length during the period of optic 
nerve shortening. The distance between Neurofascin labeled paranodes (internodal distance) 
decreased by approximately one-half from 50.3 ± 11.6 μm at Stage 58 to 28.3 ± 6.9 μm at Stage 
66, the immediate conclusion of nerve shortening (Figure 2.6B). Interestingly, the segment 
shortening appears to have been primarily accomplished between Stage 58 and Stage 62, as the 
segment length did not decrease further between Stages 62 and 66. Due to the high density of 
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axons, individual axons could not be traced reliably, thus this method was not suitable for 
obtaining myelin segment length from 4 week post-metamorphic animals.  
 
Myelin segments on axons shorten during metamorphic optic nerve shortening 
In order to determine how the structure of the myelin segments was affected during 
shortening, I performed three-dimensional reconstructions of myelinated axons from SBEM 
datasets obtained from the optic nerves from animals at Stages 58, 62, 66, and 4 weeks after 
metamorphosis.  The optic nerves were dissected and processed for SBEM as previously 
described, and embedded in Durcupan resin in a longitudinal manner. After embedding, all 
further processing and imaging was performed by Eric Bushong and colleagues in the laboratory 
of Mark Ellisman at the National Center for Microscopy and Imaging Research.  I manually 
traced the boundaries of the outer myelin membrane (blue), axon plasma membrane (yellow), and 
peri-axonal space enlargements (white) using Imod software (Kremer et al., 1996) of 
approximately ten axons per stage in order to create the reconstructions (Figure 2.7A). The axons 
were selected based on the criteria of containing nodes, the spaces between myelin segments, and 
preferentially multiple nodes. This selection criterion could not be used for the Stage 58 dataset, 
however, as the length of the myelin segments exceeded the dimensions of the volume such that 
the traced axons contained at most a single node. As a result, I was able to obtain the length of 
myelin segments for a majority of the axon reconstructions for optic nerves from animals at each 
stage except Stage 58.  
 In this way, I was able to confirm that myelin segments shorten to at least one-half of 
their original length during metamorphic climax (Figure 2.7B). There was a small discrepancy 
between the lengths of myelin segments measured using the immunohistochemistry and electron 
microscopy based methods, but due to the difficulty in unambiguously tracing the immunolabeled 
axons and the higher resolution afforded by the SBEM volumes, the values based on the 
reconstructions are likely to be more accurate. The reconstructions also revealed that myelin 
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segments were appropriately separated by intervening nodal regions and that segment lengths 
were not uniform. Since myelin segment length generally varies with axon size, a nerve 
containing axons of a wide variety of calibers, such as the optic nerve, would be expected to 
normally have a fair amount of segment length variation. The metamorphic nerves, however, also 
displayed intra-axonal myelin segment length variation. The presence of extremely short 
segments alongside longer ones such as on axons Stage 62 #7 and Stage 66 #3 in Figure 2.7A, 
suggest that at least some of the myelin segments are eliminated during optic nerve shortening, 
and that the intervening space is filled by the elongation of neighboring segments. This 
hypothesis is supported by the unexpected finding that myelin segments lengthen dramatically 
during the first 4 weeks after the completion of metamorphosis (Figure 2.7B), without a 
significant change in overall optic nerve length (Figure 2.2A). Since segment lengthening has 
been previously described in other developmental systems (Court et al., 2004; Fried et al., 1982; 
Friede et al., 1985), I chose to focus my efforts on determining the mechanism involved in the 
novel finding that myelin segments shorten during metamorphic climax.  
 
Myelin segments structurally remodel to produce detachments, branches, and protrusions 
on shortening axons 
The myelinated axon reconstructions indicate that myelin segments undergo significant 
structural changes during the period of optic nerve shortening, aside from changes in length. 
Small regions where the innermost myelin membrane has separated from the axon plasma 
membrane, accompanied by focal enlargements of the peri-axonal space occur frequently along 
the length of the metamorphic axons (Figure 2.7A). Additionally, there are protrusions of myelin 
extending from the myelin sheath at positions which continue to exhibit intact axo-glial 
attachments.  Although some focal myelin detachments and myelin protrusions can be detected in 
axons from all developmental stages examined, the size and frequency of these myelin 
aberrations were found to be greatly increased specifically during the period of metamorphic 
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optic nerve remodeling (Figure 2.7C-D).  The focal detachments often form in clusters, as clearly 
shown in axon Stage 62 #1 in Figure 2.7A, suggesting that the disruption of axo-glial adhesion in 
one region of the myelin segment may negatively affect the stability of the myelin in neighboring 
regions. Indeed the continued expansion of peri-axonal space vacuoles during remodeling (Figure 
2.7D) suggests that the adhesive complexes between detached regions get disrupted leading to the 
expansion of the detached region. This would result in the production of fewer, but larger 
stretches of detached myelin, which would be less stable and prone to form whorled and folded 
structures, both of which are readily detectable in the electron microscopy micrographs primarily 
at Stage 66.  
Several axons had out-branching of the axon itself, suggesting that part of the mechanism 
of axon shortening may involve axon branching, thus many of the myelin dystrophies may 
develop from the folding and cytoskeletal reorganization of the axon during remodeling. It is 
likely that this branching of axons and formation of the myelin detachments and out-foldings 
accounts for the decreased length of the myelin segments in metamorphic axons. Similarly, the 
branched and folded myelin would also account for the increase in the cross-sectional area of 
myelin (Figure 2.5C) that is independent of any change in myelin wrapping or thickness (Figure 
2.5A) during the period of optic nerve remodeling.   
Although the full length of the myelin segments in the pre-metamorphic (Stage 58) axons 
could not be quantified, due to the size of the dataset relative to the length of the segments, the 
similarity of appearance and many other metrics between the pre-metamorphic axons and those 4 
weeks after metamorphosis (Figures 2.2D, 2.3A, 2.5D) meant that some metrics obtained for the 
post-metamorphic axons could be used as a reasonable approximation for pre-metamorphic 
axons. The segment lengths at 4 weeks are likely similar to pre-metamorphic lengths, based on 
lengths obtained through Neurofascin labeling (Figure 2.6B). Using this approximation, the 
surface area of myelin segments could be compared over the course of optic nerve remodeling. 
These approximations revealed that even though segment lengths at 4 weeks after metamorphosis 
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(or before metamorphic climax) were on average over twice as long as during metamorphic 
climax (Figure 2.7B), the surface area of myelin on the segments remained relatively constant at 
all examined stages (Figure 2.7E), further supporting that shortening involves the reorganization 
of existing myelin segments.  Furthermore, in the myelinated axons from animals 4 weeks after 
metamorphosis, the myelin is relatively uniform and lacks axon branching or large dystrophies. 
This indicates that the branching and out-pocketing of axon and myelin material are likely 
remodeling intermediates that are eventually targeted for removal.  Therefore, I wanted to 
determine how regions of out-branched and/or detached myelin could be selectively removed 
from axons without resulting in axon degeneration.  
 
A population of myelin and axon material separated from myelinated axons increases in the 
optic nerve during metamorphic climax 
If regions of axon branching and myelin protrusions are removed from axons, this would 
lead to the production of populations of axonal material and myelin that were fully separated 
from intact axons and located within the extracellular space or inside of a phagocytic cell. I first 
attempted to identify the populations of axonal material and myelin not associated with intact 
axons in the metamorphic optic nerve using immunohistochemistry. Thick longitudinal cryo-
sections of optic nerve at Stages 58, 62 and 66 were immunolabeled with the myelin marker Mbp 
and axon marker 3A10, which preferentially labels large-caliber myelinated axons (Figure 2.9A). 
In addition, I used a second axonal marker, gamma synuclein (Sncg), which is highly enriched in 
RGCs (Soto et al., 2008) in order to identify membranes and other material derived specifically 
from axons (Figure 2.9B). I designed an antibody to the acidic C-terminus of Xenopus Sncg based 
on a similar antibody developed for Sncg in mouse (Soto et al., 2008) which has been shown to 
retain partial antigenicity in the optic nerve following treatment with proteases  (Nguyen et al., 
2011). Although expressed in all RGCs (Figure 2.8A), sncg is more highly expressed in RGCs 
that also express heavy neurofilament (Figure 2.8B), and consequently have large caliber 
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myelinated axons (Figure 2.8C-D). Additionally, the synucleins associate with membranes rather 
than neurofilaments and have been found on vesicles outside of axons (Auluck et al., 2010). 
Therefore, although Sncg and 3A10 label overlapping populations of axons (Figure 2.8E-F), Sncg 
to is better suited to label material that is derived from RGC axons but is no longer associated 
with them.   
The 3A10 immunolabeled signal was used to create a mask using Imaris software 
(Bitplane) such that any Mbp (or Sncg) signal that overlapped with the 3A10 mask was filtered 
out. Using this paradigm, a population of Mbp immunolabeled myelin that was clearly not 
associated with 3A10 immunolabeled axons was evident in the nerves during the period of optic 
nerve remodeling (Figure 2.9A). This population peaked at 4.5 ± 1.9% of the total amount of 
myelin at Stage 62, during mid-metamorphic climax (Figure 2.9C). Similar results were obtained 
with the population of axonal material that was separated from intact axons, which peaked to 12.1 
± 6.6% of the total Sncg immunolabeled signal at Stage 62 (Figure 2.9D). Furthermore, there was 
a high degree of co-localization between the populations of axonal and myelin material that were 
not associated with intact axons (Figure 2.9E). The finding that the populations of separated 
material peaked at Stage 62 was unexpected given that myelin segments are still structurally 
abnormal at Stage 66, which suggests that a large percentage of the myelin dystrophies are not 
removed until after Stage 66, during the first few weeks after metamorphosis. This result may 
indicate that this method of immunohistochemistry and light level microscopy does not provide 
sufficient resolution to identify the entire population of myelinated axon derived material 
separated from axons, that some of the separated material has lost its antigenicity, or both. 
 
Excess myelin on shortening axons is removed and accumulates inside neighboring cells in 
the optic nerve 
In order to overcome the limited resolution of light microscopy and confirm the presence 
of a population of myelin that is separated from axons, I used electron microscopy. The tracing of 
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the TEM micrographs from optic nerve cross-sections, as shown in Figure 2.2D, involved the 
segmentation of a population of myelin not associated with a contiguous myelin sheath. This 
population was composed of myelin in a variety of states ranging from whorled excess myelin 
stemming from an intact segment to separated myelin fully internalized within another cell 
(Figure 2.10A). One class of the myelin intermediates (Figure 2.10A ii) shows myelin surrounded 
by the fine lamellar processes of a nearby cell, and likely represents one of the mechanisms by 
which myelin protrusions are removed from segments.   The debris myelin was sub-classified 
based on appearance into the categories depicted in Figure 2.10A (Figure 2.10B). A large 
percentage (35-45%) of debris myelin consisted of transitional myelin intermediates that could 
not be readily classified into a single category and likely represented myelin in the process of 
being internalized. 
 Since the majority of the debris myelin at all stages is fully internalized, its source 
cannot be readily identified, and thus could be a byproduct of either active myelin removal from 
intact axons or myelin degeneration. The absence of an increased loss of myelinated axons 
(Figure 2.4E) along with the presence of debris intermediates would suggest that at least during 
metamorphosis, the majority of internalized myelin is not due to axon loss. The shift in the 
distribution of myelin intermediates showing an increase in whorled myelin extending from axons 
and being enwrapped by cellular processes from approximately 5% at Stage 58 to 25% at Stage 
66 further supports the notion that metamorphic debris myelin is an indication of myelin 
remodeling rather than axon degeneration.  The total area of this debris myelin increased from 6.8 
± 4.1μm2 at Stage 58 to 492 ± 247 μm2 at 66 (Figure 2.10C). As a result, the percentage of myelin 
not associated with axons also increased significantly during the period of metamorphic optic 
nerve remodeling (Figure 2.10D). In contrast to the Mbp immunolabeling results, the peak of 
debris myelin occurred at Stage 66, at which time approximately one-quarter (24.9 ± 8.8%) of all 
myelin in the optic nerve was found separated from axons. The discrepancy between the 
immunolabeling and electron microscopy metrics is likely explained by localization of the 
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majority of the debris myelin within cells since this internalization may have led to a 
corresponding loss of antigenicity of the myelin. This finding also explains why total myelin 
levels peaked at Stage 66 rather than 4 weeks after metamorphosis (Figure 2.5B), despite the 
increased number of myelinated axons at the later time point (Figure 2.3D). Altogether these 
results suggest that there is large scale removal of myelin from axons during metamorphosis, and 
that the majority of the removed myelin is associated with astrocytes.  
 
Focal regions of detached and branched myelin are contacted and removed from otherwise 
intact segments on axons by the cellular processes of nearby cells in the optic nerve 
In order to confirm that the debris myelin intermediates seen in the TEM micrographs 
represent the selective removal of focal myelin dystrophies on otherwise intact myelin segments, 
I looked for evidence of the active removal of myelin on the axon reconstructions from SBEM 
datasets.  Cellular processes from neighboring cells were found to contact remodeling myelin 
segments, shown in red in Figure 2.11A. Furthermore, the contact sites occurred preferentially at 
regions with focal myelin detachments or protrusions, as highlighted by boxed regions in Figure 
2.7A. The Stage 66 axon # 6 contains a long thin out-branch in which the myelin at the end is 
fully enclosed within a neighboring cell but remains attached to the main axon at its base. A 
similar, but likely, earlier, event is captured in Figure 2.11B, which appears to provide a snapshot 
of the mechanism of myelin removal. An out-branch of the Stage 62 axon is enwrapped by thin 
lamellar processes of a local cell, whose soma contains evidence of previously internalized axon 
and myelin material. The internalized myelin appears to be in various stages of degradation, 
suggesting that the internalized material localizes to degradative compartments within the cell.   
 
Internalized myelin accumulates within cells in the optic nerve and is associated with a rise 
in lipid droplet production  
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The accumulation of internalized myelin within degradative cellular compartments would 
account for the finding that increases in the size of individual units of debris myelin coincide with 
increases in the total amount of debris myelin (Figure 2.12A). The size of debris myelin units 
increases from 0.5 ± 0.2 μm2 at Stage 58 to 1.9 ± 0.2 μm2 at Stage 66, over the same time course 
that total debris levels in the optic nerve elevate dramatically (Figure 2.10C-D). Similarly, both 
the size of debris myelin units and amount of total debris fall back to pre-metamorphic levels in 
the optic nerves from juvenile frogs. The accumulation of internalized debris myelin is also 
correlated with an increase in the number and size of lipid droplets in the myelin internalizing 
cells (Figure 2.12B-E). The accumulation of lipid droplets within phagocytes has long been 
associated with myelin internalization and degradation (Stoll et al., 1989). Therefore, the 
increased presence of the lipid droplets is a further indicator that myelin is removed from axons 
and internalized for degradation by neighboring cells during metamorphic optic nerve shortening.  
Overall, my data shows that myelinated axons in the optic nerve of X. laevis remodel 
rather than degenerate during metamorphic optic nerve shortening. The RGC axons undergo a 
transient hypertrophy and out-branching as they shorten which is accompanied by the creation of 
focal axon-myelin detachments and myelin protrusions on otherwise intact myelin segments. The 
production of these myelin extensions and branches then results in the shortening of the myelin 
segments. Finally, these regions of dystrophic myelin are selectively removed and internalized for 








Figure 2.1 Morphological changes in X. laevis head during metamorphosis  
Nieuwkoop and Faber (NF) staged X. laevis, at pre-metamorphic Stage 58, metamorphic climax 

















Figure 2.2 The optic nerve shortens and transiently widens but remains structurally intact 
during metamorphosis  
(A) Optic nerve (ON) length during metamorphosis (n= 6). F= 4 weeks post-metamorphic 
froglets.  (B) Optic nerve cross-sectional area (n= 6). (C) Optic nerve cross-sectional cryo-
sections immunolabeled for acetylated tubulin (blue, axons), Blbp (green, astrocytes), and Mbp 
(red, oligodendrocyte myelin). Scale bar = 50 µm. (D) Representative traced transmission 
electron microscopy (TEM) micrographs of the optic nerve cross-sections at Stages 58, 62, 66, 
and 4 weeks post-metamorphosis (F). Myelin sheaths (blue), axoplasm (yellow), focal peri-axonal 
space enlargements (white), and non-axon-associated myelin (cyan). Scale bar = 2 µm. 

















Figure 2.3 Retinal ganglion cells proliferate and myelination increases in optic nerve during 
metamorphic climax   
(A) Average axoplasm cross-sectional area in myelinated axons per optic nerve (n= 6) from 
traced TEM micrographs. Values derive from measurement of 6975, 5759, 5267, and 6076 axons 
at Stages 58, 62, 66, and F respectively. (B) Images of whole-mount retina mosaics expressing 
the retinal ganglion cell marker rbpms, at Stages 58 and 62. Scale bar 100 μm. (C) Counts of 
retina ganglion cells, as determined by rbpms expression, per retina at Stages 58 and 62. (D) 
Number of myelinated axons per optic nerve (n= 6), derived from traced TEM micrographs, at 
Stages 58, 62, 66, and F.  (E) Optic nerve 10 μm thick longitudinal cryo-sections following in situ 
hybridization showing expression of plp (green, oligodendrocytes), pdgfrα (red, oligodendrocyte 
precursor cells), and Dapi (blue, nuclear marker) at Stages 58, 62 and 66. Scale bar = 50 μm. (F) 
Counts of pdgfrα expressing cells per optic nerve longitudinal cryo-section normalized to area at 
Stages 58, 62, and 66. (G) Counts of plp expressing cells per optic nerve longitudinal cryo-
section normalized to area at Stages 58, 62, and 66. (H) Counts of plp expressing cells per optic 
nerve longitudinal cryo-section, at Stages 58, 62, and 66. Measurements show mean ± SD with 
*P < 0.05, **P < 0.01, and ***P < 0.001 by Games-Howell test (A) and (D), Tukey’s test (F-H), 








Figure 2.4 Myelinated axons are maintained during metamorphic optic nerve shortening 
(A) Confocal images of Stage 58 cross-sectional cryo-section showing that the 3A10 
neurofilament marker (red) preferentially labels axons bound by Mbp (green) compared to pan 
axonal marker (acetylated tubulin, red). Scale bar = 20 μm. (B) Pearson’s coefficient of co-
localization between axon and myelin markers, derived from confocal images (n= 10 ONs). ***P 
< 0.001 by Student’s t-test with Welch’s correction. (C) Confocal images of Stages 58, 62 and 66 
optic nerve immunolabeled cryo-sections. Immunolabeling of myelin sheath labeled by Mbp 
(blue), large caliber axons labeled by 3A10 (red), and degenerating axons labeled by cleaved-
caspase 3 (green) show no increase in degenerating myelinated axons at metamorphosis.  Scale 
bar = 20 μm. (D) Cleaved-caspase-3 signal in optic nerve measured from cross-sectional confocal 
images (n= 10 per stage) normalized to area does not change during metamorphosis. Significance 
assessed by the Games-Howell test.  (E) Cleaved-caspase-3 signal in myelinated axons (MA) 
measured from confocal images (n= 10 per stage) normalized to area does not change over 
















Figure 2.5 Area of myelin surrounding axons increases during optic nerve shortening, but 
not through myelin thickening 
(A) Frequency distributions of G’ ratios (from 6975, 5759, 5267, and 6076 axons at Stages 58, 
62, 66, and F, respectively). G’ ratio calculated as the ratio of the area bound by inner myelin 
membrane to the area bound by the outer myelin membrane. (B) Total area of myelin per optic 
nerve cross-section (n= 6). (C) Mean ratio of myelin area over axoplasm area per axon. 
Individual axon ratios averaged per optic nerve (n= 6). (D) Total cross-sectional area of peri-
axonal space under focal myelin detachments per optic nerve (n= 6). All measurements show 
mean ± SD and were derived from traced TEM micrographs. *P < 0.05, **P < 0.01, ***P < 0.001 





Figure 2.6 Internodal distance decreases during metamorphic optic nerve shortening 
(A) z-stacks of confocal imaged optic nerve longitudinal cryo-sections immunolabeled for the 
large-caliber axon marker, 3A10 (green), and the paranodal marker, Neurofascin (red), show an 
increased density of paranodes at Stages 62 and 66 relative to Stage 58. Scale bar = 50 μm. (B) 
Internodal distances (n= 23, 28, 28 and 26 axons at Stages 58, 62, 66, and F derived from 3 optic 
nerves per stage) measured in 3A10 and Neurofascin-labeled optic nerve volumes.  Measurement 








Figure 2.7 Myelin segments remodel and shorten during metamorphic optic nerve 
shortening 
(A) Reconstructions of axons at Stages 58, 62, 66 and F based on SBEM datasets, with myelin 
(light and dark blue), axoplasm (yellow), focal peri-axonal space enlargements (white), and 
Nodes of Ranvier (arrows) show focal myelin protrusions and detachments during metamorphic 
stages. Scale bar = 5 µm. Boxed regions are also shown in Figure S3. (B) Myelin segment lengths 
measured from SBEM traced axons. Stage 58 values (gray) are minimum lengths since they 
generally exceeded the acquired volume dimensions. Values were derived from 10, 8, 6, and 8 
segments at Stages 58, 62, 66 and F, respectively. (C) Surface area of myelin in focal 
detachments on axons normalized to length (n= 11 Stages 58 and 66, n= 9 Stage 62 and F). (D) 
Volume of peri-axonal space beneath focal myelin detachments on axons per axon normalized to 
length (n= 11 Stages 58 and 66, n= 9 Stage 62 and F). (E) Surface area of myelin per myelin 
segment (n= 7, 5, and 8 for Stages 62, 66, and F, respectively). All measurements show mean ± 
SD and were derived from SBEM axon reconstructions. *P < 0.05 and **P < 0.01 by the 
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Figure 2.8 Gamma synuclein is highly expressed in RGCs with large caliber myelinated 
axons 
(A) Sub-selection of Stage 62 whole-mount retina immunolabled with gamma synuclein (Sncg, 
green) showing that it is expressed in the same cells as the mRNA for the RGC marker, rbpms 
(red). Scale bar = 50 μm. (B) Sub-selection of Stage 62 whole-mount retina showing co-
localization of mRNA for heavy neurofilament (nefh, green) in RGCs that highly express sncg 
mRNA (red). Scale bar = 50 μm. (C) Sub-selection of Stage 62 whole-mount retina 
immunolabeled with large caliber axon marker, 3A10 (green) showing the RGCs which have high 
expression of sncg mRNA (red) are labeled with 3A10. Arrows show cells labeled by both 3A10 
and sncg. Scale bar = 50 μm. (D) Immunolabled confocal images of Stage 58 cross-sectional 
optic nerve cryo-section shows co-localization of Sncg (red) with Mbp or 3A10 (green).  Scale 
bar = 20 μm. (E) Pearson’s coefficient showing co-localization of Sncg with myelinated axon 
markers based on segmented signal from confocal optic nerve cross-sectional images at Stage 58 













Figure 2.9 A population of myelinated axon derived material that is no longer associated 
with intact axons peaks during metamorphic climax 
(A) Maximum intensity projections of confocal imaged optic nerve longitudinal cryo-sections at 
Stages 58, 62, and 66, immunolabeled with Mbp (blue), and large caliber axon marker 3A10 
(white), with discrete Mbp structures not associated with axons (pseudo-colored red). Scale bar = 
50 µm.  (B) Maximum intensity projections of confocal imaged optic nerve longitudinal cryo-
sections at Stages 58, 62, and 66 immunolabeled with Sncg (green), 3A10 (white), and Sncg 
labeled structures not associated with axons (pseudo-colored red). Scale bar = 50 μm. (C) 
Percentage of Mbp not co-localizing with 3A10 per optic nerve (n= 10) based on 3D 
reconstructions of confocal datasets. (D) Percentage of Sncg not co-localizing with 3A10 per 
optic nerve (n= 10) based on 3D reconstructions of confocal datasets. (E) Pearson’s coefficient 
showing co-localization between Mbp and Sncg particles not associated with axons. All 
measurements show mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 by the Games-Howell 


















Figure 2.10 Dystrophic axonal myelin is removed from segments and internalized during 
metamorphic optic nerve shortening 
(A) Debris myelin intermediates observed in TEM micrographs from Stage 66 optic nerve cross-
sections include myelin whorls associated with axons (i), debris myelin enwrapped by phagocyte 
lamellar processes (ii), and debris myelin within phagocyte soma (iii). Scale bar = 1 µm. (B) 
Percentage of debris intermediates in each category shown in (A). The transitional category 
represents myelin separated from axons but not fully internalized by a phagocyte. Metamorphic 
climax stages have a greater proportion of myelin in the process of being removed from axons.  
(C) Total area of debris myelin per optic nerve cross-section (n= 6). (D) Percentage of myelin in 
the form of debris per optic nerve cross-section (n= 6). B-D measurements obtained from traced 
TEM micrographs. All measurements show mean ± SD, with * P < 0.05 and ** P < 0.01 assessed 





Figure 2.11 Regions of focal myelin detachments and protrusions are contacted by and 
selectively removed from axons by cellular processes from neighboring cells during optic 
nerve remodeling 
(A) Phagocyte processes contact and enwrap focal myelin protrusions and detachments on 
remodeling metamorphic axons. Subsets of axon reconstructions from SBEM datasets for Stages 
62 and 66 shown in Figures 2.7 (boxed regions), showing myelin (light and dark blue), axoplasm 
(yellow), focal peri-axonal space enlargements (white), and phagocyte processes (red).  Scale bar 
= 5 μm. (B) Reconstruction based on SBEM data shows astrocyte (red) using lamellar processes 
(dark red) to internalize axonal material, containing both myelin (blue) and axoplasm (yellow). 




Figure 2.12 Internalized myelin accumulates and increases lipid droplet production in cells 
(A) Mean area of individual debris myelin fragments averaged per optic nerve cross section (n= 
6). (B) TEM micrograph showing myelin breakdown and lipid droplet accumulation within an 
astrocyte in Stage 66 optic nerve. Scale bar = 2 μm. (C) Mean area of individual lipid droplets 
averaged per optic nerve (n= 6). (D) Area of lipid droplets relative to total myelin area per optic 
nerve cross-section, measured from traced TEM micrographs in n= 6 optic nerves per stage 
showing mean ± SD. *P < 0.05 as assessed by the Games-Howell test. (E) Correlation between 
mean value per optic nerve (n= 6) of total area of lipid droplets and total area of debris myelin at 
Stage 66. R2=0.92.  Measurements show mean ± SD. Values for (A, C-E) derived from traced 





Chapter 3: Role of thyroid hormone in RGCs, oligodendrocytes, and astrocytes in the 
regulation of optic nerve remodeling 
 
The structural remodeling of the head and accompanying shortening of the optic nerve 
represents one of many morphological changes that take place during the developmental period of 
metamorphosis in the frog, Xenopus laevis. These diverse remodeling events are all under the 
control of a single transcriptional regulator, thyroid hormone (Schreiber et al., 2001).  In many 
cases, these morphological changes require the nervous system to respond by altering innervation 
patterns.  In this way, the shortening of the optic nerve can be understood as the nervous system’s 
response to the restructuring of the head. Since this remodeling event occurs during the 
developmental period of peak thyroid hormone levels, metamorphic climax, it appeared likely 
that, similar to other previously described remodeling events, optic nerve shortening is controlled 
by thyroid hormone. 
 
Optic nerve shortening is mediated by thyroid hormone 
 I confirmed that optic nerve shortening is driven by thyroid hormone using a 
metamorphosis induction assay. Remodeling events that are under the control of thyroid hormone 
can be induced in pre-metamorphic animals, which have low circulating levels of thyroid 
hormone, through exposure to 3,5,3'-triiodothyronine (T3), the active metabolite of thyroid 
hormone (Tata, 2003). The pre-metamorphic Stage 54 X. laevis tadpoles, which have begun 
developing lower limbs but have otherwise experienced very little remodeling, were used. Stage 
54 tadpoles treated with 20 nM T3 for 3 days remodeled their heads to become smaller in size and 
more triangular in shape (Figure 3.1A), which is consistent with the structural changes that take 
place during natural metamorphosis (Figure 2.1). In accordance with the head remodeling, the 
optic nerves from these animals shortened from 3.9 ± 0.2 mm to 2.9 ± 0.1 mm as a result of T3 
treatment (Figure 3.1B). Furthermore, immunohistochemistry for myelin marker Mbp, axon 
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marker 3A10, and paranodal marker Neurofascin revealed that the internodal distance in the optic 
nerve had also decreased in length in these animals from 32.3 ± 7.7 μm at Stage 54 to 23.9 ± 3.7 
μm following T3 treatment (Figure 3.1C).  This shows that metamorphic optic nerve shortening is 
mediated by thyroid hormone, but does not indicate which cell type(s) drive this process and 
whether they are acting cell autonomously under the direct transcriptional control of thyroid 
hormone. 
 
Transgenic expression of a thyroid hormone receptor dominant negative construct 
Thyroid hormone shapes vertebrate development through a combination of 
transcriptional and non-genomic effects (Bassett et al., 2003), though amphibian metamorphic 
remodeling appears to be mediated almost exclusively through transcriptional regulation 
(Buchholz et al., 2004). Transcriptional regulation by thyroid hormone is mediated through its 
nuclear hormone receptors, which function as heterodimeric transcription factors. The binding of 
thyroid hormone or its active form, T3, to the C-terminus of its receptor leads to a conformational 
change resulting in the release of a repressor and recruitment of an activator, thereby facilitating 
gene transcription (Kim et al., 1999). Therefore, it is possible to interfere with metamorphic 
remodeling events in X. laevis through the use of transgenically expressed constructs that prevent 
the binding of thyroid hormone to its receptor(s). 
 A construct of thyroid hormone receptor α containing a C-terminal truncation, TRΔC, 
can bind to thyroid hormone regulated genes but is incapable of being activated by thyroid 
hormone, and thus works as a dominant negative (Marsh-Armstrong et al., 1999). The use of this 
dominant negative construct also circumvents the loss of gene repression that occurs with thyroid 
hormone receptor knockouts, which is the best explanation for the discrepancies between 
hypothyroid and thyroid hormone receptor knockout studies. Since there are two kinds of thyroid 
hormone receptor, α and β, often expressed within the same cell, the loss of gene repression 
through one kind can lead to the production of novel phenotypes when combined with the thyroid 
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hormone mediated gene expression by other receptor isoforms (Flamant and Samarut, 2003; 
Koibuchi et al., 2003). In contrast, the dominant negative thyroid hormone receptor α remains 
bound to thyroid hormone response genes, thus maintaining repression in the absence of 
hormone. In conjunction with the appropriate cell-type specific promoters, TRΔC can, in theory, 
be used to study any aspect of metamorphic remodeling. Indeed, this TRΔC construct has been 
effectively used to obtain mechanistic insight into other metamorphic remodeling events, such as 
limb growth, tail reabsorption, and intestinal, skin and pancreas remodeling (Buchholz et al., 
2004; Schreiber et al., 2005; Schreiber et al., 2001). Therefore, I chose to use the TRΔC construct 
in an attempt to elucidate the contribution(s) of the major optic nerve cell types to metamorphic 
optic nerve remodeling.  
 
Major cell types of the optic nerve can be targeted with cell-type specific promoters 
The optic nerve is composed primarily of RGC axons and two populations of macroglia: 
oligodendrocytes and astrocytes. Small populations of other cell types such as immune system 
derived microglia, and oligodendrocyte precursor cells also exist, but their low numbers make 
them unlikely candidates as the primary drivers of optic nerve remodeling.  Therefore, in order to 
address which cell type(s) are mediating metamorphic optic nerve remodeling, I placed the TRΔC 
construct under the control of cell-type specific promoters for RGCs, oligodendrocytes, and 
astrocytes. I used the zebrafish Islet2b (Isl2) promoter for expression in RGCs (Pittman et al., 
2008), the mouse Myelin basic protein (Mbp) promoter for expression in oligodendrocytes (Kaya 
et al., 2012), and the X. tropicalis Brain lipid binding protein (Blbp) promoter for expression in 
astrocytes (Watson et al., 2012). In order to circumvent potential developmental defects or 
confounders, the expression of TRΔC in oligodendrocytes and astrocytes was performed in a 
tetracycline inducible manner using the reverse transactivator, rtTA2 (Das and Brown, 2004) and 
tetracycline operator (abbreviated TetOp). The inducible promoters are, however, somewhat 
leaky and thus less specific in their expression of the TRΔC transgene.  As a dominant negative 
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transgene, TRΔC must be expressed at high levels to effectively block thyroid hormone mediated 
transcriptional activity, and since non-specific expression is much weaker than the cell-type 
specific expression, it is unlikely that the TRΔC transgene is functional in these off-target cell 
populations.   
The cell-type specificity and potency of the TRΔC transgene to block thyroid hormone 
mediated gene expression was validated using in situ hybridization of a known thyroid hormone 
response gene. The open reading frame, gene 12, is strongly up-regulated in response to thyroid 
hormone in nearly all cell types examined (Berry et al., 1998). Since gene 12 is sensitive to even 
low levels of thyroid hormone, I used a T3 induction assay on Stage 54 tadpoles. The tadpoles 
were treated with 3 nM T3 for 2 days in order to induce expression of the most sensitive thyroid 
hormone responsive genes without inducing the widespread morphological changes that occur 
with exposure to high concentrations of T3. This allowed me to test the ability of the TRΔC 
transgene to directly block thyroid hormone mediated transcription, as opposed to a downstream 
effect of remodeling. Animals expressing the TRΔC transgene under the tetracycline inducible 
promoters, Mbp and Blbp, received brain injections of 50 mg/L doxycycline 24 hours prior to T3 
exposure and had rearing solution supplemented with 50 mg/L doxycycline for the duration of the 
experiment. Eyes and optic nerves were obtained from the animals at the conclusion of the 
experiment for gene expression analysis via quantitative in situ hybridization.  
Expression of TRΔC transgene in RGCs prevents thyroid hormone mediated gene up-
regulation  
Following T3 induction, the thyroid hormone response gene, gene 12 was up-regulated 7 
fold in the retina (Figure 3.2A-B) and 10 fold specifically in RGCs (Figure 3.2C), as identified by 
the expression of rbpms (Figure 3.2A).  Expression of the TRΔC transgene in RGCs severely 
blunted the up-regulation of gene 12 specifically in RGCs (Figure 3.2C), as the up-regulation of 
gene 12 in non-RGCs was not affected in the retinas of these animals (Figure 3.2D). Therefore, 
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the Isl2: TRΔC transgene effectively blocks thyroid hormone mediated gene transcription 
specifically in RGCs.  
 
Expression of TRΔC transgene in optic nerve prevents thyroid hormone mediated gene up-
regulation in a cell-type specific manner 
In the optic nerve, gene 12 was up-regulated approximately 100 fold following T3 
induction (Figure 3.2E-G). Although gene 12 is up-regulated in nearly all cells in response to 
thyroid hormone, gene 12 expression appears to be unaffected in oligodendrocytes, as identified 
by the expression of plp. Gene 12 was found to be absent or weakly expressed in 
oligodendrocytes in the optic nerve (Figure 3.2E), and thus could be used to address specificity 
but not functionality of the TRΔC transgene in oligodendrocytes. The overall expression of gene 
12 in the optic nerves from animals expressing the TR∆C transgene under the Mbp promoter was 
comparable to the level of expression found in the nerves of wild-type animals treated with T3 
(Figure 3.2G), indicating that expression of this transgene does not block thyroid hormone 
mediated transcription in the other cell types of the optic nerve. In contrast, gene12 expression 
was severely blunted in the optic nerves from animals expressing the TRΔC transgene in 
astrocytes (using the Blbp promoter), such that the nerves resemble those from untreated animals 
(Figure 3.2F).  
Since oligodendrocytes do no strongly express gene 12, and the majority of cells in the 
optic nerve are astrocytes, the widespread blunting of gene 12 expression in the nerve is not an 
indication of non-specificity, but rather strong functionality of the transgene. Based on the 
strength and specificity of the Mbp promoter (Kaya et al., 2012) and potency of the TRΔC 
transgene under all promoters tested here and previously (Buchholz et al., 2003; Das et al., 2002; 
Marsh-Armstrong et al., 2004; Marsh-Armstrong et al., 1999; Nakajima and Yaoita, 2003; 
Schreiber and Brown, 2003), the TRΔC transgene expressed under the Mbp promoter likely 
blunts thyroid hormone mediated transcription in oligodendrocytes at a level comparable to those 
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shown here for the Isl2 and Blbp promoters. Overall, the gene 12 in situ hybridization analysis 
indicates that the expression of the TRΔC transgene is sufficient to block thyroid hormone 
mediated transcription in the major cell types of the optic nerve.  
 
Electron microscopy based quantitative analysis of the optic nerve during metamorphosis in 
animals expressing the TRΔC transgene 
An electron microscopy based quantitative analysis on the optic nerves of animals 
expressing the TRΔC transgene in RGCs, oligodendrocytes, or astrocytes during metamorphic 
optic nerve shortening was performed to determine the contribution of these cell types to the 
remodeling process. The electron microscopy study was similar to the one performed on wild-
type animals described in Chapter 2 with a few minor differences. In this study only the 
metamorphic time-points, Stages 62 and 66, were examined since this is the period of peak 
thyroid hormone levels and related morphological change. Furthermore, the expression of the 
TRΔC transgene was not induced in the animals in which the transgene was driven by the Mbp 
and Blbp promoters in a tetracycline inducible manner until Stage 58 to ensure that any changes 
seen in the optic nerves from these animals could be attributed to the loss of thyroid hormone 
mediated activity during remodeling and not a residual effect from an earlier point in 
development.  
The optic nerves from the TRΔC expressing animals were compared to nerves from a 
control set of animals comprised of a combination of two lines of animals expressing fluorescent 
proteins and should have no effect on remodeling or any other function of the optic nerve cells. 
Since the X. laevis frogs used in this study are an out-bred population, a high degree of natural 
variation across animals is expected, although the progeny derived from the same founder will of 
course be most similar to each other. Ideally, comparisons would be made between siblings who 
differ on their expression of the transgene, however, given the time intensive nature of manual 
tracing, having separate control groups for each transgene was not practical. Therefore, in order 
62 
 
to circumvent the potential problem of natural variation in the measured features amongst the 
transgenic lines that is unrelated to the transgene itself, two different transgenic controls were 
used.  This resulted in the metrics spanning a wider region of the phenotypic space, and thereby 
effectively increased the variability of the control group. Furthermore, the transgenic lines were 
compared to one another, although only significant comparisons between transgenic and control 
lines are shown.  
 
Optic nerve shortening is delayed but not prevented by cell-type specific expression of 
TRΔC transgene 
The analysis of the metamorphic optic nerves from the transgenic lines expressing the 
TRΔC transgene revealed that none of the cell types investigated is directly responsible for the 
shortening of the optic nerve in a thyroid hormone dependent manner.  The expression of the 
TRΔC transgene in each of the cell types tested did result in these animals having significantly 
longer optic nerves at metamorphic climax, Stage 62 (Figure 3.3A). However, this appears to be 
due to a delay rather than an inhibition of shortening since by the end of metamorphosis, Stage 
66, the nerve lengths were generally comparable for all groups (Figure 3.3B). The optic nerves 
from animals expressing the TRΔC transgene under the Mbp promoter remained significantly 
longer at 2.0 ± 0.2 mm compared to controls which were 1.6 ± 0.3 mm at this later stage, but they 
had still shortened between Stages 62 and 66. Therefore, nerve shortening does not occur in direct 
response to thyroid hormone signaling in any one of these cell types alone. The delay seen in all 
the transgenic lines suggests that proper shortening requires the coordinated actions of several 
cell populations in the optic nerve, though it appears likely that thyroid hormone activity in some 
cell types is more influential than others in this process. Furthermore, it is likely that the 
shortening itself is most directly controlled by a different cell type, particularly ones which might 
lie outside of the nervous system altogether, such as the optic nerve sheath and connective tissue 
of the head which also remodel during metamorphic climax.  
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The induction of pre-metamorphic animals with T3 indicated that both nerve shortening 
and myelin segment shortening occur in response to thyroid hormone exposure. However, since 
segment shortening has not been shown to occur outside of whole nerve shortening, it is unclear 
whether segment shortening is directly mediated by thyroid hormone or it is an indirect effect of 
thyroid hormone mediated optic nerve shortening. An analysis of internodal distance was carried 
out on longitudinal optic nerve cryo-sections from animals expressing the TRΔC transgene, 
compared to control animals, at metamorphic climax, Stage 62. Internodal distance was 
determined using maximum intensity projections of confocal imaged optic nerves following 
immunohistochemistry with the paranodal marker Neurofascin in conjunction with the myelin 
marker Mbp and myelinated axon marker 3A10 (Figure 3.3C). In this case, the control nerves 
were derived from transgenic animals containing an inducible form of the transgene, but which 
had not been induced with doxycycline. The internodal distances in optic nerves from animals 
expressing the TRΔC transgene were highly similar to those found in control nerves (Figure 
3.3C). Once again, the internodal distances from the animals expressing the TRΔC transgene 
under the Mbp promoter (32. 5 ± 6.0 μm) were slightly longer than control (27.1 ± 5.5 μm), 
which is consistent with these animals having longer nerves, or a delay in shortening. This further 
supports the notion that myelin segment shortening is coupled to optic nerve shortening, and thus 
is not solely a function of direct thyroid hormone mediated signaling in any of the cell types 
examined.  
 
Expression of TRΔC transgene does not induce cell death or an immune response in the 
optic nerve 
In order to determine whether the expression of the TRΔC transgene affected the viability 
of axons or cells in the optic nerve, an analysis was performed on the optic nerves from these 
animals using the cell death and degeneration marker cleaved-caspase-3. An increase in axon or 
cell death in the optic nerve would be expected to result in an inflammatory immune response, as 
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indicated by an increase in the presence of immune cells such as macrophages or microglia in the 
nerve. I performed immunohistochemistry on longitudinal optic nerve cryo-sections for cleaved-
caspase-3 and the microglia/macrophage marker IB4-lectin-FITC. Optic nerves from animals 
expressing the TRΔC transgene were compared to nerves from siblings that did not express the 
transgene. The optic nerves were quantified using a segmentation based script written by my 
advisor. None of the transgenes showed a significant increase in the amount of cell/axonal death 
(Figure 3.4A-F), however, there was an increase in the number of microglia/macrophages per unit 
area (Figure 3.4G-L) for animals expressing the TRΔC transgene in RGCs in the optic nerve 
during metamorphic climax. Therefore, axon health or viability is likely affected by the loss of 
TRΔC mediated signaling in RGCs. But overall, there does not appear to be a major pathological 
response to the expression of the TRΔC transgene.  
 
Loss of thyroid hormone mediated transcription leads to a decrease in number of 
myelinated axons in optic nerve 
The quantitative analysis of the TEM micrographs from the optic nerves from animals 
expressing the TRΔC transgene in RGCs revealed that these nerves had approximately 30% fewer 
myelinated axons. The optic nerves from the Isl2: GFP-TRΔC (abbreviated as Isl2: TR∆C) 
animals had 509 ± 65 and 585 ± 124 axons compared to control nerves with 746 ± 215 and 910 ± 
179 axons at Stages 62 and 66, respectively (Figure 3.5A-B). Decreases in numbers of myelinated 
axons in the optic nerve have been previously noted in studies from hypothyroid and thyroid 
hormone receptor mutant mouse studies (Baas et al., 2002; Leung et al., 1992). This result, 
however, has generally been attributed to a loss or defect in myelination, but they involved 
global, not cell specific loss of thyroid hormone activity. The decreased number of myelinated 
axons could indicate a specific deficit in new myelination during metamorphosis, or could have 
developed as a result of having a smaller pool of RGC axons available for myelination or most 
likely some combination of both. Retinas from animals expressing the Isl2: TRΔC transgene at a 
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stage prior to metamorphic climax when thyroid hormone levels are low, Stage 56, quantified for 
expression of the RGC marker, rbpms, were found to be indistinguishable from wild-type retinas 
(Figure 3.5C-D). In contrast, retinas from Isl2: TRΔC expressing animals during metamorphic 
climax, Stage 62, contained, on average, approximately 20% fewer rbpms labeled RGCs, as they 
had only 16,900 ± 430 RGCs compared to 21,000 ± 670 RGCs in wild-type retinas (Figure 3.5E-
F). This indicates that the TRΔC transgene in RGCs only produces a phenotype when thyroid 
hormone levels are elevated, as occurs during metamorphic climax.  
The decreased number of RGCs could result from a decrease in cell proliferation or an 
increase in cell death. Quantification of terminal deoxynucleotidyl transferase dUTP nick end 
labeled (TUNEL) retinas showed a nearly two-fold increase in TUNEL positive cells at 
metamorphic climax in retinas from animals expressing the Isl2: TRΔC transgene. TUNEL 
labeling is an indication of DNA fragmentation, which usually occurs in the context of apoptotic 
cell death.  Therefore, the increase in TUNEL positive cells from 0.000016  ± 0.000008 cells per 
unit area in control retinas to 0.000028 ± 0.00001 cells per unit area in Isl2: TRΔC retinas (Figure 
3.5G-H) suggests an increase in the death of RGCs, and that thyroid hormone is important for the 
survival of the RGCs during metamorphosis. The increase in cell death would also account for the 
decreased number of RGCs in these retinas. The increased presence of microglia in the optic 
nerves (Figure 3.4G-H) from these animals then could be due to the reduced viability of RGCs 
and their associated axons.  These findings further suggest that the decreased number of 
myelinated axons in the optic nerves from the Isl2: TRΔC expressing animals is related to a 
decrease in the overall number of RGC axons in the optic nerve, although an additional deficit in 
the ability of RGC axons to recruit oligodendrocytes to initiate myelination cannot be ruled out.  
The optic nerves from the animals expressing the TRΔC transgene in RGCs also had less 
total myelin, as they contained an area of 722 ± 299 μm2 per cross-section, compared to an area 
of 1050 ± 392 μm2 per cross-section in control nerves (Figure 3.5I). This likely occurs as a 
natural extension of these animals having less myelinated axons in their optic nerves. 
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Furthermore, these optic nerves also have approximately one-quarter less debris myelin. The area 
of debris per cross-section is only 151 ± 94 μm2 in Isl2: TRΔC optic nerves compared to 518 ± 
287 μm2 in control nerves (Figure 3.5J). This supports the view that debris myelin is derived from 
remodeling axons rather than degenerating axons, such that less debris is generated when there 
are less myelinated axons to be shortened. 
 
Expression of TRΔC transgene in RGCs produced a severe phenotype in a subset of 
animals.  
The decrease in the number of myelinated axons and overall myelin levels in the optic 
nerves from animals expressing the TRΔC transgene in RGCs were consistent across all animals 
examined at both metamorphic stages. In general, the optic nerves obtained from Isl2: TRΔC 
animals at Stage 62 were similar to one another on all metrics. In contrast, at Stage 66 there was a 
clear dichotomy in the optic nerves on a subset of metrics. These differences were likely due to 
variation in the expression of the transgene in the progeny of the founder lines. A subsequent 
characterization of F1 progeny revealed considerable differences in transgene expression, 
suggesting potential transgene rearrangement. All of the animals used for this study were 
screened for high transgene expression in the eye during early development, through the use of a 
fluorescent reporter, but individual genomic differences between animals may have affected the 
transgene later in development.  
 Interestingly, the axons themselves did not differ between the two groups (Figure 3.6A), 
but rather the myelin sheaths surrounding the axons. In one group of animals, there was little 
space between the axons or between the axon and myelin membranes, while in the other group 
there were large intramyelinic vacuoles and vast expansion of the peri-axonal space (Figure 3.6B-
C). The latter phenotype may have arisen due to an excessive loss of axo-glial adhesive 
attachments during metamorphic remodeling.  It is possible that severe disruption of thyroid 
hormone mediated transcriptional activity in RGC axons, as achieved through very high 
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expression of the TRΔC transgene, negatively affected the expression of genes needed to 
maintain the adhesive complexes bridging axon and myelin membranes. Therefore, as some 
attachments are disrupted in the course of axon shortening, the nearby attachments, which are 
normally maintained, are weak and thus readily lost as well, leading to the unraveling of myelin 
from the axon. In response to the impairment of thyroid hormone receptor activity in RGCs, the 
presence of two distinct groups is not unprecedented. Accelerated degeneration of RGCs was 
found in retinas of a subset of rodents lacking all thyroid hormone receptor isoforms (Baas et al., 
2002). This study had also been unable to determine the exact underlying cause, and similarly 
attributed the disparity to genetic variation.  
 
Optic nerves from animals expressing the TRΔC transgene in oligodendrocytes have 
thinner myelin sheaths and less overall myelin  
The expression of the TRΔC transgene in oligodendrocytes also led to myelin related 
changes in the optic nerve, as might be expected from interfering with myelin producing cells. 
The role of thyroid hormone in myelination is one of the best studied effects of thyroid hormone 
in the central nervous system. In mammals, thyroid hormone has been demonstrated to increase 
the production of mature myelinating oligodendrocytes during development by promoting the 
differentiation of OPCs and expression of myelin associated proteins (Billon et al., 2002; Farsetti 
et al., 1991). The effects of thyroid hormone, however, are highly dependent on the period of 
development. Animals lacking thyroid hormone in their central nervous system during the peak 
period of myelination will experience a delay in myelination and decrease in overall levels of 
myelin (Rodriguez-Pena et al., 1993; Zoeller and Rovet, 2004). Therefore, the loss of thyroid 
hormone in oligodendrocytes exclusively during the period of metamorphic climax might be 
expected to produce delays in myelin remodeling and myelination.  Consistent with these animals 
experiencing a delay and/or reduction in optic nerve shortening during metamorphosis; 
morphologically, their optic nerves more closely resembled those found in pre-metamorphic 
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animals. The myelinated axon sizes in the optic nerves of animals expressing Mbp: rtTA/TetOp: 
GFP-TRΔC (abbreviated Mbp: TR∆C) of 0.52 ± 0.06 μm2 at Stage 62 and 0.70 ± 0.12 μm2 at 
Stage 66 (Figure 3.7A-B) were reminiscent of Stage 58 axons with an average area of 0.68 ± 0.02 
μm2 (Figure 2.3A). These axons were thus much smaller than those found in control optic nerves 
with areas of 0.77 ± 0.20 μm2 and 0.92 ± 0.21 μm2 at Stages 62 and 66, respectively. 
Additionally, the myelin sheaths surrounding these axons were correspondingly smaller such that 
the area of myelin per axon was smaller (3.7C-D) and there was a rightward shift in the 
distribution of G’-ratios (Figure 3.7E), indicative of thinner myelin sheaths in these optic nerves. 
Consequently, the total area of axonal myelin per cross-section in the Mbp: TRΔC optic nerves at 
Stage 66, 473 ± 148 μm2, was significantly less than the area of 761 ±214 μm2 in control nerves 
(Figure 3.7F) 
Since the cross-sectional growth of axons is generally associated with the addition of 
myelin wraps around the axon, the decreased size of the myelinated axons in these nerves could 
be due to a deficit in myelin production by the oligodendrocytes. Alternatively, there could be a 
decrease in the production of the oligodendrocytes themselves, via a decrease in OPC 
differentiation. However, in situ hybridization for pdgfrα and plp on longitudinal optic nerve 
cryo-sections at metamorphic climax (Figure 3.7H) revealed that neither the density of OPCs 
(Figure 3.7I) nor mature oligodendrocytes (Figure 3.7J) was altered in the optic nerves from 
animals expressing the Mbp: TRΔC transgene. This suggests that the differentiation of OPCs into 
myelinating oligodendrocytes was not affected.  Additionally, although the axons were smaller, 
the amount of myelinated axons in these nerves was comparable to the optic nerves from control 
animals (Figure 3.7G). Since individual oligodendrocytes are thought to have a limit to the 
amount of myelin they can produce and maintain, the number of segments they produce is likely 
related to the overall size of the individual segments. Therefore, oligodendrocytes could produce 
many thin segments or fewer thicker ones. If the level of myelin-associated proteins such as Mbp 
and Plp is too low due to a lack of thyroid hormone mediated transcription, the oligodendrocytes 
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would be compromised in their ability to produce new myelin.  Therefore, if the myelin 
producing capacity of each oligodendrocyte in the Mbp: TRΔC optic nerves was limited, then 
each oligodendrocyte might compensate by producing thinner segments. In this way, myelination 
could proceed at a normal rate during metamorphosis.  The decreased size, but normal numbers 
of myelinated axons suggest that the lack of thyroid hormone mediated transcription in the 
oligodendrocytes during metamorphosis reduces overall levels of myelin but does not necessarily 
lead to a loss of myelination.   
Since the optic nerves from the Mbp: TRΔC expressing animals did not shorten to the 
same magnitude as wild-type animals, the myelinated axons would also be expected to experience 
a delay or reduction in remodeling. In most cases, the smaller axon size found in the Mbp: TRΔC 
optic nerves would be an indication of impairment in growth and/or myelination. However, since 
metamorphosis is accompanied by a transient enlargement of the optic nerve and its associated 
axons, the smaller axons size could be due to a lack of this shortening-related axonal hypertrophy. 
If the pre-existing axons remain longer and thinner, their associated myelin sheaths would also be 
less affected.  
The increased internodal distance in these nerves during metamorphic climax suggests 
that myelin segments remain longer and thus are unlikely to develop as many regions of 
dystrophic myelin, such that less ‘excess’ myelin would need to be removed from these segments. 
Indeed, the myelinated axons from the Mbp: TRΔC expressing optic nerves have a decrease in 
the amount of focal axo-glial detachments based on quantification of the associated peri-axonal 
space enlargements in cross-sectional TEM micrographs. The Mbp: TRΔC optic nerve cross-
sections had 0.18 ±0.06 and 0.16 ± 0.04 myelin detachments per axon compared to 0.32 ± 0.09 
and 0.30 ± 0.09 detachments per axon in control nerves at Stages 62 and 66, respectively (Figure 
3.7K-L). Additionally, the area of enlarged peri-axonal space associated with the detachment at 
Stage 66 is, at 43.4 ± 15.6 μm2, also smaller than the peri-axonal space area of 108.2 ± 37.3 μm2 
in control nerves (Figure 3.7M). Furthermore, the amount of debris myelin per optic nerve cross 
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section is decreased from 518 ± 287 μm2 in control nerves to 210 ± 138 μm2 in optic nerves 
expressing the Mbp: TRΔC transgene (Figure 3.7N).  This result is likely related to the decreased 
amount of axonal myelin, such that the area of myelin contained in a detachment or evulsion, and 
thus targeted for removal, would be less for axons with smaller thinner myelin sheaths.  
 
Expression of the TRΔC transgene in astrocytes leads to an impairment in the remodeling 
related removal of excess myelin from axons 
In contrast to the well-studied effect of thyroid hormone on oligodendrocytes and 
myelination, the effect of thyroid hormone on astrocytes is less well understood. In regards to 
thyroid hormone the primary role for astrocytes has historically been its conversion of thyroid 
hormone (T4) to its active form, T3, through the enzyme, deiodinase 2 (Anderson, 2001). This 
enzyme is not expressed in neurons, therefore thyroid hormone mediated transcription in neurons 
is dependent upon the conversion of thyroid hormone and release of active T3 by astrocytes. 
Whether astrocytes themselves were responsive to thyroid hormone had been controversial, yet 
recent evidence suggests that they are directly affected primarily through thyroid hormone 
receptor α (Morte et al., 2004). Similar to oligodendrocytes, the proliferation and maturation of 
astrocytes appears to be sensitive to thyroid hormone, at least during some periods of 
development (Mohacsik et al., 2011).  
The use of the Blbp promoter to drive TRΔC transgene expression in astrocytes could 
also potentially influence other cell types since Blbp is also found in progenitor cell populations 
such as radial glia. However, the use of the tetracycline inducible system allows expression of the 
transgene to be confined to the period of metamorphic remodeling, and thus avoid any potentially 
critical periods of early development. Nevertheless, it is possible that some thyroid hormone 
receptor mediated effects of thyroid hormone in astrocytes also impact other cell types, including 
neurons and oligodendrocytes. However, since the major phenotype was unique in relation to the 
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other cell types examined, it suggests that off-target effects of the TR∆C transgene were likely 
minimal.  
Surprisingly, the optic nerves from animals expressing the TRΔC transgene in astrocytes 
displayed phenotypes indicative of a deficit in the removal of excess myelin from remodeling 
axons during late metamorphosis. Early during the remodeling process, at Stage 62, the axons in 
the optic nerves from animals expressing Blbp: rtTA/TetOp: GFP-TRΔC (abbreviated Blbp: 
TR∆C) were largely similar to nerves from control animals in terms of numbers of myelinated 
axons (Figure 3.8A), axon size (Figure 3.8B), and myelin per axon (Figure 3.8C). There appeared 
to be, however, a delay in myelin remodeling and removal as indicated by a decreased number of 
focal myelin detachments (Figure 3.8D). By Stage 66, there was a clear distinction between optic 
nerves from Blbp: TRΔC expressing and control animals. Interestingly, the number of myelinated 
axons in the optic nerve remained flat during this time with an average of 687 ± 122 axons at 
Stage 62 and 672 ± 160 axons at Stage 66 (Figure 3.8E), suggesting there may be a deficit in new 
myelination. Since Blbp expressing astrocytes have been implicated in promoting the 
differentiation of OPCs, this may explain the effect on myelination. At Stage 62, these nerves 
have a trend toward a decreased ratio of oligodendrocytes/OPCs based on expression of plp and 
pdgfrα (Figure 3.8H), however, this could also be explained by expression of the transgene in 
progenitor cells, and thus may be an off-target effect not directly mediated by the action of 
thyroid hormone in astrocytes.  
 Most strikingly, there was an excess of myelin on the existing axons, as the ratio of 
myelin: axoplasm was elevated from 0.9 ± 0.2 in control nerves to 1.3 ± 0.3 in optic nerves from 
animals expressing Blbp: TRΔC (Figure 3.8F). This was accompanied by an increase in size of 
the focal detachments (Figure 3.8G). Together, these results suggest that optic nerve astrocytes 
also contribute to myelin remodeling during metamorphic optic nerve shortening and places them 
as the potential phagocytic cell population responsible for removing excess myelin from 
shortening axons.  
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The mechanism by which thyroid hormone activity in astrocytes contributes to their 
phagocytosis of myelin remains unclear. In metamorphic pruning in Drosophila, expression of 
the phagocytic receptor Draper is induced in the phagocytic glia in response to the equivalent 
insect metamorphic hormone, ecdysone (Awasaki et al., 2006) (Tasdemir-Yilmaz and Freeman, 
2014). In X. laevis, expression of some phagocytic receptor genes, including megf10, itgB3, and 
lrp1, appear to be slightly reduced in optic nerve astrocytes expressing the TRΔC transgene 
(Figure 3.8I). However, whether thyroid hormone directly affects the transcriptional activity of 
these genes in X. laevis astrocytes remains unknown.   
Similar to its role in mammals, thyroid hormone transcriptional activity may also 
influence the abundance of mature astrocytes, such that a smaller number of astrocytes are 
interacting with axons and removing myelin. However, a metric of the total number of myelin 
interacting and phagocytically active astrocytes cannot reliably be attained from fixed 
preparations and would require live imaging of this dynamic process at a resolution that is not 
currently available. Ultimately, the role of thyroid hormone in myelin removal by astrocytes 
cannot be adequately addressed without an assessment of which genes are transcriptionally 
regulated by thyroid hormone in optic nerve astrocytes during metamorphic climax.  
Overall, the study involving the expression of the thyroid hormone receptor dominant 
negative transgene, TRΔC, under cell-specific promoters in the optic nerve revealed that 
metamorphic optic nerve remodeling involves the coordinated activities of multiple cell types. No 
single cell type was found to control the process, but rather, all three of the major optic nerve cell 
types: RGCs, oligodendrocytes and astrocytes contribute to remodeling in a thyroid hormone 
dependent manner. The major roles of thyroid hormone during remodeling are in the myelination 
of axons and the modulation of the amount of myelin on axons, through control of myelin sheath 





Figure 3.1 Optic nerve shortening is driven by thyroid hormone 
(A) Representative image showing induced metamorphic remodeling of the head in a wild-type 
Stage 54 animal after treatment with exogenous 3,5,3´-´triiodothyronine (T3) for 3 days. Scale 
bar = 5 mm   (B) Optic nerve length of Stage 54 tadpoles treated with T3 compared to untreated 
animals (n= 5 nerves). **P < 0.01 by Student’s t-test.  (C) Internodal distances of myelin 
segments measured from confocal images of longitudinal cryo-sections immunolabeled with 
3A10 and Neurofascin from control and T3-treated Stage 54 animals. Measurements from 32 
axons derived from 4 optic nerves per condition. All measurements show mean ±SD.  ***P < 












Figure 3.2 The TRΔC transgene blocks thyroid hormone mediated transcription in a cell-
type specific manner 
(A) T3-induced gene 12 mRNA (red) is broadly up-regulated in retina by exogenous T3, but in 
Isl2: GFP-TRΔC animals the up-regulation is specifically inhibited in RGCs, which were 
identified by rbpms mRNA (green) expression. Nuclei labeled with Dapi (blue). ONL= Outer 
nuclear layer, INL= Inner nuclear layer, GCL= Retinal ganglion cell layer. Scale bar = 50 μm. (B) 
Gene 12 mRNA signal mean fluorescence intensity in all cells of retina (n= 5 retinas). **P < 0.01 
and ***P < 0.001 by the Games-Howell test. (C) Gene 12 mRNA signal mean fluorescence 
intensity in RGCs only (n= 5 retinas). ***P < 0.001 by Tukey’s test. (D) Gene 12 mRNA signal 
mean fluorescence intensity in all cells of retina except RGCs (n= 5 retinas). **P < 0.01 and ***P 
< 0.001 by the Games-Howell test.  (E) T3-induced gene 12 mRNA (red) up-regulation by T3 in 
the optic nerve, which is primarily in astrocytes, is blunted in the Blbp: rtTA/TetOp: GFP-TR∆C 
ON. In Mbp: rtTA/TetOp: GFP-TRΔC animals, total gene 12 expression is not inhibited, since 
mature oligodendrocytes, identified by expression of plp (green), only weakly express gene 12. 
Scale bar = 50 μm. (F) Up-regulation of gene 12 mRNA (red) in the optic nerve by T3 is 
primarily in Blbp immunolabeled astrocytes (green). Scale bar = 50 μm. (G) Gene 12 mRNA 
signal mean fluorescence intensity in all cells of optic nerve (n= 6, 8, or 5 ON in WT, Blbp or 







Figure 3.3 Optic nerve and myelin segment shortening is not prevented by cell-type specific 
expression of the TRΔC transgene  
(A) Optic nerve length at Stage 62 for animals expressing the TRΔC transgene under the Isl2, 
Mbp, or Blbp promoters compared to a control transgene (n= 8 nerves per transgene). (B) Optic 
nerve length at Stage 66 for animals expressing the TR∆C transgene or a control transgene (n= 8). 
(C) Internodal distances of myelin segments measured from confocal images of longitudinal 
cryo-sections immunolabeled with 3A10 and Neurofascin from animals expressing a control or 
the TRΔC transgene (n= 40 axons from 4 optic nerves per transgene). All measurements show 















Figure 3.4 Expression of TRΔC transgene does not induce cell death or microglia 
infiltration in the optic nerve  
(A) Optic nerve cryo-sections from wild-type or animals at Stage 62 immunolabeled with Mbp 
(myelinated axons, green), cleaved-caspase-3 (degenerating axons, red), Dapi (nuclei, blue) from 
animals expressing the Isl2: GFP-TRΔC transgene (or wild-type control), (C) Mbp: rtTA/TetOp: 
GFP-TRΔC transgene (or non-doxycycline induced control), or (E) Blbp: rtTA/TetOp: GFP- 
TRΔC transgene (or non-doxycycline induced control). Scale bar = 50 μm. (B) Cleaved-caspase-
3 segmented signal normalized per unit area per optic nerve for Isl2: GFP-TRΔC (n= 5 nerves), 
(D) Mbp: rtTA/TetOp: GFP-TRΔC (n= 5 nerves), or (F) Blbp: rtTA/TetOp: GFP-TRΔC (n= 5 
nerves). (G) Optic nerve cryo-sections from wild-type or animals at Stage 62 immunolabeled 
with IB4 lectin-FITC (microglia, green), Laminin (nerve sheath, red), Dapi (nuclei, blue) 
expressing the Isl2: GFP-TRΔC transgene (or wild-type), (J) Mbp: rtTA/TetOp: GFP-TRΔC (or 
non-doxycycline induced), or (L) Blbp: rtTA/TetOp: GFP- TRΔC (or non-doxycycline induced).  
Scale bar = 50 μm. (H) IB4 lectin+ cells in optic nerve parenchyma normalized per unit area Isl2: 
TRΔC (n= 5 nerves), (K) Mbp: rtTA/TetOp: GFP-TRΔC (n= 5 nerves), or (M) Blbp: 
rtTA/TetOp: GFP- TRΔC (n= 5 nerves).   All measurements show mean ± SD. *P < 0.05 by 








Figure 3.5 Thyroid hormone in RGCs is critical for maintenance of RGCs in the retina and 
number of myelinated axons in the optic nerve 
(A) Number of myelinated axons per optic nerve cross section at Stage 62 (n= 8 Isl2: GFP-
TRΔC, n= 15 Control). (B) Number of myelinated axons per optic nerve cross section at Stage 66 
(n= 8 Isl2: GFP-TRΔC, n= 16 Control). (C) Whole-mount retina Stage56 from Isl2: GFP-TRΔC 
or wild-type animal expressing mRNA for the RGC marker, rbpms. Scale bar = 100 μm. (D) 
Number of RGCs per retina at Stage 56 based on expression of rbpms (n= 4, Isl2: TRΔC vs. wild-
type). (E) Whole-mount retina Stage 62 from Isl2: GFP-TRΔC or wild-type animal expressing 
mRNA for rbpms. Scale bar = 100 μm. (F) Number of RGCs per retina at Stage 62 based on 
expression of rbpms (n= 10, Isl2: GFP-TRΔC vs. wild-type). (G) Whole-mount retina Stage 62 
following Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) from Isl2: 
GFP-TRΔC or wild-type animals. Scale bar = 100 μm. (H) Number of TUNEL+ cells in RGC 
layer per retina normalized to area at Stage 62 (n= 10, Isl2: GFP-TRΔC vs. wild-type).  (I) Total 
area of myelin per optic nerve cross-section at Stage 66 (n= 8 Isl2: GFP-TRΔC, n= 16 Control). 
(J) Area of debris myelin per optic nerve cross-section at Stage 66 (n= 8 Isl2: GFP-TRΔC, n= 16 
Control). All measurements show mean ± SD. Values for (A-B, and I-J) were derived from traced 
TEM micrographs. *P < 0.05, **P < 0.01, and ***P < 0.001 by the Games-Howell test (A and J), 









Figure 3.6 Expression of the TRΔC transgene in RGCs produced two distinct phenotypes in 
the optic nerve 
(A) Area of axoplasm per myelinated axon averaged per optic nerve at Stage 66 (n= 8 Isl2: GFP-
TRΔC, n= 12 Control). (B) TEM micrographs of optic nerves from two different animals 
expressing the Isl2: GFP-TRΔC transgene at Stage 66 showing two groups of phenotypes. The 
micrograph on the right shows a hyper-vacuolated phenotype. Scale bar = 2 μm. (C) Area of peri-
axonal space under focal myelin detachments averaged per optic nerve, nerves cluster into two 
groups having either very large or very small peri-axonal vacuoles at Stage 66 (n= 8 Isl2: GFP-
TRΔC, n= 12 Control). All measurements show mean ± SD. Values for A and C derived from 
traced TEM micrographs. Statistical comparisons were made using Dunnett’s test (A) or the 
Games-Howell test (C).  Values based on measurement of 5418 and 2265 axons from Control and 












Figure 3.7 Thyroid hormone in oligodendrocytes is necessary for proper myelination  
(A) Area of axoplasm per myelinated axon averaged per optic nerve at Stage 62 (n= 8 Mbp: 
rtTA/TetOp: GFP-TRΔC, n= 15 Control). (B) Area of axoplasm per myelinated axon averaged 
per optic nerve at Stage 66 (n= 8 Mbp: rtTA/TetOp: GFP- TRΔC, n= 12 Control). (C) Area of 
myelin per axon averaged per optic nerve at Stage 62 (n= 8 Mbp: rtTA/TetOp: GFP-TRΔC, n= 15 
Control). (D) Area of myelin per axon averaged per optic nerve at Stage 66 (n= 8 Mbp: 
rtTA/TetOp: GFP- TRΔC, n= 16 Control). (E) Frequency distribution of G’ratios at Stage 66. 
Calculated as the ratio of the areas bound by the inner to the outer myelin membranes.  (F) Total 
area of myelin on axons per optic nerve cross-section at Stage 66 (n= 8 Mbp: rtTA/TetOp: GFP-
TRΔC, n= 16 Control). (G) Myelinated axons per optic nerve at Stage 66 (n= 8 Mbp: 
rtTA/TetOp: GFP-TRΔC, n= 16 Control) (H) Optic nerve cryo-sections showing mRNA for 
pdgfrα (OPC marker, red), plp (oligodendrocyte marker, green), and nuclear marker Dapi (blue) 
from Mbp: rtTA/TetOp: GFP-TRΔC animals (+/-doxycycline). Scale bar = 50 μm. (I) Pdgfrα+ 
cells per optic nerve cryo-section normalized per unit area (n= 5 nerves). (J) Number of Plp+ cells 
per optic nerve cryo-section normalized per unit area (n= 5 nerves). (K) Focal myelin 
detachments per axon averaged per optic nerve at Stage 62 (n= 8 Mbp: rtTA/TetOp: GFP-TRΔC, 
n= 15 Control). (L) Focal myelin detachments per axon averaged per optic nerve at Stage 66 (n= 
8 Mbp: rtTA/TetOp: GFP- TRΔC, n= 12 Control). (M) Area of peri-axonal space beneath 
detachments per axon averaged per optic nerve at Stage 66 (n= 8 Mbp: rtTA/TetOp: GFP-TRΔC, 
n= 12 Control).  (N) Area of debris myelin per optic nerve cross section at Stage 66 (n= 8 Mbp: 
rtTA/TetOp: GFP-TRΔC, n= 16 Control). Measurements show mean ± SD. Values for A-F and J-
M are derived from traced TEM micrographs and based on measures from 6127 and 3572 axons 
at Stage 62, and 5418 and 3450 axons at Stage 66 from Control and Mbp: rtTA/TetOp: GFP-
TRΔC optic nerves, respectively. *P < 0.01, **P < 0.01, and ***P < 0.001 by the Games-Howell 






Figure 3.8 Loss of thyroid hormone mediated transcription in astrocytes impairs removal of 
excess myelin on remodeling axons  
(A) Number of myelinated axons per optic nerve at Stage 62 (n= 8 Blbp: rtTA/TetOp: GFP-
TRΔC, n= 15 Control). (B) Mean area of axoplasm per myelinated axon averaged per optic nerve 
at Stage 62 (n= 8 Blbp: rtTA/TetOp: GFP-TRΔC, n= 15 Control). (C) Ratio of area of myelin to 
area of axoplasm per axon averaged per optic nerve at Stage 62 (n= 8 Blbp: rtTA/TetOp: GFP-
TRΔC, n= 15 Control). (D) Number of focal myelin detachments per axon averaged per optic 
nerve at Stage 62 (n= 8 Blbp: rtTA/TetOp: GFP-TRΔC, n= 15 Control). (E) Number of 
myelinated axons per optic nerve at Stage 66 (n= 8 Blbp: rtTA/TetOp: GFP- TRΔC, n= 16 
Control). (F) Ratio of area of myelin to area of axoplasm per axon averaged per optic nerve at 
Stage 66 (n= 8 Blbp: rtTA/TetOp: GFP-TRΔC, n= 12 Control).  (G) Percentage of detached 
myelin area relative to axon size at Stage 66 (n= 8 Blbp: rtTA/TetOp: GFP- TRΔC, n= 12 
Control). (H) Ratio of cells expressing mRNA for plp (oligodendrocyte) to pdgfrα (OPC) per 
optic nerve cryo-section for Blbp: rtTA/TetOp: GFP-TRΔC (+/- doxycycline) at Stage 62 (n= 5 
nerves). (I) mRNA for phagocytic receptors itgβ3, lrp1, megf10 (red) and Blbp immunolabeling 
(green) in optic nerve cryo-sections at Stage 62 for Blbp: rtTA/TetOp: GFP-TRΔC (+/- 
doxycycline). All measurements show mean ± SD. Values derived from traced TEM micrographs 
and based on measures of 6127 and 3482 axons at Stage 62, and 5418 and 3014 axons at Stage 66 
from Control and Blbp: rtTA/TetOp: GFP-TRΔC optic nerves, respectively.  *P < 0.05, **P < 
0.01, and ***P < 0.001 by the Games-Howell test (A-C, F-G), or Dunnett’s test (D-E), or 










Chapter 4: Role of phagocytic optic nerve astrocytes in myelin segment remodeling 
 
Metamorphic remodeling of the optic nerve involves the production and resolution of 
small hyper-myelinic dystrophies. The presence of cellular processes contacting myelin evulsions 
on remodeling axons and myelin debris inside cells indicates that the excess myelin is actively 
removed from axons by cells within the optic nerve. The phenotype of excess myelin on axons at 
the conclusion of metamorphic optic nerve shortening in the optic nerves from animals 
expressing a dominant negative version of the thyroid hormone receptor α in astrocytes suggested 
that thyroid hormone signaling in astrocytes is needed for the proper removal of myelin from 
axons during remodeling. This result could indicate that astrocytes are directly involved in myelin 
removal or that thyroid hormone promotes the production and/or secretion of a signal that recruits 
other phagocytic cells. 
 Astrocytes have been shown to phagocytose axonal material during axon degeneration 
(Bechmann and Nitsch, 1997), as well as in non-pathological contexts such as in a homeostatic 
manner in the rodent optic nerve head (Nguyen et al., 2011), during metamorphic pruning in 
Drosophila (Tasdemir-Yilmaz and Freeman, 2014), and developmental synapse elimination in the 
visual system (Chung et al., 2013).  In contrast, the phagocytosis of myelin by astrocytes has only 
been demonstrated in the context of degeneration or de-myelination due to injury (Colavincenzo 
and Levine, 2000; Vaughn and Pease, 1970), aging (Peters, 2002), or disease (Lee et al., 1990). 
Furthermore, the amount of myelin found to be internalized by astrocytes pales in comparison to 
professional phagocytes, such as macrophages. Indeed, the most important role for astrocytes in 
myelin clearance established thus far is the recruitment of macrophages and microglia to lesion 
sites (Skripuletz et al., 2013). Therefore, I wanted to determine whether astrocytes recruit 
microglia into the optic nerve during metamorphic remodeling.  
 
Microglia infiltrate the optic nerve to clear degenerating axons following injury 
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The microglia associated with the optic nerve in X. laevis are primarily localized to the 
optic nerve sheath and infiltrate the optic nerve parenchyma in the context of degeneration 
inducing injury to clear axonal and cellular debris (Goodbrand and Gaze, 1991). Previous studies 
have noted the apparent lack of microglia infiltration in the optic nerve during metamorphosis 
(Cima and Grant, 1982b), therefore I wanted to confirm this observation with a quantitative 
analysis. I used the microglia/macrophage marker IB4-lectin-FITC to label microglia (Naujoks-
Manteuffel and Niemann, 1994) in longitudinal optic nerve cryo-sections.  
First, I confirmed that IB4-lectin-FITC reports microglial infiltration using an injury 
paradigm. The optic nerve was severed behind the eye in Stage 60 tadpoles and the nerves were 
examined 3 days following injury when the animals were beginning to enter metamorphic climax 
(Stage 61). The microglia residing in the optic nerve parenchyma and optic nerve sheath were 
quantified separately for both the cut and contralateral nerves for each animal. The optic nerve 
sheath was defined by immunolabeling for the extracellular matrix glycoprotein laminin. The 
number of IB4-lectin positive cells inside the nerve parenchyma and localized to the optic nerve 
sheath per optic nerve section were manually counted based on expression of both IB4-lectin-
FITC and the nuclear marker Dapi (Figure 4.1A-C). The IB4-lectin-FITC signal per unit area was 
increased in both the optic nerve parenchyma and sheath of the injured optic nerve compared to 
the contralateral control nerve. This indicates that IB4-lectin positive microglia are capable of 
infiltrating the optic nerve during metamorphosis in the context of injury. Furthermore, the 
degenerating axons were rapidly cleared in the injured optic nerves, as indicated by the decrease 
in cleaved-caspase-3 immunolabeled axons from the first day to the third day following nerve 
transection (Figure 4.1D), though myelin debris as indicated by Mbp immunolabeling persisted 
longer. 
Microglia are preferentially localized to the nerve sheath and do not infiltrate optic nerve 
core during metamorphosis 
88 
 
In order to determine whether microglia also infiltrate the optic nerve during the course 
of metamorphic optic nerve shortening, a similar IB4-lectin-FITC analysis was carried out in 
optic nerves from animals at Stages 58, 62 and 66 (Figure 4.1E). There was no increase in the 
amount of IB4-lectin FITC positive cells per unit area during the period of optic nerve 
remodeling in the optic nerve parenchyma (Figure 4.1F). Interestingly, however, there was an 
increase in the amount of IB4-lectin positive cells in the optic nerve sheath during optic nerve 
remodeling as compared to the optic nerves prior to the onset of metamorphic climax (Figure 
4.1G). This suggests that microglia are recruited to the optic nerve sheath but do not infiltrate the 
nerve parenchyma during optic nerve remodeling. Whether astrocytes drive the recruitment of 
microglia to the sheath remains unclear since optic nerves expressing the thyroid hormone 
receptor dominant negative transgene in astrocytes had normal numbers of microglia in both the 
optic nerve core and sheath. In either case, it appears unlikely that microglia are the major 
phagocytes involved in optic nerve remodeling since the debris myelin is localized to cells within 
the optic nerve core and most of the microglia reside in the sheath.  
 
Optic nerve astrocytes express phagocytic genes 
Since astrocytes are not involved in the recruitment of monocytes into the optic nerve, it 
is likely that they are the primary phagocytes involved in the removal of excess myelin from 
remodeling axons during metamorphosis. Transcriptional profiling from purified cortical 
astrocytes from early postnatal mice revealed that at least during development astrocytes are 
enriched in genes involved in phagocytosis (Cahoy et al., 2008). In order to determine whether 
the astrocytes in the optic nerve of X. laevis also express phagocytic genes, I used in situ 
hybridization. Optic nerve cryo-sections from animals at metamorphic climax, Stage 62, were 
found to express phagocytosis associated genes including homologs of the classical C. elegans 
cell death abnormal (ced) genes. The phagocytosis genes expressed in the metamorphic optic 
nerve are: the receptors megf10 (ced-1 homolog candidate) (Hamon et al., 2006; Suzuki and 
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Nakayama, 2007), megf11 (ced-1 homolog candidate) (Wu et al., 2009), lrp1 (ced-1 homolog 
candidate) (Su et al., 2002), itgβ3 (integrin receptor) (Rubartelli et al., 1997), and itgβ5 (integrin 
receptor) (Finnemann et al., 1997), the integrin interacting opsonin mfge8 (Hanayama et al., 
2002), the adaptors:  gulp (ced-6 homolog) (Su et al., 2002) and crkII (ced-2 homolog) (Reddien 
and Horvitz, 2000), the transporter abca1 (ced-7 homolog) (Wu and Horvitz, 1998a), the guanine 
nucleotide exchange factor dock1 (ced-5 homolog) (Wu and Horvitz, 1998b) with its binding 
partner elmo1 (ced-12 homolog) (Gumienny et al., 2001), and the Rho GTPase rac1 (ced-10 
homolog) (Reddien and Horvitz, 2000) (Figure 4.2). Based on the co-localization with the 
astrocyte marker Blbp, the majority of the cells expressing phagocytic genes are astrocytes. A 
subpopulation of cells that strongly express the phagocytic genes, but do not co-localize with 
Blbp can also be found in the optic nerves and likely represent the small population of 
professional phagocytes previously shown to reside in the nerve, as identified by IB4-lectin. The 
expression of these phagocytic genes in astrocytes indicates that optic nerve astrocytes contain 
the phagocytic machinery necessary to remove excess myelin from remodeling axons.  
 
Transgenic intervention of phagocytic machinery in astrocytes using dominant negative 
constructs 
Expression of the phagocytic genes alone, however, does not indicate that the astrocytes 
use their phagocytic machinery during metamorphic nerve shortening. Therefore, an intervention 
was needed to determine whether the phagocytic machinery in astrocytes plays a functional role 
in optic nerve remodeling. Since it is not currently possible to knock-out genes in the 
allotetraploid X. laevis in a conditional manner, I used transgenic over- expression of dominant 
negative constructs in order to selectively interfere with astrocyte phagocytic genes. 
Consequently, my analysis was restricted to genes for which dominant negative constructs were 
possible and had been previously characterized.  
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Lipoprotein receptor related protein 1, Lrp1, is the best receptor candidate to mediate the 
internalization of myelin by astrocytes during optic nerve remodeling. Lrp1 plays an important 
role in lipid metabolism in the central nervous system and has been shown to act as a scavenger 
receptor to clear cellular debris, including necrotic oligodendrocytes and degenerating myelin 
(Beisiegel et al., 1989; Gaultier et al., 2009). Unfortunately, Lrp1 is an approximately 85 kb gene 
which contains numerous functional domains making it an intractable target for transgenic 
overexpression. The NPXY and NPXYXXL domains in the 51 kD cytoplasmic domain of Lrp1 
would be the optimal target sites for intervention, as these sites are involved in the maturation of 
the receptor and mediating internalization (Reekmans et al., 2010), however, this type of 
intervention requires the ability to cell type restrict a knock-in a mutation to a specific site in the 
genome, which is not yet possible in X. laevis.  
Since Lrp1 could not be genetically manipulated in X. laevis, I focused on one of the 
other ced-1 homologs expressed in astrocytes, Megf11. The Multiple-epidermal-growth-factor-
like-domains (MEGF) family of proteins includes several receptors implicated in phagocytosis, 
namely Megf10, Megf11, and Megf12 (also known as Jedi-1 or Pear-1) (Wu et al., 2009). 
Megf10 has been shown to participate as a phagocytic receptor in the nervous system through the 
clearance of apoptotic neurons and during the process of synapse elimination (Chung et al., 2013; 
Scheib et al., 2012).  Over-expression of Megf10 or Megf12 with a truncation of the NPXY and 
YXXL containing cytoplasm domain has been demonstrated to act as a dominant negative 
construct with regard to phagocytic activity, at least in cell culture systems (Wu et al., 2009). 
However, as opposed to previously studied systems with predominantly Megf10 expression, the 
optic nerve astrocytes of X. laevis had very strong expression of Megf11 and much weaker 
expression of Megf10 (Figure 4.2). A C-terminal truncation of Megf11 would also eliminate its 
YXXL domain, and thus due to its high homology with Megf10 (Wu et al., 2009), is likely to also 
function in a dominant negative manner.  Therefore, I attempted to interfere with the phagocytic 
activity of optic nerve astrocytes through the transgenic overexpression of a C-terminal truncated 
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form of Megf11 fused to GFP under the astrocytic Blbp promoter, Blbp: Megf11ΔC-GFP 
(abbreviated Blbp: Megf11ΔC). 
An electron microscopy based quantitative analysis, similar to the one described for the 
thyroid hormone dominant negative transgenic lines in Chapter 3, was performed on the optic 
nerves from animals expressing dominant negative transgenes designed to interfere with 
phagocytic machinery specifically in astrocytes. Since the purpose of the study was to determine 
whether optic nerve astrocytes use their phagocytic machinery to remove excess myelin from 
remodeling axons during optic nerve shortening, the analysis was once again confined to the 
period of active nerve shortening, Stages 62 and 66. The cross-sectional optic nerve TEM 
micrographs were traced and quantified as described for the developmental analysis in wild-type 
animals in Chapter 2. Statistical analysis involved a one-way analysis of variance (ANOVA) and 
post-hoc multiple comparison tests between all six experimental transgenic lines (3 TRΔC 
transgenic lines described in Chapter 3 and 3 phagocytic machinery dominant negative transgenic 
lines described here in Chapter 4) and the control transgenic lines (described in Chapter 3). This 
method increases the stringency of the analysis so that only differences relevant to a particular 
intervention and not the small natural variations that are expected in out-bred populations are 
significant.  
 
Transgenic interference with phagocytic receptor Megf11 has little effect on optic nerve 
remodeling, but may impair degradation of internalized myelin 
The expression of the dominant negative phagocytic receptor, Megf11ΔC, in astrocytes 
did not significantly affect optic nerve remodeling. On nearly all metrics examined, the optic 
nerves from animals expressing the Blbp: Megf11ΔC transgene were similar to nerves from 
animals expressing a control transgene.  As expected for a transgene expressed in astrocytes, 
metrics relevant to RGC axons such as the number of myelinated axons (Figure 4.3A-B) and axon 
size (Figure 4.3C-D) were unaffected at both metamorphic stages. However, metrics related to 
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myelin remodeling and removal, including myelin: axoplasm (Figure 4.3E), the amount and size 
of focal myelin detachments on axons (Figure 4.3F-G), and the amount of debris myelin per optic 
nerve cross-section (Figure 4.3H) were also similar to control nerves.  The amount of myelin on 
axons and the size of the detachment regions on axons are slightly, but not significantly, elevated 
at Stage 66, which might suggest that interfering with only one of the phagocytic receptors 
slightly impairs the removal and internalization of myelin from axons, but overall the system 
compensates and optic nerve remodeling proceeds in a relatively normal manner. This 
compensation is not, however, mediated by the increased presence of professional phagocytes, 
such as microglia, since there was no change in the density of IB4-lectin positive cells in the optic 
nerves of animals expressing Blbp: Megf11ΔC, as compared to a control transgene (Figure 4.3I-
J).  
Interference with the Megf11 phagocytic receptor in astrocytes was not completely 
neutral, and did indeed lead to the production of one prominent phenotype involving debris 
myelin. The unit size of debris myelin was increased in the optic nerves from Blbp: Megf11ΔC 
expressing animals with average areas of 0.9 ± 0.3 μm2 and 1.3 ± 0.3 μm2 compared to the areas 
in control nerves of 0.6 ± 0.2 μm2 and 0.9 ± 0.3 μm2 at Stages 62 and 66, respectively (Figure 
4.3K-L). These results likely occurred due to the expression of multiple phagocytic receptors in 
optic nerve astrocytes such that the loss of any one receptor can be compensated for by an 
increase in uptake of myelin through the other receptors. Additionally, if Lrp1, not Megf11, is 
indeed the primary phagocytic receptor involved in myelin internalization then interfering with 
Megf11 would not be expected to have a major effect on debris myelin internalization. The 
intracellular domains of each receptor which serve as scaffolds for the binding of other proteins 
and initiate signaling cascades (May and Machesky, 2001) however, are not identical amongst the 
various receptors. Therefore, compensation could occur for the internalization of debris, but not 
necessarily for the downstream signaling that accompanies receptor binding. The Megf11ΔC 
construct is missing its intracellular signaling domain, and thus works as a dominant negative 
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when overexpressed by out- competing endogenous receptors for debris binding but failing to 
initiate the intracellular signaling cascades that would normally accompany receptor binding. 
Consequently, due to the high homology between Megf10 and Megf11 in the extracellular 
binding domains, and the lower expression of Megf10 relative to Megf11 in the optic nerve, it is 
likely that the Megf11ΔC construct operates as a dominant negative to diminish the activity of 
both receptors. However, if Megf10 were to have a significantly higher affinity for debris myelin 
than Megf11, the Megf11ΔC construct would have little effect on Megf10 debris binding activity. 
The fate of phagocytosed particles appears to depend on the receptors involved in the 
internalization. The signaling downstream of the ced-1 receptor and homologs such as Megf10 
and Megf11 has been shown to be involved in phagosome maturation, including lysosome based 
acidification (Zhou and Yu, 2008). Lack of Megf10/11 debris binding and intracellular signaling 
might then be expected to lead to normal internalization but impaired acidification, and thus 
degradation of debris, which would be consistent with the increased unit size of debris myelin in 
the optic nerves of Blbp: Megf11ΔC expressing animals.  
 
Mfge8-integrin interaction may also be important for myelin degradation in astrocytes and 
debris clearance  
The integrin receptors β3 and β5 were also expressed in the optic nerve astrocytes of X. 
laevis.  These receptors have also been shown to participate in the phagocytosis of apoptotic cells 
(Rubartelli et al., 1997) and photoreceptor outer segments in mammals (Finnemann et al., 1997). 
The opsonin Mfge8 is a secreted protein that acts as a bridge between apoptotic cells or other 
debris coated with the ‘eat me’ signal of the exposed membrane phospholipid phosphatidylserine 
and integrin receptors on phagocytic cells (Hanayama et al., 2002). A dominant negative version 
of Mfge8 with a point mutation in the RGD integrin binding domain, Mfge8-D89E, can bind to 
exposed phosphatidylserine on debris but cannot bind integrin receptors and thus prevents 
integrin receptor mediated internalization of debris (Hanayama et al., 2002). This dominant 
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negative construct has been used in mammals to impair the phagocytosis of apoptotic cells by 
integrin receptor expressing phagocytes (Akakura et al., 2004; Fuller and Van Eldik, 2008). In 
order to determine the role of integrin receptors in the removal of excess myelin from remodeling 
axons during metamorphic optic nerve shortening, I expressed a mCherry tagged dominant 
negative version of Xenopus Mfge8, Mfge8-D91E, in astrocytes using the Blbp promoter (Blbp: 
Mfge8-D91E-mCherry, (abbreviated Blbp: Mfge8-D91E).  
The loss of Mfge8 in mice has been associated with a hyper responsive immune system, 
but the use of the dominant negative transgene in Xenopus did not lead to an increased presence 
of microglia, as determined by IB4-FITC, in the optic nerve (Figure 4.4A-B). The analysis of 
optic nerve TEM micrographs from animals expressing the Blbp: Mfge8-D91E transgene showed 
a phenotype similar to the nerves from animals expressing the other phagocytic receptor 
transgene, Blbp: Megf11ΔC. At the earlier metamorphic time point, Stage 62, the optic nerves 
appear to show impairment in the generation of debris myelin, likely due to the decreased 
removal of myelin from axons. The total amount of myelin on axons in Blbp: Mfge8-D91E optic 
nerves was similar to control nerves (Figure 4.4C), however the percentage of myelin in the form 
of debris was lower, at only 7.6 ± 2.9% compared to 12.7 ± 4.4% in control nerves (Figure 4.4D).  
In contrast, by Stage 66, the total amount of axonal myelin was still comparable to controls 
(Figure 4.4E), yet the percentage of myelin in the form of debris was now elevated to 34.7 ± 
10.0% compared to 25.3 ± 8.3% in control nerves (Figure 4.4F).  This could be due to a sudden 
increase in the phagocytic activity of the optic nerve astrocytes during late metamorphic climax, 
or, more likely, due to an accumulation of internalized myelin within astrocytes. The latter 
alternative is supported by the slight, but not statistically significant increase in the ratio of 
myelin: axoplasm (Figure 4.4G) and the increased unit size of debris myelin in the optic nerves 
from Blbp: Mfge8-D91E expressing animals at Stage 66 (Figure 4.4H). The unit size of debris 
myelin was 1.5 ± 0.3 μm2 in Blbp: Mfge8-D91E optic nerves compared to 0.9 ± 0.3 μm2 in 
control nerves. This suggests that integrin receptors are involved in the internalization of myelin 
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early in the remodeling process, but once again they are likely not the primary receptors and the 
other phagocytic receptors eventually compensate. The primary role for Mfge8-integrin receptor 
signaling appears to be in mediating the degradation of the internalized debris. A similar role has 
been described for Mfge8 in dendritic cells since the trafficking of internalized debris to acidified 
degradative compartments was found to be impaired in dendritic cells from mice lacking Mfge8 
(Peng and Elkon, 2011).   
Since the Mfge8 transgene was tagged to the fluorophore mCherry, which maintains its 
fluorescence in acidified environments (Shaner et al., 2004), it was possible to visualize Mfge8 
tagged debris in astrocytes during metamorphosis. As a secreted protein, Mfge8 is found 
throughout the optic nerve, however the tagged Mfge8 transgene is not visible unless it is 
concentrated and bound to debris, which occurs when small pieces of debris heavily coated in 
Mfge8 are internalized.  Consequently, Mfge8 tagged to a fluorophore that does not withstand 
internalization or acidification, such as GFP, is not visible in the metamorphic optic nerve (not 
shown). Therefore, the mCherry fluorescent signal detected in the optic nerves from animals 
transgenically expressing a mCherry tagged version of Mfge8 most likely represents Mfge8 
tagged debris that has been internalized by astrocytes. The debris visible by mCherry 
fluorescence is likely to be comprised primarily of myelin, since that is the largest source of 
membranous debris found in the metamorphic optic nerve, however, this could not be confirmed 
because myelin quickly loses antigenicity following internalization (as described in Chapter 2, 
Figure 2.9).  The size of the mCherry tagged particles in astrocytes is larger in optic nerve cross-
sections from animals expressing the dominant negative transgene Mfge8-D91E-mCherry 
compared to nerves from animals transgenically expressing a wild-type version, Mfge8-mCherry, 
in astrocytes (Figure 4.4I). Consequently the overall, mCherry signal was higher in optic nerves 
expressing the dominant negative relative to the wild-type version of the Mfge8 transgene. This 
increase occurred at a developmental time point prior to optic nerve shortening, Stage 58, and 
during shortening at Stages 62 and 66 (Figure 4.4J). Although there is much less debris in the 
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optic nerve at Stage 58, some myelin/membranous debris does exists at this stage and is likely 
derived from degenerating axons. If Mfge8-integrin mediated internalization and/or signaling is 
important for the degradation of membranous debris in general, and not specific to metamorphic 
remodeling, then internalized debris generated throughout development would be expected to 
accumulate in astrocytes in animals expressing the Mfge8-D91E transgene. Alternatively, it is 
possible that the interaction with integrin is necessary for Mfge8 to disengage with internalized 
debris, such that the mCherry tagged transgene is reporting an increase in internalized debris still 
tagged with Mfge8, and not necessarily an overall buildup of astrocyte internalized debris. The 
debris myelin phenotypes seen in these animals in the TEM micrograph analysis suggest that 
membranous debris is indeed accumulating in the astrocytes. Although there is no increase in the 
amount of Mfge8-mCherry signal per unit area in the optic nerve during metamorphic climax, the 
cross-sectional area greatly increases as the nerve undergoes a transient hypertrophy at this time 
(Figure 2.2B), thus the overall amount of mCherry signal increases, but does so in proportion 
with the size of the nerve.  
 
Lysosomes and lipid droplets increase in astrocyte processes during metamorphic optic 
nerve remodeling 
The build-up of Mfge8 tagged debris within astrocyte processes in the optic nerves of 
animals expressing a dominant negative version, but not a wild-type version of Mfge8, suggests 
that debris internalized by astrocytes is normally degraded and/or released by the astrocyte. In 
order to determine whether there was an increase in the presence of degradative machinery in the 
optic nerve, I used a transgenic reporter for the tetraspaninin CD63, which is a lysosomal 
associated protein (Metzelaar et al., 1991) which has been shown to promote lysosome based 
degradation in other contexts (Takino et al., 2003). Therefore, an increase in CD63 would be 
expected to indicate an increase in overall lysosome based degradation. The use of a CD63 
reporter tagged to mCherry and driven in astrocytes with the Blbp promoter (Blbp: CD63-
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mCherry) revealed an increase in the amount of CD63-mCherry signal per unit area in optic nerve 
cross-sections at Stage 66, relative to Stages 58 and 62 (Figure 4.5A-B). The large increase in 
CD63 during the stage with the largest amount of debris myelin in the optic nerve, suggests it is 
involved in the degradation of debris, however, it is also possible that CD63 simply increases in 
astrocytes during metamorphosis independent of nerve remodeling.  
The increase in CD63 suggests that degradative processes are occurring within astrocytes 
during metamorphic climax, but does not address whether they are related specifically to the 
degradation of internalized myelin.  Lipid droplets are lipid storage organelles involved in lipid 
metabolism.  Although they can be found in most cells, their abundance generally increases in 
phagocytic cells following the internalization of lipid rich cellular debris (Franson, 1985). Since 
myelin is extremely lipid, particularly cholesterol, rich the internalization of myelin by 
phagocytes is associated with the formation of lipid droplets, as a temporary storage for some the 
lipids most intractable to digestion by the cell (Bignami and Ralston, 1969; Stoll et al., 1989). The 
developmental TEM micrograph based analysis in wild-type optic nerves revealed an increase in 
the presence of lipid droplets, particularly in cells containing internalized myelin, during 
metamorphic nerve remodeling. The use of a fluorescently tagged lipid membrane reporter 
(Zehmer et al., 2008) expressed in astrocytes, Blbp: hA-AMB-mCherry, revealed that lipid 
droplets increase in astrocytes during metamorphic climax (Figure 4.5C-D). This further supports 
the hypothesis that astrocytes are the phagocytic cells in the optic nerve involved in removal of 
myelin from remodeling axons, and that they are capable of at least partially degrading the myelin 
they internalize.  
The localization of mCherry visualized debris and lipid droplets in astrocyte processes, 
particularly along the pial lining suggest that the astrocytes may be releasing some of the more 
intractable lipid debris into the nerve sheath to be picked up by the resident microglia. The 
buildup of lipid debris in processes abutting the pial lining, no longer identifiable as myelin, is 
also visible in the TEM micrographs (Figure 4.5E). Furthermore, similar lipid debris and lipid 
98 
 
droplets are present in cells residing in the nerve sheath (Figure 4.5F), which supports the idea 
that myelin debris partially broken down by astrocytes is ultimately cleared from the nerve into 
the nerve sheath, which contains vasculature and professional phagocytes.  
 
Interfering with Rac1 impairs the removal of myelin associated with focal axon-myelin 
detachments on remodeling axons 
Due to the presence of multiple phagocytic receptors and the potential for compensation, 
interfering with the receptors had little effect on optic nerve remodeling overall. Intervention with 
the candidate phagocytic receptors in astrocytes produced phenotypes related to the processing of 
debris myelin after it had been internalized which indicates that optic nerve astrocytes are indeed 
internalizing myelin, but does not indicate the source of the myelin.  Therefore, I chose to target 
the Rho GTPase Rac1, which is involved in the re-organization of the actin cytoskeleton 
necessary for phagocytic activity and downstream of the multiple receptor pathways (Castellano 
et al., 2000; Chimini and Chavrier, 2000). I used the construct of GFP tagged Rac1-N17 which 
acts as dominant negative (Feig and Cooper, 1988) since this form of Rac1 preferentially binds 
and thereby sequesters GEFs, thus preventing them from activating endogenous Rac 
(Schweighoffer et al., 1993). The GFP-Rac1-N17 construct was transgenically overexpressed in 
astrocytes using the Blbp promoter in a tetracycline inducible manner, Blbp: rtTA/ TetOp: GFP-
Rac1-N17 (referred to as Blbp: RacN17). In order to circumvent potential developmental defects 
due to the disruption of the actin cytoskeleton in astrocytes, the transgene was induced just prior 
to metamorphic nerve remodeling, starting at Stage 58.  
Visualization of the transgene using immunohistochemistry for GFP revealed that the 
transgene is not uniformly expressed in the optic nerve astrocytes (Figure 4.6A).  Some 
astrocytes, preferentially located near the periphery of the nerve had high levels of GFP 
expression and showed a dystrophic morphology whereby they appear to have retracted some of 
their cell processes. This phenotype seems consistent with a disruption to the actin cytoskeleton, 
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as would be expected from a mutation in Rac1. Most of the astrocytes, however, have moderate 
levels of GFP expression and relatively normal morphology. The reason for this discrepancy is 
unclear and may indicate that the Blbp: RacN17 transgene is only expressed at a high enough 
level to effectively act as a dominant negative in a subset of astrocytes, and thus the potency of 
this intervention may be reduced.  
Similar to the other transgenic interventions tested, the expression of the Blbp: RacN17 
transgene did not change the amount of microglia, as determined by IB4-FITC, localized to the 
optic nerve (Figure 4.6B-C).  A quantitative analysis of cross-sectional optic nerve TEM 
micrographs at Stages 62 and 66, as described for the other transgenic lines was undertaken for 
the Blbp: RacN17 transgene expressing animals. At Stage 62, the optic nerves from the animals 
expressing the Rac1 dominant negative transgene in astrocytes were similar to control nerves on 
most metrics, however, there appears to be a specific deficit in the presence of lamellar 
enwrapped debris myelin when debris is categorized in accordance with the classification scheme 
described in Chapter 2 (Figure 2.10A-B). The fraction of lamellar enwrapped debris is reduced 
from 14.1 ± 7.8% in control nerves to 4.4 ± 5.3% in optic nerves from animals expressing the 
Blbp: RacN17 transgene (Figure 4.6D). This phenotype is consistent with the role of Rac in the 
remodeling of the actin cytoskeleton, and may be related to the altered astrocyte morphology and 
reduction in process extension seen in nerves from these animals at this stage at the light level.  
The decrease in lamellar enwrapped debris suggests an impairment in the removal of 
myelin from axons during optic nerve remodeling. By Stage 66, evidence for a myelin removal 
defect is apparent. Similar to the expression of the thyroid hormone dominant negative transgene 
in astrocytes, interference with the ability of the actin cytoskeleton to remodel in astrocytes led to 
an increase in the ratio of myelin: axoplasm for optic nerve axons. The ratio of myelin: axoplasm 
was elevated from 0.9 ± 0.2 in control nerves to 1.2 ± 0.2 in Blbp: RacN17 optic nerve at Stage 
66 (Figure 4.6E). However, unlike in the animals expressing the Blbp: TRΔC transgene, the 
number and size of the myelinated axons in the optic nerves from Blbp: RacN17 expressing 
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animals were comparable to control nerves (Figure 4.6F-G). Also, unlike intervention with the 
individual phagocytic receptors, the unit size of internalized myelin was similar to control nerves 
(Figure 4.6H), suggesting that the myelin which is internalized is processed and degraded 
normally, and further supports the hypothesis that myelin degradation is controlled by specific 
receptor mediated signaling pathways.  Instead these nerves showed a trend toward less debris 
myelin (Figure 4.6I).  
Additionally, the optic nerves show evidence of excess myelin remaining on axons 
through an increase in both the number and size of focal axon-myelin detachments (Figure 4.6J-
K), which are clearly visible in the TEM micrographs from these nerves (Figure 4.6L). The area 
of the peri-axonal space beneath the detachments doubles from 108 ± 37 μm2 in control nerves to 
218 ± 59 μm2 in nerves expressing Blbp: RacN17.  This suggests that interfering with astrocyte 
machinery involved in the reorganization of the actin cytoskeleton necessary for phagocytic 
activity impairs the removal of myelin from axons during metamorphic optic nerve remodeling. 
Overall, transgenic intervention of components of the phagocytic machinery in astrocytes 
during metamorphic optic nerve remodeling led to a reduction in the removal of myelin from 
axons and the degradation/clearance of the internalized myelin which was not compensated for by 
an increase in professional phagocytes, such as microglia. Interfering with individual phagocytic 
receptors did not significantly affect levels of myelin removal/internalization likely due to the 
presence of multiple phagocytic receptors and produced primarily defects in myelin degradation. 
Targeting the downstream effector Rac1, circumvented the compensatory effect of multiple 
receptors and led to optic nerves with too much dystrophic myelin remaining on axons by the end 
of nerve shortening. Together these results place astrocytes as the primary phagocytes in the 




Figure 4.1 Microglia infiltrate the optic nerve during injury but not during metamorphic 
remodeling 
(A) Microglia, labeled with IB4 lectin-FITC (green), found in Laminin-immunolabeled optic 
nerve sheath (red) and optic nerve parenchyma, in optic nerve longitudinal cryo-sections. IB4-
lectin+ microglia infiltrate the optic nerve parenchyma in Stage 60 animals 3 days after optic 
nerve transection. Nuclei labeled with Dapi (blue). Scale bar = 50 μm. (B) IB4 lectin+ cells per 
optic nerve cryo-section normalized to area in the optic nerve parenchyma 3 days after transection 
(n= 5). (C) IB4 lectin+ cell per optic nerve cryo-section normalized to area in the optic nerve 
sheath (n=5). (D) Optic nerve longitudinal cryo-sections immunolabeled with cleaved-caspase-3 
(degenerating axons, red) or Mbp (myelin, red), IB4 lectin-FITC (microglia, green) and Dapi 
(nuclei, blue) on Days 1, 2, and 3 following optic nerve transection at Stage 60. Scale bar = 50 
μm. (E) Optic nerve longitudinal cryo-sections immunolabeled with IB4 lectin-FITC, Laminin, 
and Dapi at Stages 58, 62, and 66. Scale bar = 50 μm. (F) IB4 lectin+ cells per optic nerve cryo-
section normalized to area in the optic nerve parenchyma (n= 5 per stage). (G) IB4 lectin+ cells 








Figure 4.2 Optic nerve astrocytes express phagocytic genes 
 Optic nerve longitudinal cryo-sections show that astrocytes, immunolabled with Blbp (green), 
express the mRNAs (red) for phagocytic genes, including abca1, crkII, dock1, elmo1, gulp, itgβ3, 























Figure 4.3 Transgenic interference with Megf11 does not prevent remodeling and leads to 
larger debris myelin 
(A) Number of myelinated axons per optic nerve at Stage 62 (n= 8 Blbp: Megf11ΔC-GFP, n= 15 
Control). (B) Number of myelinated axons per optic nerve at Stage 66 (n= 8 Blbp: Megf11ΔC-
GFP, n= 16 Control). (C) Mean area of axoplasm per myelinated axon averaged per optic nerve 
at Stage 62 (n= 8 Blbp: Megf11ΔC-GFP, n= 15 Control). (D) Mean area of axoplasm per 
myelinated axon averaged per optic nerve at Stage 66 (n= 8 Blbp: Megf11ΔC-GFP, n= 12 
Control). (E) Ratio of area of myelin to area of axoplasm per axon averaged per optic nerve at 
Stage 66 (n= 8 Blbp: Megf11ΔC-GFP, n= 12 Control). (F) Number of focal myelin detachments 
per axon averaged per optic nerve at Stage 66 (n= 8 Blbp: Megf11ΔC-GFP, n= 12 Control). (G) 
Area of peri-axonal space beneath focal myelin detachments at Stage 66 (n= 8 Blbp: Megf11ΔC-
GFP, n= 12 Control).  (H) Debris myelin area per optic nerve at Stage 66 (n= 8 Blbp: Megf11ΔC-
GFP, n= 16 Control). (I) Optic nerve cryo-section immunolabeled with IB4 lectin-FITC 
(microglia, green), Laminin (nerve sheath, red), and Dapi (nuclei, blue) from Blbp: Megf11ΔC-
GFP and control (wild-type) animals at Stage 62. Scale bar = 50 um. (J) IB4 lectin+ cells per 
optic nerve cryo-section normalized to area in optic nerve parenchyma (n= 5). (K) Mean unit size 
of debris myelin averaged per optic nerve at Stage 62 (n= 8 Blbp: Megf11ΔC-GFP, n= 15 
Control). (L) Mean unit size of debris myelin averaged per optic nerve at Stage 66 (n= 8 Blbp: 
Megf11ΔC-GFP, n= 16 Control). All measurements show mean ±SD. Values for A-H and K-L 
derived from traced TEM micrographs and based on the measurement of 6127 and 3467 axons at 
Stage 62, and 5814 and 3187 axons at Stage 66 from the Control and Blbp: Megf11ΔC-GFP optic 
nerves, respectively.  **P < 0.01 and ***P < 0.001. Statistical comparisons made using the 
Games-Howell test (A, C, E, G, H, L), Dunnett’s test (B, D, F, K), or Student’s t-test with 








Figure 4.4 Transgenic interference with Mfge8-Integrin receptor association primarily leads 
to larger debris myelin 
(A) Optic nerve longitudinal cryo-sections at Stage 62 immunolabled with IB4 lectin-FITC 
(microglia, green), Laminin (nerve sheath, red), Dapi (nuclei, blue) from animals expressing a 
transgene for the wild-type or dominant negative (Mfge8D91E) version of Mfge8 in astrocytes. 
(B) IB4 lectin+ cells per optic nerve cryo-section normalized to area in the optic nerve 
parenchyma (n= 5 Blbp: Mfge8-mCherry vs. Blbp: Mfge8D91E-mCherry). (C) Total area of 
myelin on axons at Stage 62 per optic nerve cross-section (n= 8 Blbp: Mfge8D91E-mCherry, n= 
15 Control). (D) Percent of optic nerve myelin in the form of debris at Stage 62 per optic nerve 
cross-section (n= 8 Blbp: Mfge8D91E-mCherry, n= 15 Control). (E) Total area of myelin on 
axons at Stage 66 per optic nerve cross-section (n= 7 Blbp: Mfge8D91E-mCherry, n= 16 
Control). (F) Percent of optic nerve myelin in the form of debris at Stage 66 per optic nerve 
cross-section (n= 7 Blbp: Mfge8D91E-mCherry, n= 16 Control). (G) Ratio of area of myelin to 
area of axoplasm per axon averaged per optic nerve at Stage 66 (n= 7 Blbp: Mfge8D91E-
mCherry, n= 12 Control). (H) Mean unit size of debris myelin per optic nerve cross-section at 
Stage 66 (n= 7 Blbp: Mfge8D91E-mCherry, n= 16 Control). (I) Immunofluorescence due to 
Blbp: Mfge8-mCherry or Blbp: Mfge8D91E-mCherry transgenes in optic nerve cross-sections at 
Stage 66. mCherry fluorescence (red) within Blbp immunolabeled astrocytes (green) is higher in 
animals expressing the dominant negative construct. Scale bar = 50 µm.  (G) The mCherry signal 
per unit area is elevated in the Mfge8D91E-mCherry transgene relative to the Mfge8-mCherry 
transgene at all stages. All measurements show mean ± SD. Values for C-H derived from traced 
TEM micrographs based on the measurement of 6127 and 2790 axons at Stage 62 and 5418 and 
2466 axons at Stage 66 in the Control and Blbp: Mfge8D91E optic nerves, respectively. *P < 
0.05 and ***P < 0.001 by Student’s t-test (B), the Games-Howell test (C, E, G, H, J), or 










Figure 4.5 Lysosomes and lipid droplets localized to astrocyte processes increase during 
metamorphic optic nerve remodeling 
(A) Immunofluorescence due to Blbp: CD63-mCherry transgene (exosome/lysosome marker, red) 
accumulates in processes of Blbp immunolabeled astrocytes (green) in optic nerve cross-sections 
shown at Stages 58 and 66. Scale bar = 50 μm. (B) The mCherry signal for Blbp: CD63-mCherry 
per unit area is elevated at Stage 66. Measures show mean ± SD (n= 10 optic nerves per stage). 
*P < 0.05 as assessed by the Games-Howell test. (C) Immunofluorescence due to Blbp: A-AMB-
mCherry transgene (lipid droplet marker, red) accumulates in processes of Blbp immunolabeled 
astrocytes (green) during metamorphosis in optic nerve cross-sections shown at Stages 58 and 66. 
Scale bar = 50 μm. (D) The mCherry signal for Blbp: A-AMB-mCherry per unit area is elevated 
at metamorphic Stages 62 and 66 (n= 10 optic nerves per stage). (E) TEM micrographs of optic 
nerve at Stage 66 showing accumulation of debris myelin and lipid droplets in astrocyte processes 
(boxed area) contacting the pial lining of the nerve. Scale bar = 1 μm. (F) TEM micrographs of 
optic nerve at Stage 66 showing accumulation of lipid droplets in microglial cells (arrows) 
located in optic nerve sheath. Scale bar = 1 μm. All measurements show mean ± SD.  *P < 0.05 


















Figure 4.6 Transgenic interference with Rac1 impairs the removal of myelin from 
remodeling axons during metamorphosis 
(A) Optic nerve longitudinal cryo-section from Blbp: rtTA/TetOp: GFP-Rac1N17 expressing 
animals at Stage 62 immunolabeled with GFP (transgene, green), Blbp (astrocytes, red), and Dapi 
(nuclei, blue) showing that the transgene is expressed at highest level in a subset of astrocytes 
near the periphery of the optic nerve. Scale bar = 50 μm. (B) Optic nerve longitudinal cryo-
sections from animals containing the Blbp: rtTA/TetOp: GFP-Rac1N17 transgene at Stage 62 that 
were untreated or treated with doxycycline to induce transgene expression,  immunolabeled with 
IB4 lectin-FITC (microglia, green), Laminin (nerve sheath, red), and Dapi (nuclei, blue). (C) IB4 
lectin+ cells per optic nerve cryo-section normalized to area in Blbp: rtTA/TetOp: GFP-Rac1N17 
animals with or without doxycycline (n= 5). (D) Percentage of debris myelin enwrapped by 
lamellar processes at Stage 62 per optic nerve cross-section (n= 8 Blbp: rtTA/TetOp: GFP-
RacN17, n= 15 Control). (E) Ratio of area of myelin to area of axoplasm per axon averaged per 
optic nerve at Stage 66 (n= 8 Blbp: rtTA/TetOp: GFP-Rac1N17, n= 12 Control). (F) Number of 
myelinated axons per optic nerve at Stage 66 (n= 8 Blbp: rtTA/TetOp: GFP-Rac1N17, n= 16 
Control). (G) Area of axoplasm per axon averaged per optic nerve cross- section at Stage 66 (n= 
8 Blbp: rtTA/TetOp: GFP-Rac1N17, n= 12 Control). (H) Mean unit debris myelin size at Stage 
66 per optic nerve cross-section (n= 8 Blbp: rtTA/TetOp: GFP-Rac1N17, n= 16 Control). (I) 
Total area of debris myelin per optic nerve cross-section at Stage 66 (n= 8 Blbp: rtTA/TetOp: 
GFP-Rac1N17, n= 16 Control). (J) Number of focal myelin detachments per optic nerve cross-
section at Stage 66 (n= 8 Blbp: rtTA/ TetOp: GFP-Rac1N17, n= 12 Control). (K) Total area of 
peri-axonal space beneath focal myelin detachments per optic nerve cross-section (n= 8 Blbp: 
rtTA/TetOp: GFP-Rac1N17, n= 12 Control). (L) TEM micrograph of Blbp: rtTA/TetOp: GFP-
Rac1N17 at Stage 66 showing enlargements of the myelin detachments on axons and expansion 
of peri-axonal space. Scale bar = 2 μm. All measurements show mean ± SD. Values for D-K were 
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derived from traced TEM micrographs and based on the measurement of 5418 and 2840 axons at 
Stage 66 from Control and Blbp: rtTA/TetOp: GFP-Rac1N17 optic nerves, respectively. *P < 
0.05, ** P < 0.01 and ***P < 0.001 by Student’s t-test (C), Dunnett’s test (D, F, G), or the 








Chapter 5: Discussion  
 
My thesis work has demonstrated that the metamorphic shortening of the optic nerve in 
Xenopus laevis involves the thyroid hormone regulated remodeling of myelin segments by 
phagocytic astrocytes. This remodeling requires the coordinated activities, as mediated by thyroid 
hormone, of the three major cell types of the optic nerve; the RGC axons, the myelinating 
oligodendrocytes, and the astrocytes. It also occurs within the context of massive cell 
proliferation and new outgrowth, such that new axons are being myelinated while the segments 
on pre-existing axons are being shortened. During axon shortening, small regions of myelin lose 
their interaction with the axon membrane. The dystrophic myelin in these detached regions is 
then selectively removed from the myelin segments by local astrocyte processes using classical 
phagocytic machinery.  
 
Role of thyroid hormone in optic nerve shortening 
Although the shortening of the optic nerve clearly occurs in a thyroid hormone dependent 
manner, as it can be induced prematurely through exposure to exogenous T3, it is not driven as a 
direct response to thyroid hormone mediated signaling in any one of the major cell types of the 
optic nerve. Therefore, it is likely that the shortening of the nerve occurs indirectly, through the 
thyroid hormone mediated remodeling of muscular and connective tissues in the head. 
Metamorphic tissue remodeling in other organ systems in X. laevis, have been shown to involve 
non-cell-autonomous effects of thyroid hormone through cell-cell interactions or molecular 
signals derived from the extracellular matrix (Ishizuya-Oka, 2011). Consequently, it may be that 
cues from the connective tissue of the sheath drives the shortening of the axons in the optic nerve 
itself. Incidentally, the use of the Mbp promoter to drive the dominant negative thyroid hormone 
receptor transgene (TRΔC) produced a slight deficit or delay in optic nerve shortening, which 
may be attributable to expression in facial connective tissues, which could be detected through a 
fluorescent reporter in young pre-metamorphic tadpoles. Also, optic nerve shortening is not a 
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general feature of amphibian metamorphosis, but rather occurs only in a subset of animals such as 
X. laevis, which have laterally oriented eyes during the larval period and whose head greatly 
decrease in size (Hoskins, 1990). Therefore, it may have made more sense evolutionarily for 
nerve shortening/remodeling to be initiated in response to head growth related signaling.  
 
Hypertrophy of optic nerve during shortening 
A striking feature of the optic nerve at metamorphic climax is the hypertrophy that 
accompanies shortening. This massive increase in nerve diameter is not simply a function of the 
compression of axons, but rather involves the expansion of cellular components and the 
extracellular space, as revealed through electron microscopy. Increases in extracellular fluid are 
usually associated with trauma in the nervous system, which results in the breakdown of tissue 
partitions or cellular membranes thus causing an ionic imbalance. Similarly, tissue edema can 
also occur due to a disruption in the homeostatic functioning of astrocytes (Chen and Swanson, 
2003; Manley et al., 2004; Stokum et al., 2014). In the metamorphic optic nerve, a shortening 
related disruption in the epithelial cells or extracellular matrix of the nerve sheath could lead to an 
increase in extracellular fluid in the nerve parenchyma from the subarachnoid space. 
Additionally, a disruption in the flushing of nerve fluid (Xie et al., 2013) into the sheath space, 
which in mammals also involves transient increases in extracellular space, by pial lining 
contacting astrocytes could lead to a similar phenotype. This could occur due to a shortening 
related disturbance in the attachment points of astrocyte endfeet, or thyroid hormone mediated 
changes in astrocyte function, such as the retraction or mobilization of cell processes in order to 
mediate the phagocytic removal of myelin from axons. The hypertrophy of the nerve likely 
occurs through a combination of these and other factors. However, as opposed to injury where 
such hypertrophy would be an indication of pathology and thus deleterious to the health of the 
tissue, the expansion of the optic nerve during metamorphosis is part of a highly regulated 
developmental process which may be beneficial to the remodeling process. Similarly high levels 
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of extracellular space are also seen in the optic nerve during early development in mammals, 
particularly during the time of myelination (Williams et al., 1986). Thus the expansion of the 
optic nerve may provide space for the new outgrowth and myelination of RGC axons. 
Furthermore, similar to pathological conditions, the space may provide for an increase in the 
number and mobility of phagocytes, which may enhance the efficiency of debris clearance.  
 
Optic nerve remodeling does not involve an immune response 
As a period of extensive nervous system remodeling, cell death is a major feature of 
metamorphosis. However, in the optic nerve, RGC axon loss is generally associated with new 
RGCs, and likely reflects a failure in establishing proper connections with the target tissue. In X. 
laevis, the retina grows and adds new RGCs throughout the life of the animal (Straznicky and 
Hiscock, 1984; Wilson, 1971). The cells are born in the ciliary marginal zone and thus the newest 
RGCs are located at the margins of the retina (Feldman and Gaze, 1972). Based on the 
organization of the optic nerve, the axons of these new RGCs are generally localized to the 
periphery of the nerve, particularly in the ventral region (Cima and Grant, 1982a, b). 
Consequently, immunolabeling for the dying axon marker, cleaved-caspase-3, confirmed that 
similar to pre-metamorphic nerves, the majority of dying axons during metamorphic climax are 
derived from newly projecting RGCs. Furthermore, these axons tend to be small and 
unmyelinated, whereas the myelinated axons are primarily localized to the central core of the 
nerve, which contains the largest and oldest axons (Cima and Grant, 1982a). Since these 
myelinated axons have longer lasting, more stable connections they are less prone to loss (Fried et 
al., 1982; Jenkins and Straznicky, 1986). Thus, the majority of the debris from axons undergoing 
Wallerian degeneration is derived from unmyelinated axons and is likely cleared in a typical 
manner by the small population of microglia in the optic nerve. Normally, there are very few 
microglia located within the optic nerve parenchyma in X. laevis, but they can be readily induced 
following axonal damage, suggesting their main role is in the removal of damaged cells 
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(Goodbrand and Gaze, 1991). The ratio of microglia to dying axons is generally maintained 
throughout metamorphosis, as both were found to increase proportionally with nerve area, such 
that when normalized to area, these metrics are unchanged throughout development in late stage 
tadpoles. Therefore, the microglia in the optic nerve appear to be involved in the clearance of a 
small population of primarily unmyelinated degenerating axons, and not in the shortening 
induced remodeling of myelin segments.  
 
Optic nerve remodeling involves the production of focal myelin detachments on axons 
In contrast, during metamorphosis, the removed myelin is not associated with 
degenerating axons or localized to debris fields in the extracellular space, but rather is selectively 
removed from intact myelin segments ensheathing axons. During optic nerve shortening, myelin 
segments develop focal detachments from the axons they ensheath. These detachments 
preferentially take place in the central region of the optic nerve. This likely reflects the 
developmental pattern of myelination, which starts in the center of the nerve and proceeds in a 
bidirectional manner, indicating that this region would have the highest density of myelin (Cima 
and Grant, 1982b). Additionally, the axons are likely to experience the greatest loss of tension in 
the center as the head and nerve sheath shorten, thereby leading to the bending or branching of 
the axons which occurs during metamorphic climax. This torsion then likely disrupts the already 
weak interactions between the axon and myelin membranes, leading in turn to the formation of 
these focal detachments.   
These detachments also form preferentially at internodal regions, which may be the result 
of the adhesive attachments between myelin and axons being stronger at paranodal than 
internodal regions (Tait et al., 2000). The formation of these detachments, and the shortening of 
the myelin segments overall, which also likely requires a decrease in the adhesion of the axo-glial 
complexes at paranodal regions, may be facilitated by the characteristic composition and 
maturation state of X. laevis myelin during metamorphosis. The myelin of X. laevis tadpoles, 
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similar to juveniles in other species, is poor in myelin proteins, like Mbp, and galactolipids, both 
of which are important for providing stability to the myelin structure (Okamura and Kishimoto, 
1983; Trapp et al., 1980). Moreover, a loss or lack of these components destabilize axo-glial 
interactions and leads to the formation regions of myelin which have lost contact with an axon 
and associated expansions of the peri-axonal space (Marcus et al., 2002), similar to the focal 
myelin detachments seen during metamorphic remodeling. The levels and composition of 
cerebroside, a class of galactolipid and major lipid component of myelin, affect myelin 
compaction and stability (O'Brien, 1965). Notably, the characteristic composition of cerebrosides 
in X. laevis differ significantly from mammalian myelin in having a greater proportion of 
unsaturated fatty acids, which would offer less stability to the membrane (Okamura and 
Kishimoto, 1983). Therefore, the myelin lipids in X. laevis confer greater fluidity than mammals, 
which is likely beneficial for this ectothermic species in adapting to temperature fluctuations.  
Notably, there is a decrease in myelin cerebrosides specifically during metamorphosis in X. laevis 
(Okamura and Kishimoto, 1983), which may further destabilize the myelin membranes in a 
manner that facilitates segment remodeling.  
 
Myelin segments shorten at climax then elongate in the post-metamorphic period 
Although metamorphosis is the period of transition from a larval to an adult body plan, 
the immediately post-metamorphic froglet does not yet have a fully mature nervous system. After 
metamorphosis, the juvenile frog enters another phase of growth, and continues to mature during 
this time. It is not until this post-metamorphic growth period then that the myelin also matures in 
terms of composition, structure and function (Cullen and Webster, 1979; Okamura and 
Kishimoto, 1983; Trapp et al., 1980). Indeed, the period of myelin segment remodeling appears to 
continue for several weeks past the completion of optic nerve shortening, as focal myelin 
dystrophies could still be detected at these later time points.  
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Interestingly, following the initial shortening, the myelin segments appear to elongate 
again after metamorphosis, which would require myelin synthesis to remain high and the axo-
glial interactions to remain weak. Since the length of the nerve itself does not grow significantly 
during this time, it is likely, that the lengthening of segments requires the selective removal of 
some of the segments, which would also be facilitated by the presence of weakly attached 
destabilized myelin. This type of elongation-associated removal also occurs in other species and 
regions of the nervous system during development (Berthold and Nilsson, 1987; Fried and 
Hildebrand, 1982; Fried et al., 1982), which may be mediated by the weak adhesion afforded by 
the characteristic composition of juvenile myelin. Similar to what is seen in these other 
developmental systems, post-metamorphic segment elongation likely involves a mechanism of 
competition that results in the removal of the losing segments.  
 
Radial growth and maturation of myelin occur during post-metamorphic period 
The elongation occurs alongside the thickening of the myelin segments, as noted by a 
decrease in G-ratio, which together provide for increased conduction velocity along optic nerve 
axons (Waxman, 1980). Surprisingly, in spite of all of the remodeling, conduction of the 
myelinated axons is first detected both within the optic nerve and the optic tectum during 
metamorphosis (Chung et al., 1974; Chung et al., 1975; Payne, 1977). However, the very fast 
conduction associated with the adult optic nerve, is not detected until several months after the 
completion of metamorphosis (Payne, 1977), and likely relates to changes in the composition of 
myelin and the structure of the segments. The myelin in these juvenile frogs has a higher 
proportion of stabilizing myelin proteins and galactolipids (Trapp et al., 1980), which offer 
stronger axo-glial adhesion and enhanced membrane compaction. In general, the fastest 
conduction speeds in axons are associated with myelin segments with the most wrappings and 
longest lengths. Thus, the formation of focal detachments and shortening of the segments during 
metamorphosis likely slows conduction speeds and accounts for the lag between the completion 
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of metamorphosis and the appearance of fast conduction in the optic nerve. Consequently, the 
conduction velocities necessary for fast visual processing cannot be achieved until the segments 
have elongated, adhesive attachments have strengthened and stabilized the myelin, and all myelin 
dystrophies have been resolved.  
 
Potential physiological significance of myelin segment shortening 
Whether the shortening of the myelin segments during metamorphic optic nerve 
remodeling has a physiological purpose in the development of the visual system pathway, or 
occurs simply as an intermediate byproduct of nerve shortening remains unclear. The presence of 
short myelin segments, as occurs during remyelination (Gledhill and McDonald, 1977), results in 
a decrease in action potential conduction velocity along an axon (Brill et al., 1977), and is 
typically regarded as a detriment to signal processing. However, segment length variation can 
also alter conduction timing to contribute to the synchronization or coordination of various inputs 
onto a single target. This is particularly important for the auditory system, where timing 
information from the two ears must be integrated (Cheng and Carr, 2007). Single axons that 
bifurcate to receive input from each ear will have asymmetry in the length of the collaterals, and 
thus, also need to have different conduction velocities in order to coordinate their input. Recent 
evidence suggests that the conduction velocities of the two collaterals may be coordinated 
through oligodendrocyte mediated changes in internodal distance (Seidl, 2014).  
During metamorphosis, the change in the position of the eyes in the head of X. laevis also 
underlies a transition from monocular to binocular vision, as the brain must now integrate the 
overlapping visual fields from the two eyes (Grant and Keating, 1986). Binocular vision develops 
over time in the juvenile post-metamorphic froglet during a critical period of binocular plasticity, 
which overlaps with the period of myelin maturation in the optic nerve (Udin, 2007, 2012). The 
slowed conduction afforded by these shortened segments could affect tectal activity patterns and 
potentially contribute to this period of plasticity. Conduction timing plasticity typically involves 
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differences in internodal distance along the length of an axon or between axons, whereas 
metamorphic segment shortening affects the entire nerve. However, since accurate internodal 
distance measurements were only obtained in the center region of the optic nerve, with the most 
active remodeling, it is unclear whether segment lengths in other regions were similarly altered. 
Since the myelin sheaths actively grow by adding segments along the rostral and caudal 
directions (Cima and Grant, 1982b), the length of these new segments may or may not be 
coordinated with the lengths of the remodeled center segments. 
 Furthermore, new myelin segments are also actively added to previously unmyelinated 
axons throughout this period, and whether the length of these segments is determined 
independently based on axon size, or is influenced by the remodeling process remains unknown. 
In other words, how does the length of newly generated myelin segments compare before, during, 
and after metamorphosis. Based on the increased diameter of RGC axons following nerve 
shortening, one might expect that new segments would be longer. However, since newly 
generated segments could not be unequivocally identified in the SBEM 3View volumes this 
remains an open question. 
 
Thyroid hormone influences optic nerve myelination during metamorphosis in a cell-type 
specific manner 
Next to segment shortening, the level of new myelination is one of the most striking 
features of the metamorphic optic nerve in X. laevis. Thyroid hormone has been known to 
promote myelination in mammals by inducing the differentiation of OPCs into mature 
myelinating oligodendrocytes and the expression of essential myelin components, such as Mbp 
and Plp (Baas et al., 1997). Thyroid hormone likely works in a similar manner in X. laevis, since 
the number of Plp expressing oligodendrocytes in the optic nerve increases during metamorphic 
climax. The optic nerves from animals expressing the thyroid hormone dominant negative 
receptor (TRΔC) transgene in mature oligodendrocytes had normal numbers of oligodendrocytes 
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and myelinated axons, but less overall myelin. This suggests that the rate of new myelination and 
thus number of myelinated axons is determined by the amount of mature oligodendrocytes, which 
is in turn likely determined by the differentiation rate of OPCs. However, since I did not target 
expression of the TRΔC transgene to OPCs, I cannot definitively conclude that the rise in mature 
oligodendrocytes during metamorphosis occurs as a direct response to thyroid hormone mediated 
transcriptional activity.  Furthermore, the decrease in the thickness of the myelin sheaths in the 
optic nerve may be due to a delay or deficit in the maturation of the newly differentiated 
oligodendrocytes, such as a decrease in process extension or insufficient expression of necessary 
myelin proteins from the lack of thyroid hormone mediated signaling.  
The small size of the axons themselves in animals expressing the TR∆C transgene in 
oligodendrocytes further suggests that during metamorphosis, thyroid hormone promotes the 
production of new myelin and thus the expansion of existing segments. Radial growth in axons is 
largely dependent on a network of neurofilaments, and thus factors that affect the accumulation, 
localization or phosphorylation status of these cytoskeletal features can alter axon growth 
dynamics (Williamson et al., 1996). The presence of oligodendrocytes in a nerve prior to 
myelination can trigger the accumulation and rearrangement of the axon neurofilaments leading 
to increases in axon caliber (Sanchez et al., 1996). The onset of myelination also affects 
neurofilament density and phosphorylation, which then leads to further expansion of axons (Cole 
et al., 1994), such that axon size is determined in part by oligodendrocyte-derived signals. Since 
the oligodendrocyte provides trophic support to the axon and the thickness of the myelin sheath 
increases with axon size in a characteristic manner based on the species and conduction velocity 
requirements of a particular white matter tract, it would be advantageous for a myelinating cell to 
influence the size of the axon which it ensheaths. If oligodendrocytes are compromised in their 
ability to produce compact myelin, such as seen in mice with reduced levels of Mbp or MAG, 
myelin sheaths are thinner and axon caliber is in general similarly decreased (Brady et al., 1999; 
Yin et al., 1998).   
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Thinner myelin is also a widely noted feature of remyelination after insult, but so is a 
corresponding decrease in axon diameter. On average, myelinated axons in an injured region are 
smaller, with a near absence of the largest caliber axons, suggesting that the newly generated 
oligodendrocytes may have lower myelogenic potential, and that axon size decreases to match the 
myelin carrying capacity of the new oligodendrocytes (Powers et al., 2012). In this way, although 
conduction speeds will be slower than before injury, the health of the axon and conduction can be 
preserved. In the peripheral nervous system, myelin sheath thickness and associated axon caliber 
are affected by mammalian target of rapamycin (mTOR) signaling in Schwann cells (Sherman et 
al., 2012). Notably, the G-ratio is unaffected in these myelinated axons in the absence of mTOR 
signaling, since both the axon and myelin sheaths are proportionally thinner. mTOR is involved 
in cell growth and proliferation in a variety of systems and in the central nervous system is 
thought to be involved in OPC differentiation and myelin production (Wood et al., 2013). 
Thyroid hormone has been shown to activate mTOR related signaling pathways (Cao et al., 
2005), and may also play a role in promoting the radial growth of myelinated axons. The exact 
nature of the relationship between thyroid hormone, mTOR and myelination in oligodendrocytes, 
however, remains to be elucidated.  
Thyroid hormone could also be acting to promote the rearrangement of the axon 
neurofilament network directly in RGCs. Although the decreased number of myelinated axons in 
the optic nerves of animals expressing the TR∆C transgene in RGCs is most likely due to the 
decreased number of RGCs overall, a deficit in radial axon expansion could also explain the 
lower myelination rate since myelination only occurs on axons that have reached a particular 
diameter size threshold. A lack of thyroid hormone has been shown to affect transport of 
cytoskeletal components such as microtubules and neurofilaments, and thus growth, in the rodent 
optic nerve (Stein et al., 1991a). Furthermore, the transport of synaptic proteins is also affected in 
these animals (Stein et al., 1991b), which could impact the ability these axons to produce and 
maintain synaptic connections. If these axons do not wire properly they may not receive adequate 
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trophic support and be subject to elimination. Deficits in growth and wiring could contribute to 
the decreased survival in RGCs with disrupted thyroid hormone signaling. Irrespective of the 
exact mechanism, proper myelination in the optic nerve appears to require the action of thyroid 
hormone is both RGCs and oligodendrocytes.  
In addition, optic nerve astrocytes may also contribute to myelination, since astrocyte 
processes interact with actively forming axo-oligodendroglial associations during myelination 
(Ioannidou et al., 2014) and then continue to interact with mature myelinated axons at Nodes of 
Ranvier (Waxman, 1986). Blbp expressing astrocytes, such as those found in the optic nerve of X. 
laevis, have been shown to promote the differentiation of OPCs and induce an environment 
conducive to remyelination after injury (Kipp et al., 2011b). Moreover, thyroid hormone has been 
shown to be important for the differentiation and maturation of astrocytes, including the 
production of neuronal growth promoting factors, and extracellular matrix components (Trentin, 
2006). Although, the expression of Blbp in progenitor cells may complicate the interpretation, the 
roles of Blbp expressing astrocytes in promoting axonal growth and myelination may explain the 
phenotype of decreased axon size and myelination rate in the optic nerves of X. laevis expressing 
the TR∆C transgene under the Blbp promoter. Thus, a lack of thyroid hormone could disrupt the 
balance of glial cells, inter-cellular signaling, and axon growth. Therefore, during metamorphosis, 
thyroid hormone appears to influence myelin production through a variety of mechanisms, and 
thus in turn the ability of oligodendrocytes to support large caliber axons.  
Interestingly, the caliber of the myelinated axons in the optic nerve decreases 
dramatically after metamorphosis back toward pre-metamorphic levels during the juvenile growth 
period in which myelin matures, and segments increase in length and thickness. This could be 
related to thyroid hormone mediated changes to axon neurofilaments that are intrinsic to the 
RGCs or stemming from the myelinating oligodendrocytes, since thyroid hormone levels drop off 
precipitously after metamorphic climax. Additionally, since the axons undergo a shortening 
induced hypertrophy during metamorphosis, the associated oligodendrocytes may not be capable 
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of sustaining support for these axons and trigger an axon shrinkage similar to what is seen in the 
context of injury. Alternatively, the changes in axon diameter may be explained by the disruption 
and re-establishment of axo-glial signaling as a result of the production and eventual resolution of 
focal myelin detachments during optic nerve shortening.  
Formation of focal myelin detachments is part of a regulated developmental process and not 
pathological 
Although myelin in juvenile vertebrates is relatively poor in myelin stabilizing 
components (Horrocks, 1968; Svennerholm and Vanier, 1978; Trapp et al., 1980), these young 
animals are not adversely affected, since the maturation of myelin is developmentally regulated. 
In contrast, the lack of these same components in adulthood is abnormal and leads to the onset of 
pathology (Carenini et al., 1996; Coetzee et al., 1999; Dupree et al., 1998). Similarly, the focal 
dystrophies within individual segments during metamorphosis are not accompanied by an 
increase in either axon loss or visible defects in the myelin lamellae compaction, likely because 
they also stem from a developmentally regulated rather than a pathological process. Indeed, 
interference with the remodeling process can lead to pathological myelin splitting and 
vacuolization, as seen in the optic nerves from animals with a disruption in thyroid hormone 
mediated signaling in RGCs or a component of the phagocytic machinery, Rac1, in astrocytes. 
Consequently, the process by which myelin debris is cleared during metamorphic optic nerve 
shortening is quite distinct from clearance in the context of pathology, and is instead reminiscent 
of axon pruning during early neural development. Instead of the removal of axon or neurite 
branches, however, optic nerve remodeling involves the removal of focal myelin branches.  
Removal of focal myelin dystrophies resembles developmental axon pruning 
Perhaps not surprisingly, the removal of the focal myelin detachments during X. laevis 
metamorphosis most resembles neurite pruning during Drosophila metamorphic nervous system 
remodeling (Watts et al., 2004). A key feature of metamorphic pruning is its selective removal of 
locally degenerating axon or neurite branches while the other branches remain intact (Watts 
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2003). Although the mechanism underlying this specificity is still unclear, recent evidence 
suggests that local calcium transients may trigger activation of the protease calpain (Kanamori et 
al., 2013), which is involved in Wallerian degeneration (Ma et al., 2013). These degenerating 
branches may then specifically exhibit ‘eat me’ signals. It is likely that the selective removal of 
detached myelin during X. laevis metamorphosis similarly involves the localized production of 
‘eat me’ cues on focal regions of myelin damaged by nerve shortening.  
Metamorphic myelin removal is mediated by optic nerve astrocytes 
The exact mechanism underlying this selectivity, however, remains an interesting and 
open question.  Although, unlike pruning in Drosophila, the shortening of the myelin segments 
does not require the recruitment of the astrocytes, the removal of dystrophic myelin produced as a 
result of shortening is dependent on the phagocytic activity of local astrocytes as indicated by the 
impairment in the removal of excess myelin from remodeling axons, and accompanying 
production of myelin pathology associated with the expression of a dominant negative form of 
Rac1 in astrocytes. Since Rac1 activity affects the reorganization of the actin cytoskeleton in 
response to various signaling pathways, this result does not provide much mechanistic insight. 
This phenotype was not replicated by interfering with the candidate phagocytic receptors Megfl11 
or Integrin (via Mfge8) and suggest that there is redundancy and thus compensation at the 
receptor level and/or that these are only minor players and that targeting of the primary 
phagocytic receptor, likely Lrp1, would produce a stronger phenotype. Unfortunately, due to its 
large multi-functional domain structure (Beisiegel et al., 1989), Lrp1 is not a good candidate for 
the manipulation of receptor function via the transgenic overexpression of a dominant negative 
construct, and thus could not be targeted in this study.  
 
Role of thyroid hormone in myelin removal by astrocytes 
Similar to the promotion of phagocytic activity in Drosophila glia through the ecdysone 
mediated induction of the phagocytic receptor Draper (Awasaki et al., 2006; Tasdemir-Yilmaz 
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and Freeman, 2014), thyroid hormone appears to affect the expression of at least a subset of 
phagocytic genes, such as the Draper homolog Megf10, in X. laevis optic nerve astrocytes.  
Regulation of the phagocytic machinery may then be one of the ways in which thyroid hormone 
contributes to the ability of astrocytes to remove the dystrophic myelin during metamorphosis. 
However, since expression of the TR∆C transgene was not induced in astrocytes until tadpoles 
were NF Stage 58, and thus already exposed to low levels of thyroid hormone, it is not possible to 
conclude how the transgene is mediating this response. Thyroid hormone may directly affect the 
transcription of phagocytic genes in astrocytes, as in Drosophila, or the effect on phagocytosis 
may be an indirect consequence of the disruption of other critical processes in astrocytes that are 
influenced by thyroid hormone. Since thyroid hormone is involved in astrocyte maturation, 
process out growth and motility (Trentin, 2006), the ability of astrocyte processes to just contact 
and communicate with myelinated axons could be affected by the level of thyroid hormone. The 
close association of astrocyte processes with myelinated axons makes them the ideal candidate to 
mediate this removal, since their continual sampling of the environment (Benediktsson et al., 
2005) allows them to readily detect local ‘eat me’ signals put forth by the damaged or detached 
myelin.  
 
Capacity of optic nerve astrocytes to internalize and clear myelin 
That myelin, as opposed to other cellular membranes or components, is the phagocytic 
substrate is a critical aspect of X. laevis optic nerve remodeling which differentiates it from other 
developmental glial cell mediated pruning events. The lipid rich nature of myelin makes it 
extremely difficult to break down, and as such can usually only be internalized by professional 
phagocytes with the capacity to digest this metabolically rich substance. The ability of astrocytes 
to internalize myelin is not unprecedented, particularly in frogs and fish, but usually occurs in the 
context of axonal trauma (Colavincenzo and Levine, 2000). The Blbp expressing astrocytes in 
these species appear to have a pro-regenerative response in producing pro-myelination signals 
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and having a greater capacity to clear myelin debris. The ability of these astrocytes to efficiently 
internalize and metabolize or eliminate large amounts of lipid rich material may underlie the 
enhanced debris clearance in these astrocytes relative to typical mammalian GFAP expressing 
astrocytes.  
The fatty acid binding protein family, of which Blbp (Fabp7) is a member, appears to be 
involved in lipid uptake, metabolism and transport in the cell (Furuhashi and Hotamisligil, 2008). 
Notably, the levels of Fabp in a cell are related to lipid load, which explains their high expression 
in hepatocytes and adipocytes. Exposure to a lipid rich environment increases the expression of 
Fabps, which appear to facilitate the uptake and storage of lipids (Smathers and Petersen, 2011). 
Therefore, the expression of Blbp by the optic nerve astrocytes may increase their capacity to 
internalize and metabolize lipid rich material, such as myelin. Nuclear transport of 
transcriptionally active fatty acids by Fabps can also influence gene transcription, including genes 
involved in lipid metabolism (Schroeder et al., 2008). Interestingly, loss of Blbp in hepatic 
Kupffer cells has recently been shown lead to the down regulation of the scavenger receptor 
CD36 and impair phagocytic clearance of apoptotic cells (Miyazaki et al., 2014). Consequently, 
in optic nerve astrocytes Blbp may contribute to the modulation of transcription or signaling 
mediated by myelin derived lipids, which could in turn impact the lipid internalization and 
metabolism of these cells. At this point, however, any potential contribution of Blbp itself to 
myelin internalization by phagocytic astrocyte remains purely speculative.  
Additionally, thyroid hormone affects lipid metabolism in the hepatic system and may 
also affect lipid processing in astrocytes during metamorphosis. The expression of the endocytic 
cell surface receptor involved in the uptake of lipids, Lrp1, is regulated by thyroid hormone in the 
hepatic system (Moon et al., 2013).  Based on its role in myelin uptake in other cells (Gaultier et 
al., 2009) and expression in X. laevis optic nerve astrocytes, Lrp1 is the best receptor candidate to 
mediate the internalization of myelin derived from remodeling segments. Notably, Lrp1 signaling 
has shown to be pro-regenerative (Yoon et al., 2013), therefore the presence of Lrp1 may 
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contribute to the increased capacity for regeneration and debris clearance afforded by the Blbp+ 
astrocytes.   
 
Efficient clearance of lipid rich myelin by X. laevis optic nerve astrocytes 
The enhanced capacity for myelin phagocytosis of the X. laevis optic nerve astrocytes 
may depend more on the effective metabolism and clearance of myelin lipids than the machinery 
involved in internalization. In macrophages, which have a tremendous capacity for the 
phagocytosis of lipid rich cellular material, internalization rates are largely dependent on the 
ability of these cells to efficiently metabolize and efflux these excess lipids. In atherosclerosis, 
plaque forming foam cells develop from macrophages which are unable to process and eliminate 
all of the cholesterol they have taken in (Schrijvers et al., 2007). The intake of excessive lipids, 
such as from myelin, leads to the accumulation of lipid droplets, a lipid storage organelle. 
Mammalian astrocytes can also take in small amounts of myelin, usually in the context of 
degeneration, and undergo a subsequent formation of lipid droplets (Vaughn and Pease, 1970). 
Although the formation of lipid droplets is not in itself detrimental, the long-term accumulation 
and persistence of lipid droplets in astrocytes is associated with a variety of neurodegenerative 
diseases (Liu et al., 2010). This suggests that mammalian astrocytes are less efficient at 
metabolizing lipids, namely cholesterol, than internalizing them, which in turn can have 
pathological consequences.  
In contrast, X. laevis optic nerve astrocytes appear to be able to efficiently metabolize or 
clear the large amounts of myelin they internalize during metamorphic optic nerve remodeling. 
Although the astrocytes did develop lipid droplets during the height of remodeling at 
metamorphic climax, the lipid droplets and myelin were largely cleared from the astrocytes 
within one month. Interestingly, interference with the Integrin-Mfge8 receptor system led to an 
increase in the size of the myelin debris within astrocytes, suggesting that the myelin was not 
being properly broken down. This build-up of lipid rich cellular debris could then decrease the 
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capacity for further internalization, and may contribute to decreased debris internalization seen in 
other studies (Hanayama et al., 2002). Mfge8 may be important for targeting the debris to the 
correct degradative compartments in astrocytes, as has been shown for dendritic cells (Peng and 
Elkon, 2011). However, Integrin-Mfge8 may also be involved in the removal of myelin debris 
from the astrocytes. In either case, Mfge8 appears to be important for the efficient internalization 
and degradation of myelin debris by optic nerve astrocytes during metamorphosis.  
Lipid droplets and Mfge8-tagged partially metabolized debris were found to accumulate 
within the pial contacting processes of optic nerve astrocytes. Based on the presence of similar 
looking debris in the nerve sheath, the astrocytes appear to release some of these debris contents 
into the sheath space. Furthermore, this is followed by an increase in debris and lipid droplet 
accumulation in cells localized to the periphery of the sheath, which may be a type of 
perivascular or microglial cell. A similar trajectory of internalized myelin to lipid droplet 
formation in astrocytes to lipid droplet accumulation in perivascular cells has been noted in other 
systems (Franson, 1985). This removal of debris from optic nerve astrocytes may be related to the 
daily clearance of brain waste products and metabolites into the vasculature by astrocytes (Xie et 
al., 2013). Although highly speculative, since Mfge8 is secreted and associates with exosome 
membranes (Oshima et al., 2002), and integrins are highly expressed by the sheath localized cells, 
Mfge8 coated debris released from astrocytes could be taken up in an integrin dependent manner.  
In addition to the release of partially degraded debris into the sheath, the efflux of excess 
myelin derived cholesterol also likely contributes to the efficient clearance of myelin by X. laevis 
optic nerve astrocytes during metamorphosis. Cholesterol efflux is largely mediated by ATP-
binding cassette cholesterol transporters including Abca1, the homolog of ced-6 and major 
component of the cellular phagocytic machinery (Oram and Lawn, 2001). The decreased 
expression of Abca1, and thus decreased ability to efflux cholesterol has been found to occur in 
the lipid overloaded macrophages that become foam cells and contribute to atherosclerosis (Feng 
and Tabas, 2002).  Additionally, the receptor, Lrp1, has been shown to influence expression of 
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Abca1 by decreasing signaling pathways that transcriptionally repress Abca1 (Zhou et al., 2009). 
This suggests that the expression of Lrp1 by X. laevis optic nerve astrocytes may enhance their 
ability to efflux cholesterol, and contribute to their ability to internalize and clear large amounts 
of myelin. Finally, the characteristic composition of myelin in X. laevis may contribute to the 
ability of the astrocytes to effectively clear internalized myelin.  
Although astrocytes in mammals may not have the ability to internalize and clear the 
large amounts of myelin as performed by X. laevis astrocytes during metamorphic optic nerve 
shortening, mammalian astrocytes are capable of internalizing small amounts of myelin. 
Furthermore, mammalian astrocytes express all of the relevant phagocytic machinery (Cahoy et 
al., 2008). Therefore, the mechanism of selective removal of focal myelin dystrophies on 
otherwise intact myelinated axons may be relevant to the homeostatic removal of small amounts 
of myelin by astrocytes throughout the nervous system in a variety of species. The resolution of 
focal hypermyelinations on newly myelinated axons (Snaidero et al., 2014) is a potential event 
that may involve this process, particularly since it occurs during early development when 
astrocytes are less mature and thus may be more similar to X. laevis astrocytes. Another potential 
exciting role for this process is in white matter plasticity in regions with sparse myelination, 
whereby it is hypothesized that the selective removal of individual myelin segments may affect 
the modification of conduction speeds and synaptic site selection (Tomassy et al., 2014).  
Overall, I have shown that the remodeling of the optic nerve during the amazing feat of 
metamorphic optic nerve shortening in X. laevis depends on the coordinated activities of RGCs, 
oligodendrocytes, and astrocytes as regulated by thyroid hormone. While the remodeling of 
individual myelinated axons involves the selective removal of focal myelin dystrophies induced 
through shortening by phagocytic optic nerve astrocytes, followed by the efficient clearance of 





Chapter 6: Materials and Methods 
 
Animal Care and Breedings 
Xenopus laevis were housed in a satellite animal facility located in the Kennedy Krieger 
Institute associated with the Marsh-Armstrong laboratory. Excellent frog care was provided by 
the laboratory technician, Shannon Emmel. All animal care and experimental procedures were 
performed with approval by the Animal Care and Use Committee at Johns Hopkins University. 
Experiments with wild-type staged X. laevis were performed with animals ordered from Xenopus 
Express. Experiments with transgenic X. laevis involved the breeding of founder adult frogs made 
via REMI transgenesis procedures (Amaya and Kroll, 1999). Breedings were performed between 
a transgenic founder and a wild-type frog. In preparation for breeding, females were injected with 
150 units of human chorionic gonadotropin hormone (hCG) 8-12 hours in advance, and then 
injected with another 300-400 units of hCG, depending on size, immediately prior to breeding. 
Males received a single injection of 50 units of hCG immediately prior to breeding.  Since the 
transgenic constructs were fluorescently tagged, the resulting progeny were screened for the 
presence of the transgene using fluorescence microscopy.  
 
Constructs 
X. tropicalis Blbp Promoter 
Expression of transgenes in astrocytes was achieved through use of the Blbp promoter in 
X. tropicalis (Watson et al., 2012) based on a Blbp promoter construct originally described in 
mouse (Schmid et al., 2006). A 1.7kb fragment upstream of the X. tropicalis Blbp (aka fabp7) 
gene corresponding to Scaffold 274: 1369583-1367600 in UCSC genome browser X. tropicalis 
(build Nov. 2009 JGI 4.2/xenTro3) was amplified from genomic DNA purified from X. tropicalis 
liver using the primers F and R BLBP (see Primer Table). The DNA was purified using the 
Puregene DNA purification kit (QIAGEN). The X. tropicalis Blbp 1.7kb promoter fragment was 
digested with the restriction enzymes SalI and HindIII. The vector pCS2-GFP3 was also digested 
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with SalI and HindIII to remove the sCMV IE94 promoter. The X. tropicalis 1.7kb Blbp promoter 
was inserted into the pCS2: GFP3 vector. 
Islet2 promoter construct recombination 
Constructs generated using the zebrafish Islet2b promoter (Pittman et al., 2008) were 
created via homologous recombination (Yu et al., 2000). Inserts were first cloned into a pCS2 
(1kb-Islet2) homology vector into the HindIII and XhoI restriction sites. The pCS2 (1kb Islet2) 
homology vector contains a 1kb fragment of the zebrafish Islet2b promoter between the SalI and 
HindIII restriction sites, which serves as a homology arm for recombination, and has a kanamycin 
resistance cassette. Prior to recombination the DNA was digested with SalI and either AloI or 
DraIII. The DNA was then transformed into EL250 cells, which had undergone RED induction, 
via electroporation using the settings 1.8kV, 25 μF, and 186 ohms. Colonies were selected based 
on kanamycin resistance and recombination was verified using diagnostic restriction digests for 
HindIII and XbaI. The kanamycin cassette was later removed by incubating a culture of EL250 
cells expressing the Islet2 construct with 0.1% L-arabinose for one hour.  
Thyroid hormone receptor dominant negative constructs 
  The dominant negative thyroid hormone receptor construct used (TR∆C) is a variant of a 
previous construct, pCS2:GFP*-TRΔC (Marsh-Armstrong et al., 1999), widely used to inhibit 
metamorphic events through transgenes.  The GFP3 cDNA, amplified using primers F GFP3 and 
R GFP3, replaced existing cDNA of pCS2(TetOp):GFP (Das and Brown, 2004), using HindIII 
and XhoI. TRΔC amplified from pCS2:GFP*-TRΔC using F TRΔC and R TRΔC primers was 
placed downstream of GFP3 into NheI and XhoI sites. GFP3-TRΔC was placed under the 
zebrafish Islet2 promoter by homologous recombination, as previously described. For conditional 
expression studies, rtTA2 (Das and Brown, 2004), was amplified with primers F and R rtTA2 and 
cloned into HindIII-XhoI or BamHI-XhoI pCS2+ vectors that contained a 1.7kb X. tropicalis 
Blbp promoter or 2kb mouse Mbp promoter (Kaya et al., 2012) previously cloned into SalI-




 mCherry was amplified from pRSET-B mCherry (Shaner et al., 2004) using primers F 
and R mCherry N-term tag and cloned into the pCS2 (1.7kb XtBlbp) vector into the HindIII and 
XhoI sites. A membrane tag, encoding the first 10 amino acids of X. laevis growth associated 
protein 43 (gap43), was made through the annealing of F XlGap43 and R XlGap43 overlapping 
oligos and cloning into the NheI and XhoI sites of Blbp: mCherry. 
Isl2: hA-AMB-mCherry 
Isl2: hA-AMB-mCherry amplified from pRSET-B mCherry using primers F and R 
mCherry C-term tag and cloned into the pCS2 (1kb Islet2) homology vector into the HindIII and 
XhoI sites. The lipid droplet tag human A-AMB (Zehmer et al., 2008) was made through the 
annealing of overlapping oligos F hA-AMB and R hA-AMB and their cloning upstream of 
mCherry into HindIII-NheI sites of the pCS2(1kb Isl2)-mCherry vector as an intermediate for 
recombination to make the Isl2: hA-AMB-mCherry plasmid via recombination as previously 
described.   
Megf11 dominant negative construct (Blbp: Megf11ΔC-GFP3) 
The Megf11ΔC construct containing the first 902 amino acids of X. laevis Megf11 was 
made by amplifying X. laevis Megf11 from IMAGE clone 4680607 (Open Biosystems) using the 
primers F and R XlMegf11ΔC and digested with NheI and XhoI and cloned into the pCS2 (1.7kb 
XtBlbp) vector. GFP3 was then cloned into the XhoI and NotI of the Blbp: Megf11ΔC vector to 
create the construct Blbp: Megf11ΔC-GFP3.  
Mfge8 constructs 
mCherry was amplified from pRSET-B mCherry using primers F and R mCherry N-term 
tag and cloned into the HindIII and XhoI sites of the pCS2 (1.7kb XtBlbp) vector. X. tropicalis 
Mfge8 was amplified from IMAGE clone 5379147 using primers F XtMfge8 and R XtMfge8 and 
cloned upstream of mCherry into the HindIII and NheI sites of Blbp: mCherry. Blbp: Mfge8-
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mCherry was mutagenized to Blbp: Mfge8-D91E-mCherry using the QuikChange II Site 
Directed Mutagenesis Kit (Agilent). 
Blbp: CD63-mCherry 
Mouse CD63 was amplified from IMAGE clone 6530532 using primers F MsCD63 and 
R MsCD63 and cloned into the EcoRI and BamHI sites of pCS2: mCherry. CD63-mCherry was 
then placed under the Blbp promoter by cloning into the NheI and XhoI sites of the pCS2(1.7kb 
XtBlbp) vector. 
Blbp: hA-AMB-mCherry 
The hA-AMB-mCherry insert was cloned from pCS2 (1kb Isl2): hA-AMB-mCherry and 
cloned into the pCS2 (1.7kb XtBlbp) vector into the HindIII and XhoI sites.  
  Rac1 dominant negative construct (Blbp: rtTA/ TetOp: GFP3-Rac1-N17) 
X. tropicalis Rac1 was amplified from IMAGE clone 5336565 using F and R XtRac1 
primers and cloned into pCS2 (TetOp): GFP3 NheI-XhoI sites downstream of GFP3. The pCS2 
(TetOp): GFP3-Rac1 was mutagenized to introduce the Rac1N17 mutation using the QuikChange 
II Site Directed Mutagenesis Kit (Agilent). This construct was used in conjunction with Blbp: 
rtTA2.  
In situ hybridization probe template 
The Xl pdgfrα probe DNA template was made using RT-RCR. A 820 base pair region of 
X. laevis pdgfrα was amplified from X. laevis brain cDNA using the primers F and R rt-XlPdgfrα. 
RNA was isolated from X. laevis tadpole brain using Trizol (Invitrogen) extraction according to 
the manufacturer’s protocol. The cDNA was obtained through a reverse transcriptase reaction 
using Superscript III (Invitrogen) according to manufacturer’s protocol with random hexamers. 
The pdgfrα PCR product was then cloned into the Bluescript KS+ expression vector (Agilent) 






Primer Table legend: Restriction enzyme sites are capitalized. Kozack sequence is italicized. 




Primer Table  









GFP3 Reverse cgCTCGAGttattgtatagttcatccatgcc 
TRΔC Forward aaggagGCTAGCgaccagaatctcagcgggctgga  
TRΔC Reverse cgCTCGAGtcaggggcactcgaccttcatg 
rtTA2 Forward agctagGGATCCgccaccatgtctagactggacaagagc 
rtTA2 Reverse aaggagCTCGAGttacccggggagcatgtcaaggtcaaa 
XlMegf11ΔC Forward aaggagGCTAGCgatatcCACGTGcagcaggatacacaggagaga
gatgccaggaggagt 
XlMegf11ΔC Reverse cgCTCGAGcatgcatagccggggtgta 
XtRac1 Forward aaggagGCTAGCcaggccattaaatgtgtggtcg 



















XlGap43 tag Forward ctagcatgctgtgctgtatgagaaggacaaaacagtagc 








XtMfge8 Forward aagagAAGCTTgccaccatggatggatccgtccgcgct 







MsCD63 Forward aaggagGAATTCgccaccatggcggtggaaggaggaat 
MsCD63 Reverse aaggagGGATCCtttgtatagttcatccat 
rt-XlPdgfra Forward aaggagAAGCTTactggcgaaagtgaggtgag 
rt-XlPdgfra Reverse cgCTCGAGacatgggctccaggtcaatg 
 
 
T3 induction Assay 
For 3,3',5-triiodo-L-thyronine (T3) induction assays to examine optic nerve shortening, 5 
wild-type Stage 54 X. laevis were placed in rearing solution containing 20 nM T3 for 3 days. For 
T3 induction assays to test TRΔC transgenes, ethyl 3-aminobenzoate methanesulfonate (MS222) 
anesthetized Blbp: rtTA/TetOp: GFP-TRΔC and Mbp: rtTA/TetOp: GFP-TRΔC transgenic 
animals received ventricular brain injections of 100 nl of 50 mg/mL doxycycline, and 
subsequently placed in a rearing solution of 50 mg/L doxycycline. After 24 hours of transgene 
induction, 3 nM T3 was also added to the rearing water for 2 days.  Wild-type and Isl2: TR∆C 
animals just received the T3 induction. 
 
Transgenesis 
Transgenic X. laevis were created using restriction enzyme mediated integration (REMI) 
(Amaya and Kroll, 1999). Female X. laevis were pre-primed with an injection of 100 units of 
hCG approximately 1-4 weeks prior to transgenesis and primed with 400 units of hCG the 
evening prior to transgenesis and placed in small tanks of 1 X Marc’s Modified Ringers (MMR: 
100 mM NaCl, 2 mM KCl, 1mM MgCl2, 2mM CaCl2, 5 mM Hepes pH 7.5) solution, so that laid 
eggs, and not only squeezed eggs, could be used for transgenesis. The transgenic lines Blbp: 
Mfge8-mCherry, Blbp: Mfge8D91E-mCherry, Blbp: CD63-mCherry, Blbp: hA-AMB-mCherry, 
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Blbp: ctgap43-mCherry and Blbp: Megf11ΔC-GFP were made using 125 ng of NotI linearized 
DNA which had been purified with the GeneClean II Kit (MPBio). The transgenic lines Blbp: 
rtTA/TetOp: GFP-TRΔC, Mbp: rtTA/TetOp: GFP-TRΔC, and Blbp: rtTA/TetOp: GFP-Rac1N17 
were made using 100 ng of rtTA construct together with 100 ng of TetOp construct, which had 
been linearized with NotI and purified with the GeneClean II Kit. The linearized DNA was 
diluted in distilled water to a total volume of 5 μl and combined with approximately 300,000 X. 
laevis sperm nuclei (80-150 sperm/nl) and incubated at room temperature for 5 minutes. 1 μl of 
1:20 NotI enzyme was added to the DNA mixture along with 10 μl of X. laevis egg extract and 
sperm dilution buffer (2mM Hepes, 250 mM sucrose, 75mM KCl, 0.5mM spermidine, 0.2mM 
spermine, 5mM MgCl2 pH7.5) to reach a total volume of 37 μl, which was then incubated at 
room temperature for 15 minutes. The DNA was then diluted in sperm dilution buffer (10.5 μl 
into 200 μl sperm dilution buffer) and loaded into a borosilicate glass capillary tube (WPI 
TW100-6) which had been pulled using a micropipette puller (Sutter Instruments) using the 
settings Pull: 70, Velocity: 50, broken to 100 micron diameter tip, beveled to a 30o angle, coated 
internally with Sigmacote (Sigma) before washing with water.  
The transgenic lines with the Islet2 promoter (Isl2: GFP-TRΔC and Isl2: hA-AMB-
mCherry) were made using a transgenesis protocol modified for large constructs. Approximately 
4 μg of the Islet2b construct DNA was linearized in a 25 μl reaction with NotI and heat 
inactivated prior to transgenesis. The DNA was incubated with 2.5 μl of reaction mix (10 μl egg 
extract and 0.5 μl 1:20 NotI enzyme) for 3 minutes at room temperature. Then 1 μl of 80 sperm/nl 
(or 0.7 μl 150 sperm/nl) was added and incubated 15 minutes. The DNA was diluted in 300 μl of 
sperm dilution buffer and loaded into a needle for injection. For all transgenic lines eggs were 
plated on 2% agarose plates in a solution of 0.4X MMR/6% Ficoll/50 μg/mL gentamycin pH 7.6. 
Injected eggs were transferred to a 16oC incubator and cleaving embryos were screened at the 4 
cell stage (approximately 2-3 hours after injection) and transferred to a solution of 0.1X 
MMR/6% Ficoll/50 μg/mL gentamycin and incubated at 16oC overnight. The following day 
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healthy embryos were transferred to fresh 0.1X MMR. Screening of transgenic embryos was 
performed using fluorescence microscopy.  
 
RNA probe synthesis 
Digoxigenin or fluorescein labeled RNA probes were synthesized to be used for in situ 
hybridization using DIG or FLU dUTP RNA labeling mix (Roche). The DNA templates for the 
probes were in RNA expression vectors with T7 and/or T3 RNA polymerase promoters and are 
listed in the RNA Probe Template Table. The probe synthesis transcription reaction was 
performed in accordance with the protocol for DIG/FLU RNA labeling mix using T7 or T3 RNA 
polymerase. Following the transcription reaction, the RNA probe mixture was treated with DNase 
to remove the DNA template. The probes were then hydrolyzed by adding 2.5 volumes of 
Hydrolysis solution (0.08M NaHCO3, 0.12M Na2CO3) and incubated at 60oC for 30 minutes. The 
solution was neutralized by adding Neutralization solution (0.1% Acetic acid, 0.2M Sodium 
acetate pH 5.2). The RNA was precipitated using 0.1 volume of 4M Lithium chloride and 2 
volumes of 100% ethanol and incubating at -20oC overnight. The precipitated RNA was 







































In situ hybridization 
In situ hybridization of optic nerve and retina cryo-sections was performed using the 
following general procedure. X. laevis tadpoles and juvenile frogs were euthanized using 0.1% 
(w/v) ethyl 3-aminobenzoate methanesulfonate (MS222). Optic nerves and/or eyes were dissected 
in 4% MEM-PFA (0.1M MOPS (pH 7.4), 2mM EGTA, 1mM MgSO4, 4% Paraformaldehyde) at 
4oC overnight then cryo-protected with 30% (w/v) sucrose in Phosphate buffered saline (PBS: 
137 mM NaCl, 2.7 mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4 pH 7.4) at 4oC overnight. Optic 
nerves or eyes were then embedded in cryo-molds with Optimal Cutting Temperature media 
(O.C.T.) (Sakura Finetek) and stored at -80oC. Cryo-sections 10 μm thickness were made using a 
Leica CM3050 cryo-stat, placed on Tissue Tack (Polysciences) slides and stored at -80oC.  
Day 1: All steps on the first day of the procedure were carried out at room temperature. 
Slides were washed with 1X PBS, fixed in 4% PFA (pH 7.4) 10 minutes, and washed with 1X 
GENE Source 
Xt abca1 IMAGE 7799155 
Xt crkII IMAGE 5307606 
Xt dock1 IMAGE 6976388 
Xt elmo1 IMAGE 6991908 
Xl gene12 U41854 (Wang and Brown, 1991) 
Xt gulp IMAGE 7794219 
Xl rbpms NM_001088395(Gerber et al., 
1999b) 
Xl itgβ3 IMAGE 5512565 
Xl Itgβ5 IMAGE 6860110 
Xl lrp1 IMAGE 6873186 
Xt megf10 IMAGE 7684763 
Xl megf11 IMAGE 4680607 
Xt mfge8 IMAGE 5379147 
Xt nefh IMAGE 7652316 
Xl pdgfrα NM_00108708 
Xl plp IMAGE 6949052 
Xt rac1 IMAGE 5336565 
Xt Sncg IMAGE 7584500 
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PBS. In some cases slides were incubated with proteinase K and then re-fixed in 4% PFA for 10 
minutes. Slides were then acetylated with 0.25% Acetic Acid in 0.1M Triethanolamine (TEA) 
(pH 8.0) for 10 minutes and washed with 1X PBS. DIG and FLU labeled probes were diluted to 1 
ng/μl in hybridization buffer (50% 2X Hybridization solution (sigma H-7140), 50% formamide, 
0.25 mg tRNA) and heated to 80oC for 5 minutes.  Diluted probe mixture was placed on plastic 
coverslips and onto slides incubated in a chamber humidified with 50% formamide/5X Saline-
sodium citrate buffer (SSC 1X: 150 mM NaCl, 15 mm Sodium citrate pH 7.0) at 65oC overnight. 
Day2: Coverslips were removed by placing slides in 65oC 5X SSC. Slides were then incubated in 
0.2X SSC for 1 hour at 65oC and 5 minutes at room temperature, followed by a wash in Buffer 
B1. For a single, but not a double in situ, peroxidases were quenched by incubating slides in 0.1 
% Sodium Azide + 0.3% Hydrogen peroxide for 10 minutes. Slides were placed in a blocking 
solution of 1% Blocking Buffer (Roche) in Buffer B1 for 1 hour at room temperature prior to 
antibody incubation. Slides were then incubated with 1:500 Anti-DIG-POD (Roche) or Anti-
FLU-POD (Roche) diluted in 1% Roche block/Buffer B1 solution 4oC overnight. Day 3: After 
antibody incubation slides were washed in Buffer B1 at room temperature. The POD antibody 
was detected using Cy3 or Cy5 tyramide (Perkin-Elmer) diluted 1:100 in amplification buffer. 
Then the slides were washed in Buffer B1.  
For a double in situ hybridization: Peroxidases are quenched with 0.1% Sodium Azide 
and 0.3% Hydrogen peroxide, blocked with Roche block in Buffer B1, incubated with the other 
POD antibody (DIG or FLU) overnight, which was detected with the other tyramide (Cy3 or 
Cy5).  
In situ hybridization of wholemount retinas was performed using the following general 
procedure. Retinas were dissected from MS222 euthanized X. laevis, fixed in 4% MEM-PFA at 
4oC overnight, and stored in 100% Methanol at -20oC. Day 1: Retinas were rehydrated by 
washing in a mixture of methanol and PBT (1X PBS, 0.5% Triton-X) at the ratios 3:1, 1:1, 1:3. 
Retinas were sealed between sheets of 125µm nylon mesh (Small Parts) using an impulse sealer 
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and placed into glass scintillation vials. Meshed retinas were washed in PBT 3 times, acetylated 
with 0.25% acetic anhydride followed by 0.5% acetic anhydride in 0.1M TEA (pH 8.0) for 5 
minutes each, washed in PBT, fixed in 4% PFA for 20 minutes, and washed in PBT at room 
temperature. Retinas were then incubated with Hybridization buffer (50% 2X hybridization 
solution (sigma H-7140), 50% formamide, 10 mg yeast tRNA, 0.1% of 10% Chaps, 0.05% 
Tween-20) for 1 hour at 65oC. Probes were diluted to 1 ng/μl in hybridization buffer and heated 
to 80oC for 5 minutes.  Retinas were incubated in probe solution in vials rotating on a nutator 
65oC overnight. Day 2: Retinas were washed with a mixture hybridization buffer and 2X SSC at 
the ratios 3:1, 1:1, 1:3 0:1 at 65oC 15 minutes per wash. Retinas were then incubated in 0.2X SSC 
at 65oC for one hour. Retinas were then washed in a mixture of 0.2X SSC and PBT at the ratios 
3:1, 1:1, 1:3, 0:1, at room temperature 5 minutes per wash. Peroxidases were quenched with 0.1% 
sodium azide and 0.3% hydrogen peroxide for 45 minutes. Retinas were washed with PBT (1X 
PBS, 1% Triton-X) and removed from nylon mesh into individual wells of a 48 well plate. 
Retinas were blocked with 1% Roche block in PBT for 1 hour then incubated with 1:300 Anti-
DIG-POD or Anti-FLU-POD 4oC overnight. Day 3: After antibody incubation retinas were 
washed with PBT then the antibody was detected with Cy3 or Cy5 tyramide diluted 1:100 in 
amplification buffer then washed in PBT.  
Immunohistochemistry 
Immunohistochemistry of optic nerve cryo-sections was carried out using the following 
general procedure. Optic nerves were dissected from MS222 euthanized X. laevis and fixed in 4% 
MEM-PFA at 4oC overnight then cryo-protected with 30% (w/v) sucrose in PBS at 4oC overnight. 
Optic nerves were then embedded in cryo-molds in O.C.T. and stored at -80oC. Cryo-sections 
were cut to 10-16 μm thickness and placed onto Tissue Tack slides and stored at -80oC. Day1: 
Slides were washed in PBS, washed with PBT (PBS, 0.1-0.3% Triton-X, 0.1% BSA), blocked in 
10% goat serum (NGS) then incubated with primary antibody diluted in PBT and 5% NGS at 4oC 
overnight. Day 2: Slides were washed in PBT, incubated with secondary antibody diluted in PBT 
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and 5% NGS at room temperature for 30 minutes, then washed with PBT and PBS.  Nuclei were 
labeled using 4’,6-diamidino-2-phenylindole (DAPI).  
The primary antibodies used were: Blbp (rabbit polyclonal, Abcam, 1:2000 or 1:500 if 
after in situ hybridization), Mbp [12] (rat monoclonal, Abcam, 1:300), Acetylated tubulin (mouse 
monoclonal, Abcam, 1:1500), Laminin (rabbit polyclonal, Fitzgerald, 1:200), pan Neurofascin 
NFC2 (rabbit polyclonal, gift of Peter Brophy, University of Edinburgh, 1:2500), GFP (chicken 
polyclonal, Aves, 1:1000), mCherry (mouse monoclonal, Clontech, 1:500), Cleaved Caspase-3 
(Asp175 rabbit polyclonal, Cell Signaling Technology, 1:300), the 3A10 epitope (mouse 
monoclonal, DSHB, 1:400), X. tropicalis Sncg (rabbit polyclonal, custom-made Covance, 
1:10,000).  IB4 lectin-FITC (Sigma-Aldrich, 1:200 of 1mg/ml solution) was used together with 
primary antibodies.  Secondary antibodies used were Alexa Fluor 488 goat-anti mouse IgG 
(Invitrogen), Alexa Fluor 647 goat-anti rabbit IgG, Cy3 goat-anti-rabbit IgG, Cy3 goat-anti rat 
IgG, and Cy5 goat anti-mouse (Jackson ImmunoResearch).  
Generation of X. tropicalis gamma synuclein antibody 
The Sncg antibody was generated through the company, Covance. A KHL conjugated 
peptide for the residues encoding the acidic C-terminus of X. tropicalis gamma synuclein, 
(CKK)-EATESTEQVGDGEN was generated and injected into 2 rabbits (#6395 and 6396), and 
the terminal bleed was affinity purified. The specificity of the antibody was confirmed using 
rabbit test bleeds for immunohistochemistry on wholemount retinas. Since #6396 was found to be 
more specific, this was the antibody used for all experiments using the Sncg antibody. 
 
RGC counts 
In situ hybridization for rbpms was performed on wholemount retinas from wild-type X. 
laevis at Stages 56, 58, 62 and animals expressing the Isl2: GFP-TRΔC transgene at Stage 56 and 
62. Retinas were imaged at 20X as a mosaic using an automated script in IPLab on a Zeiss 200M 
inverted microscope using the rbpms signal as the focal plane reference. The number of rbpms 
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expressing cells in each imaged retina was counted using an automated segmentation based script 
in IPLab.  
 
TUNEL assay 
Wholemount retinas from wild-type and X. laevis expressing the Isl2: GFP-TRΔC 
transgene at Stage 62 were assayed for Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) using the Apoptag Peroxidase In situ Apoptosis Detection Kit (Millipore). 
Retinas were washed in PBS, and then washed in PBT (PBS, 0.5% Triton-X). Day 1:  
Endogenous peroxidases were quenched with 0.1% Sodium azide 0.3% hydrogen peroxide for 45 
minutes, then washed in PBT. Retinas were transferred to individual wells of a 48-well plate and 
incubate with 100 μl Equilibration buffer per retina for 5 minutes then incubate in TdT (56 μl 
reaction buffer, 24 μl TdT enzyme per retina) for 2 hours at 37oC. Stop reaction with Stop wash 
buffer 40 minutes at 37oC, wash in PBT, block in 1% Blocking reagent (Roche), and incubate in 
1:300 Anti-DIG-POD antibody 4oC overnight. Day 2: Wash retinas in PBT, detect DIG-POD 
antibody with Cy3 tyramide (Perkin Elmer) and wash with PBT and PBS. Nuclei were then 
labeled with DAPI. Retinas were imaged as mosaics at 20X using an automated script in IPLab 
on a Zeiss 200M inverted microscope using the DAPI signal in the RGC layer as the focal 
reference. TUNEL positive RGCs were identified and manually counted based on the presence of 
TUNEL signal co-localizing with DAPI signal from the RGC layer.  
 
Internodal distance measurements 
Longitudinal optic nerve 16 μm cryo-sections from wild-type X. laevis at Stages 58, 62, 
66, and 4 weeks post-metamorphosis were immunolabeled with Neurofascin and 3A10. 
Longitudinal optic nerve 16 μm cryo-sections from transgenic X. laevis (Blbp: rtTA/TetOp: GFP-
TRΔC, Isl2: GFP-TRΔC, Mbp: rtTA/ TetOp: GFP-TRΔC, Blbp: rtTA control) at Stage 62, and 
wild-type X. laevis at Stage 54 with or without 20 nM T3 induction were immunolabeled with 
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Neurofascin, 3A10, and Mbp. All optic nerve sections (n= 3-4 per Stage/genotype) were imaged 
at 60X on a FV1000 (Olympus) laser scanning confocal microscope a using a 0.45 micron z step. 
Maximum intensity projections were imported into Imaris software and the distance between 
Neurofascin immunolabeled paranodes along individual axons was measured using the 
measurement points tool. Due to the high density of axons in optic nerves of the wild-type 4 
weeks post-metamorphic animals, accurate internodal distance measures could not be obtained.  
 
Axon degeneration quantification 
Axon markers that label preferentially myelinated axons were determined from confocal 
images of cross-sectional cryo-sections of wild-type X. laevis optic nerve at Stage 58 
immunolabeled with Mbp, 3A10 and Sncg, or Mbp, Acetylated tubulin and Sncg acquired at 60X 
magnification with a 0.45 μm z-step (FV1000, Olympus). The signal from each channel was 
automatically segmented in IPLab and co-localization between segmented channels was 
calculated using Pearson’s coefficient.  
Confocal images of optic nerve cross-sectional cryo-sections from wild-type 
metamorphic X. laevis at Stages 58, 62 and 66, immunolabeled with 3A10, Mbp, and cleaved-
caspase-3 were acquired at 60X magnification with a 0.45 μm z-step (FV1000, Olympus). The 
signal for each channel was segmented using IPLab software (Becton Dickinson). The total area 
for each segmented channel was measured. The area of degenerating myelinated axons was 
calculated by measuring the area of segmented cleaved-caspase-3 that overlapped with segmented 
MBP. Values were normalized to the total area of optic nerve cross-section measured.  
Longitudinal 10 μm thick optic nerve cryo-sections from transgenic lines (Blbp: rtTA/ 
TetOp: GFP-TRΔC, Isl2: GFP-TRΔC, Mbp: rtTA/TetOp: GFP-TRΔC) and their respective 
controls (Blbp: rtTA not induced with doxycycline, wild-type, Mbp: rtTA not induced with 
doxycycline) at Stage 62 were immunolabeled with cleaved-caspase-3 and Mbp. The entire 
length of each optic nerve (n= 5 per transgene) was imaged at 20X on a Zeiss 200M inverted 
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microscope as a mosaic and the amount of cleaved-caspase-3 signal was quantified using an 
automated segmentation based script in IPLab and normalized to total area measured.  
 
Microglia quantification 
Longitudinal 10 μm optic nerve cryo-sections immunolabeled with IB4 lectin-FITC, 
laminin, and DAPI, were imaged by fluorescence at 20X for wild-type X. laevis optic nerves at 
Stages 58, 62 and 66, three days following unilateral optic nerve transection in Stage 60 animals, 
and in the transgenic lines (Blbp: rtTA/TetOp: GFP-TRΔC, Isl2: GFP-TRΔC, Mbp: rtTA/TetOp: 
GFP-TRΔC, Blbp: Megf11ΔC-GFP, Blbp: Mfge8-D91E-mCherry, Blbp: rtTA/TetOp: GFP-
Rac1N17) along with their respective controls (Blbp: rtTA/TRΔC not induced, wild-type, Mbp: 
rtTA/TRΔC not induced, wild-type, Blbp: Mfge8-mCherry, Blbp: rtTA/Rac1N17 not induced).  
The optic nerves were imaged as mosaics, such that the entire length of the longitudinal optic 
nerve section was imaged.  The boundaries of the laminin-labeled optic nerve sheath were 
manually traced and IB4 lectin-FITC cells that co-localized with DAPI were traced and 
segmented.  The amount of segmented IB4 signal within the optic nerve parenchyma and optic 
nerve sheath were quantified using a multiple-segmentation script written in IPLab which 
analyzes fluorescence intensities over a wide range of segmentation values (Nguyen et al., 2011).  
The values were normalized to the amount of optic nerve parenchyma or sheath area measured. 
 
OPC and oligodendrocyte quantification 
Longitudinal 10 μm thick optic nerve cryo-sections from wild-type Stage 58, 62 and 66 
X. laevis and transgenic lines expressing Mbp: rtTA/TetOp: GFP-TRΔC or Blbp: rtTA/TetOp: 
GFP-TR∆C (along with control nerves from same line that had not been induced with 
doxycycline) were used for in situ hybridization. Riboprobes were used for pdgfrα (DIG) to 
identify OPCs and plp (FLU) to identify mature oligodendrocytes. For the wild-type study 16-20 
optic nerve images, corresponding to approximately four images per nerve (averaged during 
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quantification) were captured at 20X magnification on Zeiss 200M inverted microscope. For the 
Mbp and Blbp studies, four consecutive images were captured per optic nerve, which were 
averaged following quantification. Pdgfrα and plp expressing cells were manually traced based 
on co-localization with nuclear marker DAPI and counted using an automated script in IPLab.  
 
Mbp/Sncg debris quantification 
Confocal images of Mbp, Sncg and 3A10 immunolabeled optic nerve longitudinal 16 μm 
thick cryo-sections taken at 20X magnification with a 1 μm z-step (FV1000, Olympus) were 
imported into Imaris software (Bitplane).The immunohistochemistry used a PBT buffer with 
0.3% Triton-X. In Imaris, a surface of the 3A10 channel was created at 50% of threshold 
intensity. This surface was used to mask the Mbp and Sncg channels channel. An outside mask 
produced a channels of Mbp or Sncg co-localizing with 3A10 and an inside mask produced a 
channels of MBP or Sncg that did not co-localize with 3A10. Surfaces were created from the new 
Mbp channels using a threshold of 550 and filter of 550 and from the new Sncg channels using a 
threshold of 650 and filter of 650. Ratios of the volume of MBP outside of axons to total volume 
of MBP were calculated using Excel software.  
 
Thyroid hormone receptor dominant negative validation  
Fluorescence microscope images of retinas or longitudinal 10 μm thick optic nerve cryo-
sections from Stage 54 wild-type or TR∆C transgenic lines (Blbp: rtTA/TetOp: GFP-TRΔC, Isl2: 
GFP-TRΔC, Mbp: rtTA/ TetOp: GFP-TRΔC) after treatment with T3 were taken at 20X 
magnification on a Zeiss 200M inverted microscope following double fluorescence in situ 
hybridization. Retinas were labeled by riboprobes for gene 12 (DIG) and the RGC marker rbpms 
(FLU), while optic nerves were labeled by riboprobes for gene 12 (DIG) and the oligodendrocyte 
marker plp (FLU) or OPC marker pdgfrα (FLU). The entire retinas and optic nerve sections were 
imaged by creating mosaics. For retinas, three consecutive sections were imaged per retina and 
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averaged following quantification to overcome inconsistencies of tyramide labeling between 
sections.  Retina images were then quantified using a multiple-segmentation based script written 
in IPLab, using the rbpms signal to create a mask to distinguish the up-regulation of gene 12 
inside and outside RGC. Optic nerves were quantified using the same multiple-segmentation 
based script but used the quantified the overall level of gene 12 signal in the nerve, normalized to 
area.   
 
Phagocytic gene expression 
In situ hybridization using the DIG-dUTP labeled riboprobes for the Xenopus genes: 
abca, crkII, dock1, elmo1, gulp, lrp1, itgβ3, itgβ5, megf10, megf11, mfge8, rac1 was performed 
on 10 μm thick longitudinal optic nerve cryo-sections from wild-type and Blbp: rtTA/TetOp: 
GFP-TR∆C Stage 62 X. laevis. On Day1 of the in situ hybridization procedure the slides were 
treated with 10 μg/mL Proteinase K for 2 minutes. Following the in situ hybridization procedure, 
immunohistochemistry for Blbp was performed on the slides. Optic nerve sections were imaged 
at 20X magnification on a Zeiss 200M inverted microscope.  
 
Transgenic fluorescent reporters in astrocytes 
Fluorescence microscopy images of cross-sectional cryo-sections from Blbp:Mfge8-
mCherry, Blbp:Mfge8D91E-mCherry, Blbp:CD63-mCherry, or Blbp: hA-AMB-mCherry  
animals at Stages 58, 62, and 66 immunolabeled with mCherry and Blbp antibodies were 
acquired at 20X magnification on a Zeiss 200M inverted microscope.  The area of mCherry signal 
in the images was quantified using a multiple-segmentation script in IPLab. Values were 
normalized to the total area of optic nerve measured.  The values graphed are for the 
segmentation value that most closely approximates the mean difference of all segmentation 




Electron microscopy and image tracing 
Optic nerves were dissected in fixative (2% paraformaldehyde, 2.5% glutaraldehyde, 
3mM CaCl2, 0.15 M Sodium cacodylate), post-fixed 4oC overnight, and processed for SBEM. 
Washes were carried out in small glass vials. Optic nerves were kept attached throughout 
processing in order to maintain orientation and separated from the eye for embedding. Optic 
nerves were washed in 0.1M Sodium cacodylate on ice then fixed in 2% Osmium tetroxide, 1.5% 
Potassium ferrocyanide for 1 hour at room temperature. Tissue was washed distilled water 
(ddH2O) then incubated with filtered 1% Thiocarbohydrazide for 20 minutes, washed in ddH2O, 
fixed with 2% Osmium tetroxide 30 minutes, and washed in ddH2O.  They were incubated in 1% 
Uranyl acetate 4oC overnight. Tissues were washed with ddH2O, incubated with filtered Lead 
aspartate (0.66g Lead nitrate in 10 mL L-Aspartic acid (0.998 g L-aspartic acid in 250 mL ddH2O 
pH 3.8) pH 5.5) at 60oC 30 minutes, and washed with ddH2O. Tissue was dehydrated with a 
series of ethanol washes: 50%, 70%, 90%, 100%, and 100% ethanol on ice. Tissues was washed 
with 100% acetone and infiltrated with Durcupan resin (Sigma) using diluted in acetone at 25%, 
50%, 75%, 100%. Tissue in 100% Durcupan resin was placed under vacuum prior to embedding 
in molds and baking 60oC.    
For the initial characterization of metamorphic changes, the ONs from six wild-type X. 
laevis each at NF Stages 58, 62, 66, and 4 weeks post-metamorphosis were processed.  For the 
transgenic perturbation studies, four animals each at Stage 62 and Stg. 66 for each of the 
transgenic lines, including the two transgenic controls (Blbp: gap43-mCherry and Isl2: hA-AMB-
mCherry) were processed for TEM. The lengths of the ONs were measured at the time of 
dissection. One optic nerve of the wild-type animals for each of Stages 58, 62, 66 and 4 weeks 
post-metamorphosis was sectioned in a longitudinal orientation and processed by SBEM.  All 
other optic nerves were sectioned in a cross-sectional orientation.   
Optic nerve cross-sectional area was measured in 1 µm semi-thin cross-sections.  For 
TEM, 60-90 nm cross-sections were placed on formvar-coated copper grids, and imaged at 
151 
 
5000X magnification with a H7600 transmission electron microscope (Hitachi); each optic nerve 
was imaged as ten generally non-overlapping images spanning all areas of the optic nerve. For 
SBEM imaging, samples were imaged on an FEI Quanta 200 (Stage 62), Zeiss Sigma (Stages 58 
and 66) or Zeiss Merlin (juvenile frog) SEM equipped with a Gatan 3View unit. Microtome slices 
were 70 nm thick. Images were aligned by cross-correlation using IMOD (Kremer et al., 1996) 
prior to segmentation.  
Manual tracing of the axoplasm, outer myelin sheath and focal peri-axonal space 
enlargements per myelinated axon as well as the debris myelin was carried out for ten 
micrographs per optic nerve in a blinded-fashion, and images were quantified using IPLab 
(Becton Dickinson) custom scripts. Debris myelin was subsequently sub-classified as being 
partially attached to the sheath, enwrapped by lamellar processes, fully within a phagocyte, or a 
transition between classes. To extrapolate myelin inner diameter for the calculation of G’-ratios, 
the areas of the axoplasm and peri-axonal spaces were subtracted from the area bounded by the 
myelin sheath for each axon. For the measurements of myelin area, myelin was automatically 
segmented based on it being the most-electron dense structure in the micrographs, using the mean 
and standard deviation of the manually traced myelin segments to automatically tailor the 
segmentation cut-offs to different micrographs. 
Optic nerve volumes obtained from 3View SBEM processing were imported into IMOD. 
Individual myelinated axons were selected for tracing by the presence of nodes, except in the case 
of Stage 58 optic nerves, where the internodal distance exceeded the dimensions of the volume, 
and manually traced. Surface areas and volumes of traced objects (axoplasm, peri-axonal space 
vacuoles, and outer myelin membrane) were calculated in IMOD.  Internodal distance 
measurements were obtained by importing IMOD traced model files into Imaris (Bitplane) 
followed by use of the Measurement Points tool.  
 
Statistical Analysis  
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Statistical analysis involved the comparison of means using t-tests or single variable 
ANOVAs using Graphpad (Graphpad software) and Brightstat (Stricker, 2008). With the 
exception of the transgenic TEM analysis, pairwise comparisons were performed using Tukey’s 
test when variance between the groups was equal or the Games-Howell test when variance was 
unequal, as determined by the Bartlett’s test for equal variance. The pairwise comparisons 
between the control transgenic and experimental transgenic lines for the transgenic TEM analysis 
were performed using the Dunnett’s test when variance was equal or the Games-Howell test when 
variance was unequal. The control transgenic group consisted of optic nerves obtained from 2 
lines of transgenic animals expressing red fluorescent reporter genes (Blbp: ctgap43-mCherry and 
Isl2: hA-AMB-mCherry). All statistical comparisons were performed using all of the transgenic 
lines, although only the statistically significant comparisons against the control group are shown.  
Since Stages 62 and 66 differed in many parameters in wild-type animals, analyses of transgenic 
animals was separated by stage, such that all of the optic nerves from experimental Stage 62 
transgenic animals were compared to the Stage 62 transgenic controls, and all of the optic nerves 
from experimental Stage 66 transgenic animals were compared to the Stage 66 transgenic 
controls. Since the internodal distances calculated in the Stage 58 SBEM traced axons were not 
actual values but rather minimum values due to the size of the Stage 58 acquired volume, the non-
parametric Kruskal-Wallis test was used to compare segment SBEM-based segment lengths in 
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